Hemophilia RM Emails

esperoct-novoeight Emails
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • esperoct-wwh-advocacy  
  • esperoct-wwh-advocacy.html
  • US25ESP00043   August 2025
  • Last updated: 2025-11-12 20:47:40

  • Version: 14

Subject Line
  • 1) Tammy also lives with hemophilia A

  • 2) 👋 Have you met Tammy?

  • 3) 🩸❤ Women with hemophilia A deserve better

  • 4) Too often, women with hemophilia A are ignored

Preheader
  • 1) Her story will inspire you.
  • 2) She’s on a mission for women with hemophilia A.
  • 3) Meet a community advocate making a difference.
  • 4) It’s time to fight back.
View / Download

Handoff: August 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=tammystory&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • esperoct-wwh-efficacy  
  • esperoct-wwh-efficacy.html
  • US25ESP00044   August 2025
  • Last updated: 2025-12-04 23:37:02

  • Version: 15

Subject Line
  • 1) Women living with hem A have a LOT going on

  • 2) Busy women need effective bleed protection

  • 3) 💨 Women are always on the go…

  • 4) Bleed protection that keeps up with women 🏃

Preheader
  • 1) You do you. We do bleed protection.
  • 2) Priorities? In order. 💅
  • 3) Your bleed protection should be too.
  • 4) Hem A treatment at the pace of your life.
View / Download

Handoff: August 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=womenwhemophilia&utm_id=<%= message.delivery.deliverycode %>
mim8 Emails
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-still-happen-h4h-2026   (Version for H4H)
  • mim8-patient-bleeds-still-happen-h4h-2026.html
  • US25HRBD00119   September 2025
  • Last updated: 2026-01-13 17:56:04

  • Version: 1

Subject Line
  • A) Are you anxious about bleed protection?

  • B) Does your prophy treatment give you adequate bleed protection?

  • C) Still experiencing breakthrough bleeds?🩸

  • D) Despite how far we've come, breakthrough bleeds remain

  • E) Make sure you’re reporting ALL your bleeds ✅

  • F) Does your provider know about your Hem A management concerns? 🩺

Preheader
  • A) It may be time to speak with your doctor about your hemophilia management.
  • B) Speak with your doctor about your concerns.
  • C) Many people who live with hemophilia A do too—and it may be time to speak your truth about them with your doctor.
  • D) Is it time to speak your truth about challenges to your Hem A management experience?
  • E) Whenever you have a bleed, it’s important to record it—and speak up about it.
  • F) Speaking up could make a difference.
View / Download

Handoff: Jan 13, 2026

(Version for H4H)

view | download
Tracking
  • (GA) ?utm_campaign=DSA+Hemophilia+A&utm_medium=email&utm_source=H4H&utm_content=breakthroughbleeds&utm_id=nmtDC00008349
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-admin-H4H   (Version with Signup)
  • mim8-patient-bleeds-admin-H4H.html
  • US25HRBD00121   September 2025
  • Last updated: 2025-11-25 22:03:12

  • Version: 2

Subject Line
  • A) Speak up about your treatment burden 🗣️

  • B) Making trade-offs with your hemophilia A management?

  • C) Talk to your doctor about your Hem A management 🩸

  • D) Frequent infusions? Painful injections? Limiting activities? 💉

  • E) Are you satisfied with your current Hem A management?

Preheader
  • A) It may be time to speak with your doctor about managing challenges with hemophilia A.
  • B) Learn to self-advocate about your hemophilia A management when speaking with your doctor.
  • C) During your next visit, speak your truth about challenges you might be experiencing.
  • D) Compromising on bleed protection or ease of administration? Talk to your doctor about your Hem A management.
  • E) It might be time to speak your truth to your healthcare provider.
View / Download

Handoff: September 18, 2025

(Version with Signup)

view
Tracking
  • (GA) ?utm_campaign=Hemophilia+A&utm_medium=email&utm_source=H4H&utm_content=bleedsadmin&utm_id=nmtDC00008300
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-still-happen-ches   (Version for CHES)
  • mim8-patient-bleeds-still-happen-ches.html
  • US25HRBD00119   September 2025
  • Last updated: 2025-11-04 23:14:20

  • Version: 1

Subject Line
  • A) Are you anxious about bleed protection?

  • B) Does your prophy treatment give you adequate bleed protection?

  • C) Still experiencing breakthrough bleeds?🩸

  • D) Despite how far we've come, breakthrough bleeds remain

  • E) Make sure you’re reporting ALL your bleeds ✅

  • F) Does your provider know about your Hem A management concerns? 🩺

Preheader
  • A) It may be time to speak with your doctor about your hemophilia management.
  • B) Speak with your doctor about your concerns.
  • C) Many people who live with hemophilia A do too—and it may be time to speak your truth about them with your doctor.
  • D) Is it time to speak your truth about challenges to your Hem A management experience?
  • E) Whenever you have a bleed, it’s important to record it—and speak up about it.
  • F) Speaking up could make a difference.
View / Download

Handoff: September 18, 2025

(Version for CHES)

view | download
Tracking
  • (GA) ?utm_campaign=DSA+Hemophilia+A&utm_medium=email&utm_source=CEFD&utm_content=breakthroughbleeds&utm_id=nmtDC00008116
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-admin-la-kelley   (Version with Signup)
  • mim8-patient-bleeds-admin-la-kelley.html
  • US25HRBD00121   September 2025
  • Last updated: 2025-10-14 17:58:21

  • Version: 5

Subject Line
  • A) Speak up about your treatment burden 🗣️

  • B) Making trade-offs with your hemophilia A management?

  • C) Talk to your doctor about your Hem A management 🩸

  • D) Frequent infusions? Painful injections? Limiting activities? 💉

  • E) Are you satisfied with your current Hem A management?

Preheader
  • A) It may be time to speak with your doctor about managing challenges with hemophilia A.
  • B) Learn to self-advocate about your hemophilia A management when speaking with your doctor.
  • C) During your next visit, speak your truth about challenges you might be experiencing.
  • D) Compromising on bleed protection or ease of administration? Talk to your doctor about your Hem A management.
  • E) It might be time to speak your truth to your healthcare provider.
View / Download

Handoff: September 18, 2025

(Version with Signup)

view | download
Tracking
  • (GA) ?utm_campaign=Hemophilia+A&utm_medium=email&utm_source=LA&utm_content=bleedsadmin&utm_id=nmtDC00007966
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-admin-burden-H4H   (Version with Signup)
  • mim8-patient-admin-burden-H4H.html
  • US25HRBD00120   September 2025
  • Last updated: 2025-10-06 22:27:51

  • Version: 3

Subject Line
  • A) Overloaded with hemophilia A management burdens? 😖

  • B) Don’t compromise on ease of administration

  • C) Are you making trade-offs with your Hem A treatment? ⚖️

  • D) Injection site pain? High injection volumes? Multiple steps?

Preheader
  • A) Speaking your truth to your doctor could lighten your load.
  • B) If your hemophilia A management isn’t working for you, maybe it’s time to speak to your doctor.
  • C) You shouldn’t have to give up ease of administration for bleed protection. Learn more.
  • D) Speak to your doctor about your Hem A treatment burdens.
View / Download

Handoff: September 23, 2025

(Version with Signup)

view | download
Tracking
  • (GA) ?utm_campaign=Hemophilia+A&utm_medium=email&utm_source=H4H&utm_content=adminchallenges&utm_id=nmtDC00007965
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-admin-burden   (Version with Signup)
  • mim8-patient-admin-burden.html
  • US25HRBD00120   September 2025
  • Last updated: 2025-09-23 19:23:55

  • Version: 4

Subject Line
  • A) Overloaded with hemophilia A management burdens? 😖

  • B) Don’t compromise on ease of administration

  • C) Are you making trade-offs with your Hem A treatment? ⚖️

  • D) Injection site pain? High injection volumes? Multiple steps?

Preheader
  • A) Speaking your truth to your doctor could lighten your load.
  • B) If your hemophilia A management isn’t working for you, maybe it’s time to speak to your doctor.
  • C) You shouldn’t have to give up ease of administration for bleed protection. Learn more.
  • D) Speak to your doctor about your Hem A treatment burdens.
View / Download

Handoff: September 23, 2025

(Version with Signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=adminchallenges&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-admin-burden-no-signup   (Version without Signup)
  • mim8-patient-admin-burden-no-signup.html
  • US25HRBD00120   September 2025
  • Last updated: 2025-09-23 19:09:12

  • Version: 6

Subject Line
  • A) Overloaded with hemophilia A management burdens? 😖

  • B) Don’t compromise on ease of administration

  • C) Are you making trade-offs with your Hem A treatment? ⚖️

  • D) Injection site pain? High injection volumes? Multiple steps?

Preheader
  • A) Speaking your truth to your doctor could lighten your load.
  • B) If your hemophilia A management isn’t working for you, maybe it’s time to speak to your doctor.
  • C) You shouldn’t have to give up ease of administration for bleed protection. Learn more.
  • D) Speak to your doctor about your Hem A treatment burdens.
View / Download

Handoff: September 23, 2025

(Version without Signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=adminchallenges&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-still-happen-h4h   (Version for H4H)
  • mim8-patient-bleeds-still-happen-h4h.html
  • US25HRBD00119   September 2025
  • Last updated: 2025-09-18 16:50:26

  • Version: 1

Subject Line
  • A) Are you anxious about bleed protection?

  • B) Does your prophy treatment give you adequate bleed protection?

  • C) Still experiencing breakthrough bleeds?🩸

  • D) Despite how far we've come, breakthrough bleeds remain

  • E) Make sure you’re reporting ALL your bleeds ✅

  • F) Does your provider know about your Hem A management concerns? 🩺

Preheader
  • A) It may be time to speak with your doctor about your hemophilia management.
  • B) Speak with your doctor about your concerns.
  • C) Many people who live with hemophilia A do too—and it may be time to speak your truth about them with your doctor.
  • D) Is it time to speak your truth about challenges to your Hem A management experience?
  • E) Whenever you have a bleed, it’s important to record it—and speak up about it.
  • F) Speaking up could make a difference.
View / Download

Handoff: September 18, 2025

(Version for H4H)

view | download
Tracking
  • (GA) ?utm_campaign=DSA+Hemophilia+A&utm_medium=email&utm_source=H4H&utm_content=breakthroughbleeds&utm_id=nmtDC00007870
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-admin-ches   (Version for CHES)
  • mim8-patient-bleeds-admin-ches.html
  • US25HRBD00121   September 2025
  • Last updated: 2025-09-18 16:50:52

  • Version: 2

Subject Line
  • A) Speak up about your treatment burden 🗣️

  • B) Making trade-offs with your hemophilia A management?

  • C) Talk to your doctor about your Hem A management 🩸

  • D) Frequent infusions? Painful injections? Limiting activities? 💉

  • E) Are you satisfied with your current Hem A management?

Preheader
  • A) It may be time to speak with your doctor about managing challenges with hemophilia A.
  • B) Learn to self-advocate about your hemophilia A management when speaking with your doctor.
  • C) During your next visit, speak your truth about challenges you might be experiencing.
  • D) Compromising on bleed protection or ease of administration? Talk to your doctor about your Hem A management.
  • E) It might be time to speak your truth to your healthcare provider.
View / Download

Handoff: September 18, 2025

(Version for CHES)

view | download
Tracking
  • (GA) ?utm_campaign=DSA+Hemophilia+A&utm_medium=email&utm_source=CEFD&utm_content=bleedsadmin&utm_id=nmtDC00007869
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-still-happen   (Version with Signup)
  • mim8-patient-bleeds-still-happen.html
  • US25HRBD00119   September 2025
  • Last updated: 2025-09-18 13:26:05

  • Version: 5

Subject Line
  • A) Are you anxious about bleed protection?

  • B) Does your prophy treatment give you adequate bleed protection?

  • C) Still experiencing breakthrough bleeds?🩸

  • D) Despite how far we've come, breakthrough bleeds remain

  • E) Make sure you’re reporting ALL your bleeds ✅

  • F) Does your provider know about your Hem A management concerns? 🩺

Preheader
  • A) It may be time to speak with your doctor about your hemophilia management.
  • B) Speak with your doctor about your concerns.
  • C) Many people who live with hemophilia A do too—and it may be time to speak your truth about them with your doctor.
  • D) Is it time to speak your truth about challenges to your Hem A management experience?
  • E) Whenever you have a bleed, it’s important to record it—and speak up about it.
  • F) Speaking up could make a difference.
View / Download

Handoff: September 18, 2025

(Version with Signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=bleedsstillhappen&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-still-happen-no-signup   (Version without Signup)
  • mim8-patient-bleeds-still-happen-no-signup.html
  • US25HRBD00119   September 2025
  • Last updated: 2025-09-18 13:58:27

  • Version: 6

Subject Line
  • A) Are you anxious about bleed protection?

  • B) Does your prophy treatment give you adequate bleed protection?

  • C) Still experiencing breakthrough bleeds?🩸

  • D) Despite how far we've come, breakthrough bleeds remain

  • E) Make sure you’re reporting ALL your bleeds ✅

  • F) Does your provider know about your Hem A management concerns? 🩺

Preheader
  • A) It may be time to speak with your doctor about your hemophilia management.
  • B) Speak with your doctor about your concerns.
  • C) Many people who live with hemophilia A do too—and it may be time to speak your truth about them with your doctor.
  • D) Is it time to speak your truth about challenges to your Hem A management experience?
  • E) Whenever you have a bleed, it’s important to record it—and speak up about it.
  • F) Speaking up could make a difference.
View / Download

Handoff: September 18, 2025

(Version without Signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=bleedsstillhappen&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-admin   (Version with Signup)
  • mim8-patient-bleeds-admin.html
  • US25HRBD00121   September 2025
  • Last updated: 2025-09-18 14:06:31

  • Version: 5

Subject Line
  • A) Speak up about your treatment burden 🗣️

  • B) Making trade-offs with your hemophilia A management?

  • C) Talk to your doctor about your Hem A management 🩸

  • D) Frequent infusions? Painful injections? Limiting activities? 💉

  • E) Are you satisfied with your current Hem A management?

Preheader
  • A) It may be time to speak with your doctor about managing challenges with hemophilia A.
  • B) Learn to self-advocate about your hemophilia A management when speaking with your doctor.
  • C) During your next visit, speak your truth about challenges you might be experiencing.
  • D) Compromising on bleed protection or ease of administration? Talk to your doctor about your Hem A management.
  • E) It might be time to speak your truth to your healthcare provider.
View / Download

Handoff: September 18, 2025

(Version with Signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=bleedsadmin&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-bleeds-admin-no-signup   (Version with Signup)
  • mim8-patient-bleeds-admin-no-signup.html
  • US25HRBD00121   September 2025
  • Last updated: 2025-09-18 14:09:44

  • Version: 6

Subject Line
  • A) Speak up about your treatment burden 🗣️

  • B) Making trade-offs with your hemophilia A management?

  • C) Talk to your doctor about your Hem A management 🩸

  • D) Frequent infusions? Painful injections? Limiting activities? 💉

  • E) Are you satisfied with your current Hem A management?

Preheader
  • A) It may be time to speak with your doctor about managing challenges with hemophilia A.
  • B) Learn to self-advocate about your hemophilia A management when speaking with your doctor.
  • C) During your next visit, speak your truth about challenges you might be experiencing.
  • D) Compromising on bleed protection or ease of administration? Talk to your doctor about your Hem A management.
  • E) It might be time to speak your truth to your healthcare provider.
View / Download

Handoff: September 18, 2025

(Version with Signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=bleedsadmin&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-self-advocacy   (Version with Sign Up block)
  • mim8-patient-self-advocacy.html
  • US25HRBD00122   September 2025
  • Last updated: 2025-09-17 13:15:25

  • Version: 3

Subject Line
  • A) Is your doctor aware of your Hem A treatment concerns? 🩺

  • B) Need to talk about your Hem A treatment? 📣

  • C) “I wish my Hem A treatment required fewer trade-offs.” ⚖️

  • D) How are you managing your Hem A treatment trade-offs?

Preheader
  • A) Make discussions easier with this simple self-advocacy guide.
  • B) Speaking up about your challenges could result in change. This guide can help you speak to your doctor.
  • C) Sound familiar? Use this helpful discussion guide at your next appointment.
  • D) If your treatment isn’t working for you, this simple guide can help you speak with your provider.
View / Download

Handoff: September 17, 2025

(Version with Sign Up block)

view | download
Tracking
  • (GA) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=tradeoffs&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-self-advocacy-no-signup   (Version without Sign Up block)
  • mim8-patient-self-advocacy-no-signup.html
  • US25HRBD00122   September 2025
  • Last updated: 2025-09-17 13:15:25

  • Version: 3

Subject Line
  • A) Is your doctor aware of your Hem A treatment concerns? 🩺

  • B) Need to talk about your Hem A treatment? 📣

  • C) “I wish my Hem A treatment required fewer trade-offs.” ⚖️

  • D) How are you managing your Hem A treatment trade-offs?

Preheader
  • A) Make discussions easier with this simple self-advocacy guide.
  • B) Speaking up about your challenges could result in change. This guide can help you speak to your doctor.
  • C) Sound familiar? Use this helpful discussion guide at your next appointment.
  • D) If your treatment isn’t working for you, this simple guide can help you speak with your provider.
View / Download

Handoff: September 17, 2025

(Version without Sign Up block)

view | download
Tracking
  • (GA) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=tradeoffs&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-efficacy-h4h   (Newer version for Hope for Hemophilia with updated GA tagging)
  • mim8-patient-efficacy-h4h.html
  • US24HRBD00099   March 2025
  • Last updated: 2025-07-21 21:28:25

  • Version: 11

Subject Line
  • A1 Are you reporting all of your hemophilia bleeds? 📋

  • A2 Every bleed matters - Speak up if you are having any hemophilia bleeds 📢

  • A3 Are you worried about bleed protection?

  • A4 Are hemophilia bleeds holding you back? 🤔

Preheader
  • A1 Speak your truth if you are having breakthrough bleeds with your current hemophilia A therapy
  • A2 If you have hemophilia A, are you sharing all your bleeds with your doctor?
  • A3 Breakthrough bleeds still remain and if untreated can cause long-term joint damage.
  • A4 Open up about any trade-offs you may be making so your care team can meet your needs
View / Download

Handoff: July 21, 2025

(Newer version for Hope for Hemophilia with updated GA tagging)

view | download
Tracking
  • (GA) ?utm_campaign=Hemophilia+A&utm_medium=email&utm_source=H4H&utm_content=bleedprotection&utm_id=nmtDC00007458
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-hcp-uncover-their-truth   (Version with Signup)
  • mim8-hcp-uncover-their-truth.html
  • US25HRBD00115   July 2025
  • Last updated: 2025-08-07 7:45:01

  • Version: 9

Subject Line
  • A1 💉🩸 Satisfied with current hemophilia A prophylaxis?

  • B1 Are your hem A patients making treatment tradeoffs⁉️

  • C1 ⚠️ Are current prophylaxis options falling short?

Preheader
  • A1 See what other physicians had to say.
  • B1 Find out by asking the right questions.
  • C1 Explore trade-offs in current hemophilia A management.
View / Download

Handoff: August 07, 2025

(Version with Signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=Shared+Decisionmaking_US25HRBD00115&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-hcp-uncover-their-truth-no-sign-up   (Version without signup)
  • mim8-hcp-uncover-their-truth-no-sign-up.html
  • US25HRBD00115   July 2025
  • Last updated: 2025-08-07 7:30:06

  • Version: 10

Subject Line
  • A1 💉🩸 Satisfied with current hemophilia A prophylaxis?

  • B1 Are your hem A patients making treatment tradeoffs⁉️

  • C1 ⚠️ Are current prophylaxis options falling short?

Preheader
  • A1 See what other physicians had to say.
  • B1 Find out by asking the right questions.
  • C1 Explore trade-offs in current hemophilia A management.
View / Download

Handoff: August 7, 2025

(Version without signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=Shared+Decisionmaking_US25HRBD00115&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-hcp-addressing-tradeoffs   (Version with Signup)
  • mim8-hcp-addressing-tradeoffs.html
  • US25HRBD00116   July 2025
  • Last updated: 2025-08-07 7:29:40

  • Version: 6

Subject Line
  • A1 Could evolving treatment strategies make a difference for your patients?

  • B1 Is near-normal hemostasis possible?

  • C1 What’s next in hemophilia A treatment?

  • D1 How are researchers exploring mimetic optimization?

Preheader
  • A1 Learn more about hemophilia A treatment research.
  • B1 Check out ongoing research in hemophilia A.
  • C1 Learn how researchers are addressing unspoken treatment compromises.
  • D1 Find out what it could mean for hemophilia A.
View / Download

Handoff: August 7, 2025

(Version with Signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=Unspoken+Tradeoffs_US25HRBD00116&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-hcp-addressing-tradeoffs-no-sign-up   (Version without Signup)
  • mim8-hcp-addressing-tradeoffs-no-sign-up.html
  • US25HRBD00116   July 2025
  • Last updated: 2025-08-07 7:55:08

  • Version: 7

Subject Line
  • A1 Could evolving treatment strategies make a difference for your patients?

  • B1 Is near-normal hemostasis possible?

  • C1 What’s next in hemophilia A treatment?

  • D1 How are researchers exploring mimetic optimization?

Preheader
  • A1 Learn more about hemophilia A treatment research.
  • B1 Check out ongoing research in hemophilia A.
  • C1 Learn how researchers are addressing unspoken treatment compromises.
  • D1 Find out what it could mean for hemophilia A.
View / Download

Handoff: August 7, 2025

(Version without Signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=Unspoken+Tradeoffs_US25HRBD00116&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-efficacy-ches   (Added Preheader Variable Token)
  • mim8-patient-efficacy-ches.html
  • US24HRBD00099   March 2025
  • Last updated: 2025-06-25 19:39:28

  • Version: 2

Subject Line
  • A1 Are you reporting all of your hemophilia bleeds? 📋

  • A2 Every bleed matters - Speak up if you are having any hemophilia bleeds 📢

  • A3 Are you worried about bleed protection?

  • A4 Are hemophilia bleeds holding you back? 🤔

Preheader
  • A1 Speak your truth if you are having breakthrough bleeds with your current hemophilia A therapy
  • A2 If you have hemophilia A, are you sharing all your bleeds with your doctor?
  • A3 Breakthrough bleeds still remain and if untreated can cause long-term joint damage.
  • A4 Open up about any trade-offs you may be making so your care team can meet your needs
View / Download

Handoff: April 30, 2025

(Added Preheader Variable Token)

view | download
Tracking
  • (GA) ?utm_campaign=Hemophilia+A&utm_medium=email&utm_source=CEFD&utm_content=bleedprotection&utm_id=nmtDC00007177
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-administration-h4h   (Added h4h Channel Partner handoff)
  • mim8-patient-administration-h4h.html
  • US24HRBD00100   March 2025
  • Last updated: 2025-06-25 19:40:38

  • Version: 2

Subject Line
  • A1 Are you making compromises with your hemophilia treatment? ⚖️

  • A2 Injection pain, large volume doses... Speak up about hemophilia treatment concerns

  • A3 Do you have administration challenges with your hemophilia treatment? 📣

  • A4 Are you trading off ease of administration for bleed protection? 🤔

Preheader
  • A1 You may be putting up with large needles or pain when injecting in order to achieve bleed protection
  • A2 Discuss the difficulties with your doctor so they can better support you in your management
  • A3 Share them with your health care team–you shouldn’t have to make compromises when it comes to managing your hemophilia
  • A4 Talk to your health care team–your voice matters in your hemophilia A management plan
View / Download

Handoff: June 16, 2025

(Added Preheader Variable Token)

view | download
Tracking
  • (GA) ?utm_campaign=Hemophilia+A&utm_medium=email&utm_source=LA&utm_content=administration&utm_id=nmtDC00006788
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-hcp-bleed-protection-no-signup   (Version without signup)
  • mim8-hcp-bleed-protection-no-signup.html
  • US24HRBD00097   April 2025
  • Last updated: 2025-05-22 17:21:48

  • Version: 7

Subject Line
  • A1 Are your patients speaking up about all hemophilia bleeds?

  • A2 Are bleeds in hemophilia going unreported?

Preheader
  • A1 Learn how bleeds are still happening in hemophilia A.
  • A2 See data on prevalence of bleed despite current management options in hemophilia A
View / Download

Handoff: May 22, 2025

(Version without signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=EfficacyChallenges&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-hcp-admin-burden-no-signup   (Version without signup)
  • mim8-hcp-admin-burden-no-signup.html
  • US24HRBD00098   April 2025
  • Last updated: 2025-05-22 17:16:39

  • Version: 8

Subject Line
  • A1 Are there unspoken trade-offs that patients face when managing hemophilia A?

  • A2 Are patients with hemophilia A facing administration challenges?

Preheader
  • A1 Uncover the compromises patients may be making
  • A2 Explore data on challenges with their current management of hemophilia A
View / Download

Handoff: May 22, 2025

(Version without signup)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=AdministrationBurden&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-hcp-bleed-protection   (Added Preheader Variable Token)
  • mim8-hcp-bleed-protection.html
  • US24HRBD00097   April 2025
  • Last updated: 2025-04-28 22:29:32

  • Version: 5

Subject Line
  • A1 Are your patients speaking up about all hemophilia bleeds?

  • A2 Are bleeds in hemophilia going unreported?

Preheader
  • A1 Learn how bleeds are still happening in hemophilia A.
  • A2 See data on prevalence of bleed despite current management options in hemophilia A
View / Download

Handoff: April 28, 2025

(Added Preheader Variable Token)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=EfficacyChallenges&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-hcp-admin-burden   (Added Preheader Variable Token)
  • mim8-hcp-admin-burden.html
  • US24HRBD00098   April 2025
  • Last updated: 2025-04-28 22:18:32

  • Version: 6

Subject Line
  • A1 Are there unspoken trade-offs that patients face when managing hemophilia A?

  • A2 Are patients with hemophilia A facing administration challenges?

Preheader
  • A1 Uncover the compromises patients may be making
  • A2 Explore data on challenges with their current management of hemophilia A
View / Download

Handoff: April 28, 2025

(Added Preheader Variable Token)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=AdministrationBurden&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-administration   (Added Preheader Variable Token)
  • mim8-patient-administration.html
  • US24HRBD00100   March 2025
  • Last updated: 2025-04-30 17:38:39

  • Version: 8

Subject Line
  • A1 Are you making compromises with your hemophilia treatment? ⚖️

  • A2 Injection pain, large volume doses... Speak up about hemophilia treatment concerns

  • A3 Do you have administration challenges with your hemophilia treatment? 📣

  • A4 Are you trading off ease of administration for bleed protection? 🤔

Preheader
  • A1 You may be putting up with large needles or pain when injecting in order to achieve bleed protection
  • A2 Discuss the difficulties with your doctor so they can better support you in your management
  • A3 Share them with your health care team–you shouldn’t have to make compromises when it comes to managing your hemophilia
  • A4 Talk to your health care team–your voice matters in your hemophilia A management plan
View / Download

Handoff: April 30, 2025

(Added Preheader Variable Token)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=administration&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-efficacy   (Added Preheader Variable Token)
  • mim8-patient-efficacy.html
  • US24HRBD00099   March 2025
  • Last updated: 2025-04-30 17:42:21

  • Version: 11

Subject Line
  • A1 Are you reporting all of your hemophilia bleeds? 📋

  • A2 Every bleed matters - Speak up if you are having any hemophilia bleeds 📢

  • A3 Are you worried about bleed protection?

  • A4 Are hemophilia bleeds holding you back? 🤔

Preheader
  • A1 Speak your truth if you are having breakthrough bleeds with your current hemophilia A therapy
  • A2 If you have hemophilia A, are you sharing all your bleeds with your doctor?
  • A3 Breakthrough bleeds still remain and if untreated can cause long-term joint damage.
  • A4 Open up about any trade-offs you may be making so your care team can meet your needs
View / Download

Handoff: April 30, 2025

(Added Preheader Variable Token)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=bleedprotection&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-administration-la-kelley   (Version for LA Kelley)
  • mim8-patient-administration-la-kelley.html
  • US24HRBD00100   March 2025
  • Last updated: 2025-04-22 21:51:55

  • Version: 3

Subject Line
  • A1 Are you making compromises with your hemophilia treatment? ⚖️

  • A2 Injection pain, large volume doses... Speak up about hemophilia treatment concerns

  • A3 Do you have administration challenges with your hemophilia treatment? 📣

  • A4 Are you trading off ease of administration for bleed protection? 🤔

Preheader
  • A1 You may be putting up with large needles or pain when injecting in order to achieve bleed protection
  • A2 Discuss the difficulties with your doctor so they can better support you in your management
  • A3 Share them with your health care team–you shouldn’t have to make compromises when it comes to managing your hemophilia
  • A4 Talk to your health care team–your voice matters in your hemophilia A management plan
View / Download

Handoff: April 21, 2025

(Version for LA Kelley, Updated header, footer, GA tagging)

view | download
Tracking
  • (GA) ?utm_campaign=Hemophilia+A&utm_medium=email&utm_source=LA&utm_content=administration&utm_id=nmtDC00006788
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-hcp-welcome   (Updated GA Tagging and opt-out token)
  • mim8-hcp-welcome.html
  • US25HRBD00045   March 2025
  • Last updated: 2025-03-19 19:23:23

  • Version: 7

Subject Line
  • 1) You’re signed up, thanks

  • 2) You’re in. Thanks for signing up

  • 3) Welcome, and thanks for signing up

Preheader
  • 1) Explore information and tools designed to help you support your patients.
  • 2) Stay tuned for insights and information to help you support your patients.
  • 3) Understanding patient treatment challenges starts here.
View / Download

Handoff: March 2025

(Updated GA Tagging and opt-out token)

view | download
Tracking
  • (GA) ?utm_campaign=TheirHemTruthHurts&utm_medium=email&utm_source=ADBE&utm_content=Welcome+sign+up&utm_id=THTH_WelcomeEM
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • mim8-patient-welcome  
  • mim8-patient-welcome.html
  • US25HRBD00046   March 2025
  • Last updated: 2025-03-18 18:02:31

  • Version: 6

Subject Line
  • 1) You’re signed up, thanks!

  • 2) Thanks for signing up!

  • 3) Your signup is complete, thanks!

Preheader
  • 1) We’ll help you stay informed with information and tools to help you keep the conversation going.
  • 2) We’ll send updates and tips to help you navigate discussions with your doctor about hemophilia A.
  • 3) Keep speaking up about hemophilia A treatment challenges.
View / Download

Handoff: March 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=welcomeandsignup&utm_id=<%= message.delivery.deliverycode %>
alhemo Emails
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-personalized-dosing  
  • alhemo-patient-personalized-dosing.html
  • US25AHM00428   January 2026
  • Last updated: 2025-12-11 04:12:56

  • Version: 1

Subject Line
  • 1) 🩸Are you administering bleed prevention every day? Find out more!

  • 2) Got hemophilia with inhibitors?

  • 3) Find out what hemophilia with inhibitors patients are saying.

  • 4) No mixing? No vials? No kidding!

  • 5) 💫 A prefilled pen option’s administration designed with you in mind.

  • 6) Hear a patient’s story about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

Preheader
  • 1) Discover daily administration for hemophilia with inhibitors.
  • 2) Discover a subcutaneous treatment option in a prefilled pen!
  • 3) Did you know there’s a PPx option in a prefilled pen?
  • 4) Could this prefilled pen option for hemophilia with inhibitors be right for you?
  • 5) Explore personalized dosing for hemophilia with inhibitors.
  • 6) Discover one patient’s treatment journey and why self-advocacy is important.
View / Download

Handoff: January 25, 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=morethanapen&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-hemb-update-CHB-microhealth  
  • alhemo-patient-hemb-update-CHB-microhealth.html
  • US25AHM00177   September 2025
  • Last updated: 2025-11-24 17:55:37

  • Version: 1

Subject Line
  • 1) 🩸 New prophylaxis indication for hemophilia B

  • 2) Got hemophilia?

  • 3) Find out what hemophilia patients are saying.

  • 4) No mixing? No vials? No kidding!

  • 5) 💫 A prefilled pen option's administration designed with you in mind.

  • 6) Hear a patient's story about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • 7) Novo Nordisk has some exciting news to share!

Preheader
  • 1) Exciting news to share from Novo Nordisk!
  • 2) Discover a subcutaneous treatment option in a prefilled pen!
  • 3) Did you know there's a new PPx option in a prefilled pen?
  • 4) Could this prefilled pen option for hemophilia be right for you?
  • 5) Could this prefilled pen option for hemophilia be right for you?
  • 6) Discover one patient's treatment journey and why self-advocacy is important.
  • 7) Have you heard about this new indication for Hem B?
View / Download

Handoff: November 24, 2025

view | download
Tracking
  • (GA) ?utm_campaign=Alhemo+Hem+B&utm_medium=email&utm_source=CHB&utm_content=alhemopatient&utm_id=nmtDC00008296
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-hemb-update-la-kelley  
  • alhemo-patient-hemb-update-la-kelley.html
  • US25AHM00177   September 2025
  • Last updated: 2025-11-05 20:29:58

  • Version: 4

Subject Line
  • 1) 🩸 New prophylaxis indication for hemophilia B

  • 2) Got hemophilia?

  • 3) Find out what hemophilia patients are saying.

  • 4) No mixing? No vials? No kidding!

  • 5) 💫 A prefilled pen option's administration designed with you in mind.

  • 6) Hear a patient's story about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • 7) Novo Nordisk has some exciting news to share!

Preheader
  • 1) Exciting news to share from Novo Nordisk!
  • 2) Discover a subcutaneous treatment option in a prefilled pen!
  • 3) Did you know there's a new PPx option in a prefilled pen?
  • 4) Could this prefilled pen option for hemophilia be right for you?
  • 5) Could this prefilled pen option for hemophilia be right for you?
  • 6) Discover one patient's treatment journey and why self-advocacy is important.
  • 7) Have you heard about this new indication for Hem B?
View / Download

Handoff: August 15, 2025

view | Download
Tracking
  • (GA) ?utm_campaign=HB+Now+Approved&utm_medium=email&utm_source=LA&utm_content=Pen&utm_id=nmtDC00008121
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-hcp-hem-b-phase-2-without-nml  
  • alhemo-hcp-hem-b-phase-2-without-nml.html
  • US25AHM00307   September 2025
  • Last updated: 2025-10-17 17:01:46

  • Version: 4

Subject Line
  • 1) 🛡Everyday bleed protection for your hem B patients

  • 2) Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • 3) 🩸Support your Hem B patients with routine prophylaxis!

  • 4) Rethink routine prophylaxis for your Hem B patients

  • 5) 🩸SubQ hemophilia B routine prophylaxis in a prefilled pen

  • 6) 🔄 Rethink hemophilia B prophylaxis for your appropriate patients

  • 7) 💡 Offer your hem B patients daily bleed protection

Preheader
  • 1) Discover a routine prophylaxis delivered in a prefilled, subQ pen.
  • 2) See how Alhemo® works.
  • 3) Could this treatment be right for your patients?
  • 4) Check out the efficacy data! 📊
  • 5) Learn more about the efficacy of this option for your patients!
  • 6) Discover an option with individualized dosing!
  • 7) Explore routine prophylaxis and a tool to individualize dosing
View / Download

Handoff: September 16, 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%=message.delivery.operation.label%>&utm_medium=email&utm_source=ADBE&utm_content=HB+Efficacy_US25AHM00307&utm_id=message.delivery.deliveryCode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-hcp-hem-b-phase-2  
  • alhemo-hcp-hem-b-phase-2.html
  • US25AHM00307   September 2025
  • Last updated: 2025-10-21 17:10:19

  • Version: 11

Subject Line
  • 1) 🛡Everyday bleed protection for your hem B patients

  • 2) Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • 3) 🩸Support your Hem B patients with routine prophylaxis!

  • 4) Rethink routine prophylaxis for your Hem B patients

  • 5) 🩸SubQ hemophilia B routine prophylaxis in a prefilled pen

  • 6) 🔄 Rethink hemophilia B prophylaxis for your appropriate patients

  • 7) 💡 Offer your hem B patients daily bleed protection

Preheader
  • 1) Discover a routine prophylaxis delivered in a prefilled, subQ pen.
  • 2) See how Alhemo® works.
  • 3) Could this treatment be right for your patients?
  • 4) Check out the efficacy data! 📊
  • 5) Learn more about the efficacy of this option for your patients!
  • 6) Discover an option with individualized dosing!
  • 7) Explore routine prophylaxis and a tool to individualize dosing
View / Download

Handoff: September 16, 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%=message.delivery.operation.label%>&utm_medium=email&utm_source=ADBE&utm_content=HB+Efficacy_US25AHM00307&utm_id=message.delivery.deliveryCode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-hemb-update-H4H  
  • alhemo-patient-hemb-update-H4H.html
  • US25AHM00177   September 2025
  • Last updated: 2025-09-22 19:46:58

  • Version: 6

Subject Line
  • 1) 🩸Treatment information about a [new] indication for Hemophilia B!

  • 2) Got hemophilia?

  • 3) Find out what hemophilia patients are saying.

  • 4) No mixing? No vials? No kidding!

  • 5) 💫 A prefilled pen option's administration designed with you in mind.

  • 6) Hear a patient's story about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • 7) Novo Nordisk has some exciting news to share!

Preheader
  • 1) Exciting news to share from Novo Nordisk!
  • 2) Discover a subcutaneous treatment option in a prefilled pen!
  • 3) Did you know there's a new PPx option in a prefilled pen?
  • 4) Could this prefilled pen option for hemophilia be right for you?
  • 5) Explore personalized dosing for hemophilia B.
  • 6) Discover one patient's treatment journey and why self-advocacy is important.
  • 7) Have you heard about this new indication for Hem B?
View / Download

Handoff: September 15, 2025

view | download
Tracking
  • (GA) ?utm_campaign=HB+Now+Approved&utm_medium=email&utm_source=H4H&utm_content=Pen&utm_id=nmtDC00007780
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-hemb-update-CHES  
  • alhemo-patient-hemb-update-CHES.html
  • US25AHM00177   September 2025
  • Last updated: 2025-09-22 19:48:56

  • Version: 6

Subject Line
  • 1) 🩸Treatment information about a [new] indication for Hemophilia B!

  • 2) Got hemophilia?

  • 3) Find out what hemophilia patients are saying.

  • 4) No mixing? No vials? No kidding!

  • 5) 💫 A prefilled pen option's administration designed with you in mind.

  • 6) Hear a patient's story about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • 7) Novo Nordisk has some exciting news to share!

Preheader
  • 1) Exciting news to share from Novo Nordisk!
  • 2) Discover a subcutaneous treatment option in a prefilled pen!
  • 3) Did you know there's a new PPx option in a prefilled pen?
  • 4) Could this prefilled pen option for hemophilia be right for you?
  • 5) Explore personalized dosing for hemophilia B.
  • 6) Discover one patient's treatment journey and why self-advocacy is important.
  • 7) Have you heard about this new indication for Hem B?
View / Download

Handoff: September 15, 2025

view | download
Tracking
  • (GA) ?utm_campaign=HB+Now+Approved&utm_medium=email&utm_source=CEFD&utm_content=Pen&utm_id=nmtDC00007779
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-hemb-update-CHB  
  • alhemo-patient-hemb-update-CHB.html
  • US25AHM00177   September 2025
  • Last updated: 2025-11-05 20:31:30

  • Version: 11

Subject Line
  • 1) 🩸 New prophylaxis indication for hemophilia B

  • 2) Got hemophilia?

  • 3) Find out what hemophilia patients are saying.

  • 4) No mixing? No vials? No kidding!

  • 5) 💫 A prefilled pen option's administration designed with you in mind.

  • 6) Hear a patient's story about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • 7) Novo Nordisk has some exciting news to share!

Preheader
  • 1) Exciting news to share from Novo Nordisk!
  • 2) Discover a subcutaneous treatment option in a prefilled pen!
  • 3) Did you know there's a new PPx option in a prefilled pen?
  • 4) Could this prefilled pen option for hemophilia be right for you?
  • 5) Could this prefilled pen option for hemophilia be right for you?
  • 6) Discover one patient's treatment journey and why self-advocacy is important.
  • 7) Have you heard about this new indication for Hem B?
View / Download

Handoff: August 15, 2025

view | download
Tracking
  • (GA) ?utm_campaign=HB+Now+Approved&utm_medium=email&utm_source=CHB&utm_content=Pen&utm_id=nmtDC00008120
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-pt-hem-b-update-outlook (Outlook email template file .oft)
  • alhemo-pt-hem-b-update-outlook
  • US25AHM00196   September 2025
  • Last updated: 2025-08-27 17:22:51

  • Version: 1

Subject Line
  • New prophylaxis indication for hemophilia B

  • Have you heard about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg?

  • Prophylaxis information about a new indication for hemophilia B

  • Product information about an indication for Hem B

  • New information about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • I have some new information for you

  • I have some exciting new information for you. Let’s chat!

Preheader
  • N/A
View / Download

Handoff: August 27, 2025

Fileset includes:
- Outlook email template file (.oft)
- subject line text (.txt) file

view | download
Tracking
  • N/A
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-hemb-welcome  
  • alhemo-patient-hemb-welcome.html
  • US25AHM00112   September 2025
  • Last updated: 2025-10-08 20:01:47

  • Version: 6

Subject Line
  • 1) 👋 Thanks for signing up to learn more about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg.

  • 2) Get helpful info on treatment with Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg.

  • 3) Considering Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg?

  • 4) ❤ Sometimes you just need to talk to someone who gets it.

  • 5) 🩸Hear from people like you living with hemophilia.

  • 6) 🔬Want to learn about the science behind Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg?

Preheader
  • 1) You’re in the right place. Let’s get started.
  • 2) Support is just a click away.
  • 3) Start the conversation with our community team.
  • 4) Connect with a hemophilia liaison.
  • 5) Explore what’s possible with our rare blood community team.
  • 6) Our community liaisons are here to help.
View / Download

Handoff: August 26, 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=morethanapen&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-hemb-update  
  • alhemo-patient-hemb-update.html
  • US25AHM00177   September 2025
  • Last updated: 2025-09-23 19:48:29

  • Version: 9

Subject Line
  • 1) 🩸Treatment information about a [new] indication for Hemophilia B!

  • 2) Got hemophilia?

  • 3) Find out what hemophilia patients are saying.

  • 4) No mixing? No vials? No kidding!

  • 5) 💫 A prefilled pen option's administration designed with you in mind.

  • 6) Hear a patient's story about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • 7) Novo Nordisk has some exciting news to share!

Preheader
  • 1) Exciting news to share from Novo Nordisk!
  • 2) Discover a subcutaneous treatment option in a prefilled pen!
  • 3) Did you know there's a new PPx option in a prefilled pen?
  • 4) Could this prefilled pen option for hemophilia be right for you?
  • 5) Explore personalized dosing for hemophilia B.
  • 6) Discover one patient's treatment journey and why self-advocacy is important.
  • 7) Have you heard about this new indication for Hem B?
View / Download

Handoff: August 15, 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=nowapproved&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-hcp-hem-b-without-nml  
  • alhemo-hcp-hem-b-without-nml.html
  • US25AHM00183   August 2025
  • Last updated: 2025-08-08 20:35:00

  • Version: 5

Subject Line
  • A1 🩸Ready for everyday bleed protection?

  • A2 What could a prefilled pen mean for your patients with hemophilia?

  • A3 Leave vials and mixing behind!

  • A4 Your hemophilia patients with and without inhibitors have bleed prevention options

  • A5 Explore Alhemo® (concizumab-mtci} injection 60 mg, 150 mg, 300 mg

  • A6 This routine prophylaxis is now indicated for Hem Band A without inhibitors

  • A7 Everyday bleed protection-now approved for Hem Band A

  • A8 Finally, it's here! SubQ prophylaxis now approved for Hem Band A

  • A9 Ready to rethink Hem B prophylaxis?

  • A10 A new plan A for your patients with Hem B

Preheader
  • A1 Dive into handling and usability data for patients with hemophilia
  • A2 Get the facts about everyday bleed protection.
  • A3 Discover a subQ prophy pen for bleed protection.
  • A4 See how an easy-to-use, prefilled pen could make a difference.
  • A5 Could this treatment option be right for your patients?
  • A6 Could this treatment option be right for your patients?
  • A7 In the same prefilled, subQ pen you prescribe for your HBwl and HAwl patients.
  • A8 New indication. Familiar administration. Proven bleed protection.
  • A9 A proven subQ, once-daily option-now FDA-approved.
  • A10 Prophylaxis treatment in a prefilled, subQ pen.
View / Download

Handoff: August 4, 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=Now+Approved+HB_US25AHM00183&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-hcp-hem-b  
  • alhemo-hcp-hem-b.html
  • US25AHM00183   August 2025
  • Last updated: 2025-08-04 22:39:56

  • Version: 5

Subject Line
  • A1 🩸Ready for everyday bleed protection?

  • A2 What could a prefilled pen mean for your patients with hemophilia?

  • A3 Leave vials and mixing behind!

  • A4 Your hemophilia patients with and without inhibitors have bleed prevention options

  • A5 Explore Alhemo® (concizumab-mtci} injection 60 mg, 150 mg, 300 mg

  • A6 This routine prophylaxis is now indicated for Hem Band A without inhibitors

  • A7 Everyday bleed protection-now approved for Hem Band A

  • A8 Finally, it's here! SubQ prophylaxis now approved for Hem Band A

  • A9 Ready to rethink Hem B prophylaxis?

  • A10 A new plan A for your patients with Hem B

Preheader
  • A1 Dive into handling and usability data for patients with hemophilia
  • A2 Get the facts about everyday bleed protection.
  • A3 Discover a subQ prophy pen for bleed protection.
  • A4 See how an easy-to-use, prefilled pen could make a difference.
  • A5 Could this treatment option be right for your patients?
  • A6 Could this treatment option be right for your patients?
  • A7 In the same prefilled, subQ pen you prescribe for your HBwl and HAwl patients.
  • A8 New indication. Familiar administration. Proven bleed protection.
  • A9 A proven subQ, once-daily option-now FDA-approved.
  • A10 Prophylaxis treatment in a prefilled, subQ pen.
View / Download

Handoff: August 4, 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=Now+Approved+HB_US25AHM00183&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-pt-hwi-outlook (Outlook email template file .oft)
  • alhemo-pt-hwi-outlook.oft
  • US25AHM00176   June 2025
  • Last updated: 2025-06-27 12:02:51

  • Version: 6

Subject Line
  • More than a pen–learn about a hemophilia with inhibitors PPx treatment

  • Have you heard about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg?

  • Let’s chat about reimagined bleed protection.

  • No mixing!? No vials!? Hemophilia with Inhibitor Treatment!

  • I have some exciting information for you. Let’s chat!

  • Hear a patient’s experience with Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

Preheader
  • N/A
View / Download

Handoff: June 27, 2025

Fileset includes:
- Outlook email template file (.oft)
- subject line text (.txt) file

download
Tracking
  • N/A
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-hwi-email  
  • alhemo-patient-hwi-email.html
  • US25AHM00175   June 2025
  • Last updated: 2025-06-26 18:41:51

  • Version: 9

Subject Line
  • 1) 🩸Are you administering bleed prevention every day? Find out more!

  • 2) Got hemophilia with inhibitors?

  • 3) Find out what hemophilia with inhibitors patients are saying.

  • 4) No mixing? No vials? No kidding!

  • 5) 💫 A prefilled pen option’s administration designed with you in mind.

  • 6) Hear a patient’s story about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

Preheader
  • 1) Discover daily administration for hemophilia with inhibitors.
  • 2) Discover a subcutaneous treatment option in a prefilled pen!
  • 3) Did you know there’s a PPx option in a prefilled pen?
  • 4) Could this prefilled pen option for hemophilia with inhibitors be right for you?
  • 5) Explore personalized dosing for hemophilia with inhibitors.
  • 6) Discover one patient’s treatment journey and why self-advocacy is important.
View / Download

Handoff: June 25, 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=morethanapen&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-hcp-hwi-without-nml-email   (Email version without NML slab)
  • alhemo-hcp-hwi-without-nml-email.html
  • US25AHM00194   June 2025
  • Last updated: 2025-06-25 14:59:46

  • Version: 21

Subject Line
  • A1 🩸Ready for everyday bleed protection?

  • A2 What could a prefilled pen mean for your patients?

  • A3 Leave vials and mixing behind!

  • A4 Your HBwI and HAwI patients have bleed control options

  • A5 Explore Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

Preheader
  • A1 Dive into handling and usability data for HBwI and HAwI patients.
  • A2 Get the facts about everyday bleed protection.
  • A3 Discover a subQ prophy pen for bleed protection.
  • A4 See how an easy-to-use, prefilled pen could make a difference.
  • A5 Could this treatment option be right for your patients?
View / Download

Handoff: June 20, 2025

(Email version without NML slab)

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=More+Than+a+Pen_US25AHM00194&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-hcp-hwi-email  
  • alhemo-hcp-hwi-email.html
  • US25AHM00194   June 2025
  • Last updated: 2025-06-20 22:21:13

  • Version: 20

Subject Line
  • A1 🩸Ready for everyday bleed protection?

  • A2 What could a prefilled pen mean for your patients?

  • A3 Leave vials and mixing behind!

  • A4 Your HBwI and HAwI patients have bleed control options

  • A5 Explore Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

Preheader
  • A1 Dive into handling and usability data for HBwI and HAwI patients.
  • A2 Get the facts about everyday bleed protection.
  • A3 Discover a subQ prophy pen for bleed protection.
  • A4 See how an easy-to-use, prefilled pen could make a difference.
  • A5 Could this treatment option be right for your patients?
View / Download

Handoff: June 23, 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=ADBE&utm_content=More+Than+a+Pen_US25AHM00194&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-now-approved-ches (Version for CHES. Top banner text update: NOW AVAILABLE)
  • alhemo-patient-now-approved-ches.html
  • US24AHM00045   December 2024
  • Last updated: 2025-03-07 00:22:39

  • Version: 4

Subject Line
  • A1 Now Approved: A prefilled pen for daily bleed protection

  • A2 Now Approved: Daily prophylaxis in a prefilled pen

  • B1 No more vials?! See what this new pen prophylaxis could mean for you!

  • B2 No infusions! No mixing! No vials!

  • C1 Have you heard? A new way to prevent bleeds!

  • C2 Finally! A new medication for hemophilia B with inhibitors

  • C3 A new option is almost here for hemophilia B with inhibitors!

Preheader
  • A1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • A2 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B2 Learn about this new prefilled pen for daily bleed protection.
  • C1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • C2 Learn about this new once-daily prophylactic prefilled pen.
  • C3 Discover once-daily prophylaxis in a prefilled pen.
View / Download

Handoff: March 6, 2025

(Top banner text update:
NOW AVAILABLE)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Now+Approved&utm_medium=email&utm_source=CEFD&utm_content=Pen&utm_id=nmtDC00006300
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-hcp-now-approved (GA tagging update with previous top banner text update)
  • alhemo-hcp-now-approved.html
  • US24AHM00020   December 2024
  • Last updated: 2025-02-17 23:32:07

  • Version: 14

Subject Line
  • 1) Now approved: a new prophylactic option for patients with hemophilia B or A with inhibitors

  • 2) It’s finally here: the first and only prefilled pen for patients with hemophilia B or A with inhibitors

  • 3) Learn about a new FDA-approved medication for hemophilia B or A with inhibitors

  • 4) Now approved: the first and only injection pen for hemophilia B or A with inhibitors

  • 5) A new PPx option for hemophilia B or A with inhibitors

  • [object Object]

  • 7) Have you heard about Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg?

  • 8) Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg is now approved

  • 9) Meet FDA-approved Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, 300 mg

  • 10) Your patients living with hemophilia with inhibitors have a new option

Preheader
  • 1) Learn about the first and only once-daily, prefilled pen injection for patients with inhibitors.
  • 2) A subcutaneous option to prevent or reduce bleeding episodes.
  • 3) Administered subcutaneously via a prefilled pen injection.
  • 4) Learn more about this new subcutaneous option.
  • 5) Learn more about this once-daily prefilled pen injection.
  • 6) Get to know this new medication.
  • 7) Learn about this FDA-approved medication.
  • 8) Explore this new option.
  • 9) Learn about this new option.
  • 10) Discover the first and only once-daily, prefilled pen injection.
View / Download

Handoff: February 17, 2025

(GA tagging update with previous top banner text update)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=Now+available+CHwI&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-now-approved-chb (Version for CHB)
  • alhemo-patient-now-approved-chb.html
  • US24AHM00045   December 2024
  • Last updated: 2025-02-19 08:34:39

  • Version: 3

Subject Line
  • A1 Now Approved: A prefilled pen for daily bleed protection

  • A2 Now Approved: Daily prophylaxis in a prefilled pen

  • B1 No more vials?! See what this new pen prophylaxis could mean for you!

  • B2 No infusions! No mixing! No vials!

  • C1 Have you heard? A new way to prevent bleeds!

  • C2 Finally! A new medication for hemophilia B with inhibitors

  • C3 A new option is almost here for hemophilia B with inhibitors!

Preheader
  • A1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • A2 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B2 Learn about this new prefilled pen for daily bleed protection.
  • C1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • C2 Learn about this new once-daily prophylactic prefilled pen.
  • C3 Discover once-daily prophylaxis in a prefilled pen.
View / Download

Handoff: January 19, 2025

(GA tagging update, imsges hosted, top banner text update, header/footer updates)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=Now+Approved&utm_content=Pen&utm_id=nmtDC00006299
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-now-approved (Top banner date updated)
  • alhemo-patient-now-approved.html
  • US24AHM00045   December 2024
  • Last updated: 2025-02-07 16:45:50

  • Version: 22

Subject Line
  • A1 Now Approved: A prefilled pen for daily bleed protection

  • A2 Now Approved: Daily prophylaxis in a prefilled pen

  • B1 No more vials?! See what this new pen prophylaxis could mean for you!

  • B2 No infusions! No mixing! No vials!

  • C1 Have you heard? A new way to prevent bleeds!

  • C2 Finally! A new medication for hemophilia B with inhibitors

  • C3 A new option is almost here for hemophilia B with inhibitors!

Preheader
  • A1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • A2 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B2 Learn about this new prefilled pen for daily bleed protection.
  • C1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • C2 Learn about this new once-daily prophylactic prefilled pen.
  • C3 Discover once-daily prophylaxis in a prefilled pen.
View / Download

Handoff: February 7 2025

(Top banner date updated)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=nowapproved&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-now-approved-h4h (Channel partner version for Hope for Hemophilia, with images hosted)
  • alhemo-patient-now-approved-h4h.html
  • US24AHM00045   December 2024
  • Last updated: 2025-01-29 21:15:37

  • Version: 3

Subject Line
  • A1 Now Approved: A prefilled pen for daily bleed protection

  • A2 Now Approved: Daily prophylaxis in a prefilled pen

  • B1 No more vials?! See what this new pen prophylaxis could mean for you!

  • B2 No infusions! No mixing! No vials!

  • C1 Have you heard? A new way to prevent bleeds!

  • C2 Finally! A new medication for hemophilia B with inhibitors

  • C3 A new option is almost here for hemophilia B with inhibitors!

Preheader
  • A1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • A2 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B2 Learn about this new prefilled pen for daily bleed protection.
  • C1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • C2 Learn about this new once-daily prophylactic prefilled pen.
  • C3 Discover once-daily prophylaxis in a prefilled pen.
View / Download

Handoff: January 2025

(Channel partner version for Hope for Hemophilia, with hosted images)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=H4H&utm_campaign=Now+Approved&utm_content=Pen&utm_id=nmtDC00006189
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • alhemo-patient-now-approved-la-kelley (Channel partner version for LA Kelley)
  • alhemo-patient-now-approved-la-kelley.html
  • US24AHM00045   December 2024
  • Last updated: 2025-01-28 06:40:44

  • Version: 1

Subject Line
  • A1 Now Approved: A prefilled pen for daily bleed protection

  • A2 Now Approved: Daily prophylaxis in a prefilled pen

  • B1 No more vials?! See what this new pen prophylaxis could mean for you!

  • B2 No infusions! No mixing! No vials!

  • C1 Have you heard? A new way to prevent bleeds!

  • C2 Finally! A new medication for hemophilia B with inhibitors

  • C3 A new option is almost here for hemophilia B with inhibitors!

Preheader
  • A1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • A2 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • B2 Learn about this new prefilled pen for daily bleed protection.
  • C1 For hemophilia B with inhibitors or hemophilia A with inhibitors.
  • C2 Learn about this new once-daily prophylactic prefilled pen.
  • C3 Discover once-daily prophylaxis in a prefilled pen.
View / Download

Handoff: January 2025

(Channel partner version for LA Kelley)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=LA&utm_campaign=Now+Approved&utm_content=Pen&utm_id=nmtDC00006152
changing-hemophilia Emails
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • CH H-Fit Welcome Email RBCL Update (3 Versions)
  • ch-h-fit-welcome-adults-rbcl-update (Adults version)
  • ch-h-fit-welcome-caregivers-rbcl-update (Caregivers version)
  • ch-h-fit-welcome-someone-else-rbcl-update (Someone Else version)
  •  
  • US24HRBD00168   December 2024
  • Last updated: 2025-02-25 03:15:39

  • Version: 1

Subject Line
  • A1: Welcome to Changing Hemophilia! Your H-Fit workout is waiting for you

  • A2: Hi [FirstName]! Enjoy hemophilia-friendly fitness that matches your mood

  • A3: Welcome to Changing Hemophilia! Let’s start your H-Fit workout

  • A4: Hi [FirstName]! Start watching your hemophilia-friendly workouts now

Preheader
  • A1: Explore hemophilia-friendly fitness videos designed to match your mood.
  • A2: How are you feeling today? We have an H-Fit workout for that.
  • A3: Explore resources and fitness videos made for the hemophilia community.
  • A4: Enjoy H-Fit workout videos that match your mood.
View / Download

Handoff: February 26, 2025

(RBCL Update, 3 email versions,
Adults, Caregivers, Someone Else)

Download zip file
(3 email versions + images)
download

Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-h-fit-patient-sign-up-chb (CHB Version)
  • ch-h-fit-patient-sign-up-chb.html
  • US21HRBD00173   August 2021
  • Last updated: 2024-11-06 23:14:36

  • Version: 4

Subject Line
  • A1 H-Fit is an on-demand exercise program that’s designed for people with hemophilia.

  • A2 Imagine you could select a hemophilia-friendly workout that fits your mood.

  • A3 Your moods change and so should your workouts. 😀 💪

  • A4 Celebrity trainer? Hemophilia-friendly workouts designed to fit your mood?

Preheader
  • A1 Discover hemophilia-friendly workouts designed to fit your mood 😀 😌
  • A2 You can with H-Fit! 😀 💪 😌 💪
  • A3 Explore workouts to fit your mood.
  • A4 Is it too good to be true?
View / Download

Handoff: November 6, 2024

(GA Tagging Updates, Images hosted)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=H-fit&utm_content=hfit&utm_id=nmtDC00005945
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-market-shaping-02-la-kelley LA Kelley Version
  • ch-market-shaping-02-la-kelley.html
  • US22HRBD00225   April 2023
  • Last updated: 2024-11-04 16:41:31

  • Version: 2

Subject Line
  • A1 Are you up to date on hemophilia research?

  • A2 Different approaches to hemophilia management are being researched.

  • A3 The hemophilia management landscape is changing

  • A4 Did you know? New approaches to hemophilia management are being researched.

  • B1 When is it time to turn the tide?

  • B2 New in hemophilia research

Preheader
  • A1 When is it time to turn the tide?
  • A2 When is it time to turn the tide?
  • A3 When is it time to turn the tide?
  • A4 When is it time to turn the tide?
  • B1 Different approaches to hemophilia management are being researched.
  • B2 Different approaches to hemophilia management are being researched.
View / Download

Handoff: November 4, 2024

(GA Tagging Updates)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=LA&utm_campaign=TTT_Launch&utm_content=timetottt&utm_id=nmtDC00005944
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-market-shaping-01-chb CHB Version
  • ch-market-shaping-01-chb.html
  • US22HRBD00224   April 2023
  • Last updated: 2024-08-15 10:23:51

  • Version: 2

Subject Line
  • A1 Managing hemophilia can feel like riding a wave of uncertainty

  • A2 Managing hemophilia isn’t easy

  • A3 Are you struggling to manage hemophilia?

  • B1 If you’re struggling, you’re not alone

  • B2 Explore [new] hemophilia survey data

Preheader
  • A1 When is it time to turn the tide?
  • A2 When is it time to turn the tide?
  • A3 When is it time to turn the tide?
  • B1 Discover educational resources to help you advocate for yourself.
  • B2 Discover educational resources to help you advocate for yourself.
View / Download

Handoff: August 28, 2024

(GA Tagging Updates, images hosted, added Novo Nordisk logo to zip package)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=TTT_Launch&utm_content=timetottt&utm_id=nmtDC00005653
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-market-shaping-02-ches CHES Version
  • ch-market-shaping-02-ches.html
  • US22HRBD00225   April 2023
  • Last updated: 2024-08-14 16:46:06

  • Version: 5

Subject Line
  • A1 Are you up to date on hemophilia research?

  • A2 Different approaches to hemophilia management are being researched.

  • A3 The hemophilia management landscape is changing

  • A4 Did you know? New approaches to hemophilia management are being researched.

  • B1 When is it time to turn the tide?

  • B2 New in hemophilia research

Preheader
  • A1 When is it time to turn the tide?
  • A2 When is it time to turn the tide?
  • A3 When is it time to turn the tide?
  • A4 When is it time to turn the tide?
  • B1 Different approaches to hemophilia management are being researched.
  • B2 Different approaches to hemophilia management are being researched.
View / Download

Handoff: August 14, 2024

(GA Tagging Updates)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=CEFD&utm_campaign=TTT_Launch&utm_content=timetottt&utm_id=nmtDC00005662
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-market-shaping-01-h4h H4H Version
  • ch-market-shaping-01-h4h.html
  • US22HRBD00224   April 2023
  • Last updated: 2023-11-15 06:33:51

  • Version: 2

Subject Line
  • A1 Managing hemophilia can feel like riding a wave of uncertainty

  • A2 Managing hemophilia isn’t easy

  • A3 Are you struggling to manage hemophilia?

  • B1 If you’re struggling, you’re not alone

  • B2 Explore [new] hemophilia survey data

Preheader
  • A1 When is it time to turn the tide?
  • A2 When is it time to turn the tide?
  • A3 When is it time to turn the tide?
  • B1 Discover educational resources to help you advocate for yourself.
  • B2 Discover educational resources to help you advocate for yourself.
View / Download

Handoff: April 2023

(GA Tagging Update, images hosted)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=H4H&utm_campaign=TTT_Launch&utm_content=turnthetide&utm_id=nmtDC00004582
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-market-shaping-02-chb CHB Version
  • ch-market-shaping-02-chb.html
  • US22HRBD00225   April 2023
  • Last updated: 2023-11-07 08:15:51

  • Version: 4

Subject Line
  • A1 Are you up to date on hemophilia research?

  • A2 Different approaches to hemophilia management are being researched.

  • A3 The hemophilia management landscape is changing

  • A4 Did you know? New approaches to hemophilia management are being researched.

  • B1 When is it time to turn the tide?

  • B2 New in hemophilia research

Preheader
  • A1 When is it time to turn the tide?
  • A2 When is it time to turn the tide?
  • A3 When is it time to turn the tide?
  • A4 When is it time to turn the tide?
  • B1 Different approaches to hemophilia management are being researched.
  • B2 Different approaches to hemophilia management are being researched.
View / Download

Handoff: April 2023

(GA Tagging Update, images hosted)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=TTT_Launch&utm_content=turnthetide&utm_id=nmtDC00004497
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-market-shaping-01-ches CHES Version
  • ch-market-shaping-01-ches.html
  • US22HRBD00224   April 2023
  • Last updated: 2023-08-22 17:03:24

  • Version: 5

Subject Line
  • A1 Managing hemophilia can feel like riding a wave of uncertainty

  • A2 Managing hemophilia isn’t easy

  • A3 Are you struggling to manage hemophilia?

  • B1 If you’re struggling, you’re not alone

  • B2 Explore new hemophilia survey data

Preheader
  • A1 When is it time to turn the tide?
  • A2 When is it time to turn the tide?
  • A3 When is it time to turn the tide?
  • B1 Discover educational resources to help you advocate for yourself.
  • B2 Discover educational resources to help you advocate for yourself.
View / Download

Handoff: August 22, 2023

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=CHES&utm_campaign=TTT_Launch&utm_content=TTT_Survey&utm_id=nmtDC00003831
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-market-shaping-01-la-kelley LA Kelley Version
  • ch-market-shaping-01-la-kelley.html
  • US22HRBD00224   April 2023
  • Last updated: 2023-06-16 13:46:06

  • Version: 1

Subject Line
  • A1 Managing hemophilia can feel like riding a wave of uncertainty

  • A2 Managing hemophilia isn’t easy

  • A3 Are you struggling to manage hemophilia?

  • B1 If you’re struggling, you’re not alone

  • B2 Explore new hemophilia survey data

Preheader
  • A1 When is it time to turn the tide?
  • A2 When is it time to turn the tide?
  • A3 When is it time to turn the tide?
  • B1 Discover educational resources to help you advocate for yourself.
  • B2 Discover educational resources to help you advocate for yourself.
View / Download

Handoff: April 2023

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=LA&utm_campaign=TTT_Launch&utm_content=TTT_Survey&utm_id=nmtDC00003833
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-market-shaping-02
  • ch-market-shaping-02.html
  • US22HRBD00225   April 2023
  • Last updated: 2023-06-02 16:29:49

  • Version: 12

Subject Line
  • A1 Are you up to date on hemophilia research?

  • A2 Different approaches to hemophilia management are being researched.

  • A3 The hemophilia management landscape is changing

  • A4 Did you know? New approaches to hemophilia management are being researched.

  • B1 When is it time to turn the tide?

  • B2 New in hemophilia research

Preheader
  • A1 When is it time to turn the tide?
  • A2 When is it time to turn the tide?
  • A3 When is it time to turn the tide?
  • A4 When is it time to turn the tide?
  • B1 Different approaches to hemophilia management are being researched.
  • B2 Different approaches to hemophilia management are being researched.
View / Download

Handoff: April 2023

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=turnthetide&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-market-shaping-01
  • ch-market-shaping-01.html
  • US22HRBD00224   April 2023
  • Last updated: 2023-05-04 16:40:45

  • Version: 3

Subject Line
  • A1 Managing hemophilia can feel like riding a wave of uncertainty

  • A2 Managing hemophilia isn’t easy

  • A3 Are you struggling to manage hemophilia?

  • B1 If you’re struggling, you’re not alone

  • B2 Explore new hemophilia survey data

Preheader
  • A1 When is it time to turn the tide?
  • A2 When is it time to turn the tide?
  • A3 When is it time to turn the tide?
  • B1 Discover educational resources to help you advocate for yourself.
  • B2 Discover educational resources to help you advocate for yourself.
View / Download

Handoff: April 2023

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=turnthetide&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • CH H-Fit Welcome Email Versions (No Instagram)
  • ch-h-fit-welcome-adults-no-instagram
  • ch-h-fit-welcome-caregivers-no-instagram
  • ch-h-fit-welcome-someone-else-no-instagram
  •  
  • CH H-Fit Welcome Email Versions (With Instagram)
  • ch-h-fit-welcome-adults-with-instagram
  • ch-h-fit-welcome-caregivers-with-instagram
  • ch-h-fit-welcome-someone-else-with-instagram
  •  
  • US21HRBD00290   March 2022
  • Last updated: 2022-03-03 11:15:39

  • Version: 2

Subject Line
  • A1: Welcome to Changing Hemophilia! Your H-Fit workout is waiting for you

  • A2: Hi [FirstName]! Enjoy hemophilia-friendly fitness that matches your mood

  • A3: Welcome to Changing Hemophilia! Let’s start your H-Fit workout

  • A4: Hi [FirstName]! Start watching your hemophilia-friendly workouts now

Preheader
  • A1: Explore hemophilia-friendly fitness videos designed to match your mood.
  • A2: How are you feeling today? We have an H-Fit workout for that.
  • A3: Explore resources and fitness videos made for the hemophilia community.
  • A4: Enjoy H-Fit workout videos that meet your goals and match your mood.
View / Download

Handoff: February 17, 2022

Download (no instagram emails) zip file (3 emails + images):
download


Handoff: March 03, 2022

Download (with instagram emails) zip file (3 emails + images):
download

Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-h-fit-forgot-password
  • ch-h-fit-forgot-password.html
  • US21HRBD00213   November 2021
  • Last updated: 2021-10-26 11:05:39

  • Version: 2

Subject Line
  • Resetting Your password

Preheader
View / Download

Handoff: October 26, 2021

view | download
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-h-fit-patient-sign-up-ches (CHES version)
  • ch-h-fit-patient-sign-up-ches.html
  • US21HRBD00173   August 2021
  • Last updated: 2021-09-29 11:05:39

  • Version: 2



  • emoji codes:
    😀 U+1F600
    💪 U+1F4AA
    😌 U+1F60C
Subject Line
  • A1 H-Fit is an on-demand exercise program that’s designed for people with hemophilia.

  • A2 Imagine you could select a hemophilia-friendly workout that fits your mood.

  • A3 Your moods change and so should your workouts. 😀 💪

  • A4 Celebrity trainer? Hemophilia-friendly workouts designed to fit your mood?

Preheader
  • A1 Discover hemophilia-friendly workouts designed to fit your mood 😀 😌
  • A2 You can with H-Fit! 😀 💪 😌 💪
  • A3 Explore workouts to fit your mood.
  • A4 Is it too good to be true?
View / Download

Handoff: September 16, 2021

view | download
Tracking
  • (Google Analytics) ?utm_source=CHES&utm_medium=Email&utm_campaign=acquisition&utm_term=US21HRBD00173&utm_content=
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-h-fit-patient-ches (CHES version)
  • ch-h-fit-patient-ches.html
  • US21HRBD00173   August 2021
  • Last updated: 2021-09-16 11:09:51

  • Version: 1



  • emoji codes:
    😀 U+1F600
    💪 U+1F4AA
    😌 U+1F60C
Subject Line
  • A1 H-Fit is an on-demand exercise program that’s designed for people with hemophilia.

  • A2 Imagine you could select a hemophilia-friendly workout that fits your mood.

  • A3 Your moods change and so should your workouts. 😀 💪

  • A4 Celebrity trainer? Hemophilia-friendly workouts designed to fit your mood?

Preheader
  • A1 Discover hemophilia-friendly workouts designed to fit your mood 😀 😌
  • A2 You can with H-Fit! 😀 💪 😌 💪
  • A3 Explore workouts to fit your mood.
  • A4 Is it too good to be true?
View / Download

Handoff: September 16, 2021

view | download
Tracking
  • (Google Analytics) ?utm_source=CHES&utm_medium=Email&utm_campaign=acquisition&utm_term=US21HRBD00173&utm_content=
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-h-fit-patient-chb (CHB version)
  • ch-h-fit-patient-chb.html
  • US21HRBD00173   August 2021
  • Last updated: 2021-08-23 15:39:51

  • Version: 1



  • emoji codes:
    😀 U+1F600
    💪 U+1F4AA
    😌 U+1F60C
Subject Line
  • A1 H-Fit is an on-demand exercise program that’s designed for people with hemophilia.

  • A2 Imagine you could select a hemophilia-friendly workout that fits your mood.

  • A3 Your moods change and so should your workouts. 😀 💪

  • A4 Celebrity trainer? Hemophilia-friendly workouts designed to fit your mood?

Preheader
  • A1 Discover hemophilia-friendly workouts designed to fit your mood 😀 😌
  • A2 You can with H-Fit! 😀 💪 😌 💪
  • A3 Explore workouts to fit your mood.
  • A4 Is it too good to be true?
View / Download

Handoff: August 23, 2021

view | download
Tracking
  • (Google Analytics) ?utm_source=CHB&utm_medium=Email&utm_campaign=acquisition&utm_term=US21HRBD00173&utm_content=
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-h-fit-patient-sign-up-h4h (Hope for Hemophilia version with hosted images)
  • ch-h-fit-patient-sign-up-h4h.html
  • US21HRBD00173   August 2021
  • Last updated: 2021-08-26 13:55:39

  • Version: 2



  • emoji codes:
    😀 U+1F600
    💪 U+1F4AA
    😌 U+1F60C
Subject Line
  • A1 H-Fit is an on-demand exercise program that’s designed for people with hemophilia.

  • A2 Imagine you could select a hemophilia-friendly workout that fits your mood.

  • A3 Your moods change and so should your workouts. 😀 💪

  • A4 Celebrity trainer? Hemophilia-friendly workouts designed to fit your mood?

Preheader
  • A1 Discover hemophilia-friendly workouts designed to fit your mood 😀 😌
  • A2 You can with H-Fit! 😀 💪 😌 💪
  • A3 Explore workouts to fit your mood.
  • A4 Is it too good to be true?
View / Download

Handoff: August 26, 2021

(Update, images hosted)

view | download
Tracking
  • (Google Analytics) ?utm_source=H4H&utm_medium=Email&utm_campaign=acquisition&utm_term=US21HRBD00173&utm_content=
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-h-fit-patient-h4h (Hope for Hemophilia version with hosted images)
  • ch-h-fit-patient-h4h.html
  • US21HRBD00173   August 2021
  • Last updated: 2021-08-26 13:55:51

  • Version: 2



  • emoji codes:
    😀 U+1F600
    💪 U+1F4AA
    😌 U+1F60C
Subject Line
  • A1 H-Fit is an on-demand exercise program that’s designed for people with hemophilia.

  • A2 Imagine you could select a hemophilia-friendly workout that fits your mood.

  • A3 Your moods change and so should your workouts. 😀 💪

  • A4 Celebrity trainer? Hemophilia-friendly workouts designed to fit your mood?

Preheader
  • A1 Discover hemophilia-friendly workouts designed to fit your mood 😀 😌
  • A2 You can with H-Fit! 😀 💪 😌 💪
  • A3 Explore workouts to fit your mood.
  • A4 Is it too good to be true?
View / Download

Handoff: August 26, 2021

(Update, images hosted)

view | download
Tracking
  • (Google Analytics) ?utm_source=H4H&utm_medium=Email&utm_campaign=acquisition&utm_term=US21HRBD00173&utm_content=
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-h-fit-patient-sign-up
  • ch-h-fit-patient-sign-up.html
  • US21HRBD00173   August 2021
  • Last updated: 2021-07-29 21:21:39

  • Version: 1



  • emoji codes:
    😀 U+1F600
    💪 U+1F4AA
    😌 U+1F60C
Subject Line
  • A1 H-Fit is an on-demand exercise program that’s designed for people with hemophilia.

  • A2 Imagine you could select a hemophilia-friendly workout that fits your mood.

  • A3 Your moods change and so should your workouts. 😀 💪

  • A4 Celebrity trainer? Hemophilia-friendly workouts designed to fit your mood?

Preheader
  • A1 Discover hemophilia-friendly workouts designed to fit your mood 😀 😌
  • A2 You can with H-Fit! 😀 💪 😌 💪
  • A3 Explore workouts to fit your mood.
  • A4 Is it too good to be true?
View / Download

Handoff: August 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • ch-h-fit-patient
  • ch-h-fit-patient.html
  • US21HRBD00173   August 2021
  • Last updated: 2021-07-29 21:19:51

  • Version: 1



  • emoji codes:
    😀 U+1F600
    💪 U+1F4AA
    😌 U+1F60C
Subject Line
  • A1 H-Fit is an on-demand exercise program that’s designed for people with hemophilia.

  • A2 Imagine you could select a hemophilia-friendly workout that fits your mood.

  • A3 Your moods change and so should your workouts. 😀 💪

  • A4 Celebrity trainer? Hemophilia-friendly workouts designed to fit your mood?

Preheader
  • A1 Discover hemophilia-friendly workouts designed to fit your mood 😀 😌
  • A2 You can with H-Fit! 😀 💪 😌 💪
  • A3 Explore workouts to fit your mood.
  • A4 Is it too good to be true?
View / Download

Handoff: August 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
novomedlink Emails
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-mature-brands-device-training  
  • nml-mature-brands-device-training.html
  • US25HCP00068   June 2025
  • Last updated: 2025-07-23 18:27:28

  • Version: 6

Subject Line
  • A1 Need Pen Training?

  • A2 Pen device training for you and your team

  • B1 Start your pen device training today

  • B2 The wait is over! Start your pen device training now.

  • C1 Learn how to use a variety of pens and devices

  • C2 Get training to use a variety of pens and devices

Preheader
  • A1 <%= recipient.firstName %>, novoMEDLINK™ has you covered
  • A2 <%= recipient.firstName %>, video trainings are available today!
  • B1 <%= recipient.firstName %>, try our quick-start video training modules.
  • B2 <%= recipient.firstName %>, try our quick-start video training modules.
  • C1 <%= recipient.firstName %>, online pen device trainings available now!
  • C2 <%= recipient.firstName %>, online pen device trainings available now!
View / Download

Handoff: June 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=email&utm_source=TOOL&utm_content=PatientSupport_US25HCP00068&utm_id=PDT_HCP_NML_Jul25
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-account-welcome-refresh
  • nml-account-welcome-refresh.html
  • US22HCP00088   March 2023
  • Last updated: 2023-04-10 21:42:15

  • Version: 9

Subject Line
  • Welcome to novoMEDLINK™

  • novoMEDLINK™ welcomes you!

  • Thank you for signing up for novoMEDLINK™

Preheader
  • Support for you and your patients.
  • With resources, tools, and educational materials.
  • We’re here for you and your patients.
View / Download

Handoff: March 2023

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=NMDL&utm_campaign=NovoMedLink%20Welcome%20Email&utm_content=Welcome+Static&utm_id=NMLJYE1AD_Wel_Brand_Static
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-insulin-pen-certification
  • nml-insulin-pen-certification.html
  • US21DI00012   May 2021
  • Last updated: 2021-05-27 11:20:12

  • Version: 1

Subject Line
  • Your [Brand name] [device] Certificate

Preheader
  • Congratulations on completing your training.
View / Download

Handoff: May 2021

view | download

View the email specs (PDF)

Tracking
  • (Google Analytics) ?utm_campaign=Insulin%20Pen%20Training&utm_medium=email&utm_source=novoMEDLINK&utm_content=Certification%20Completed
    NOTE: the &utm_term is dynamic and should pull in {brandname}%20{devicename}
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-account-reset-password
  • nml-account-reset-password.html
  • US20HCP00097   March 2021
  • Last updated: 2021-04-01 09:52:12

  • Version: 1

Subject Line
  • Reset your novoMEDLINK™ password

Preheader
  • Just follow the link in this email.
View / Download

Handoff: April 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Account%20Management&utm_medium=email&utm_source=novoMEDLINK%20Account&utm_content=Password%20Reset
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-account-password-reset-success
  • nml-account-password-reset-success.html
  • US20HCP00108   March 2021
  • Last updated: 2021-04-01 09:52:12

  • Version: 1

Subject Line
  • We updated your novoMEDLINK™ account

Preheader
  • Your password has been reset.
View / Download

Handoff: April 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Account%20Management&utm_medium=email&utm_source=novoMEDLINK%20Account&utm_content=Password%20Reset%20Success
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-account-password-reset-error
  • nml-account-password-reset-error.html
  • US20HCP00098   March 2021
  • Last updated: 2021-04-01 09:52:12

  • Version: 1

Subject Line
  • Your novoMEDLINK™ password reset request

Preheader
  • Please review your account information.
View / Download

Handoff: April 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Account%20Management&utm_medium=email&utm_source=novoMEDLINK%20Account&utm_content=Password%20Reset%20Error
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-account-print-sample-request-form
  • nml-account-print-sample-request-form.html
  • US20HCP00099   March 2021
  • Last updated: 2021-04-01 09:52:12

  • Version: 1

Subject Line
  • Your novoMEDLINK™ Sample Request Form is ready

Preheader
  • Next steps: Click, print, sign and fax.
View / Download

Handoff: April 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Samples&utm_medium=email&utm_source=novoMEDLINK%20Account&utm_content=Sample%20Request%20Confirmation
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-account-order-shipped
  • nml-account-order-shipped.html
  • US20HCP00103   March 2021
  • Last updated: 2021-04-01 09:52:12

  • Version: 1

Subject Line
  • Your novoMEDLINK™ order #[123456] has shipped

Preheader
  • Track your package.
View / Download

Handoff: April 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Order%20Fulfillment&utm_medium=email&utm_source=novoMEDLINK%20Account&utm_content=Order%20Shipped%20Notification
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-account-order-details
  • nml-account-order-details.html
  • US20HCP00102   March 2021
  • Last updated: 2021-04-01 09:52:12

  • Version: 1

Subject Line
  • novoMEDLINK™ order #[123456] confirmation

Preheader
  • Please review your order details.
View / Download

Handoff: April 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Order%20Fulfillment&utm_medium=email&utm_source=novoMEDLINK%20Account&utm_content=Order%20Confirmation
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • nml-account-welcome
  • nml-account-welcome.html
  • US20HCP00101   March 2021
  • Last updated: 2021-03-26 15:52:12

  • Version: 3

Subject Line
  • Thank you for creating a novoMEDLINK™ account

Preheader
  • Learn about information and support for you and your patients.
View / Download

Handoff: March 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoMEDLINK Registration Welcome &utm_medium=email &utm_source=novoMEDLINK Account &utm_content=TRACKING_CONTENT
novoseven Emails
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-gt-and-factor-vii-ii-ches  
  • n7-gt-and-factor-vii-ii-ches.html
  • US25NSVN00035   September 2025
  • Last updated: 2025-11-25 22:27:25

  • Version: 7

Subject Line
  • 🩸Questions about bleeds or treatment? Start here.

  • ✨Treatment insights. Real support. All in one place.

  • 🙋 Let’s talk about managing bleeds—together.

  • 💛 There’s more support for bleeding disorders than you might think.

  • Why do so many people trust this bleed control option?

  • Seeking support for Glanzmann’s thrombasthenia when platelets don’t work or Factor 7 deficiency?

  • 👋 Hello there, have you met your Community Liaison yet?

Preheader
  • Get 1-1 support on taking charge of your care.
  • Learn who can provide 1-1 support.
  • Take the next step. Speak with a bleeding disorders expert.
  • Connect with a Community Liaison today.
  • See what’s possible with decades of research and innovation.
  • Talk to a rare bleeding disorders expert.
  • Find resources, info on local events, and more!
View / Download

Handoff: September 2025

view | download
Tracking
  • (GA) ?utm_campaign=fviidgt&utm_medium=email&utm_source=CEFD&utm_content=rbcl&utm_id=nmtDC00008206
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-gt-and-factor-vii-rbcl-ches  
  • n7-gt-and-factor-vii-rbcl-ches.html
  • US25NSVN00046   September 2025
  • Last updated: 2025-12-11 18:34:36

  • Version: 5

Subject Line
  • 🩸 Looking for info about your rare bleeding disorder?

  • You don’t have to navigate rare bleeding disorders alone.

  • 👋 Where are you in your rare bleeding disorder journey?

  • Rare bleeding disorders can feel overwhelming at times.

  • Searching for fast bleed control when you need it?

  • Interested in resources for Glanzmann's Thrombasthenia or Factor 7 Deficiency?

Preheader
  • Our community team is here to help.
  • Get one-on-one support and guidance.
  • Connect with our Community Liaisons for 1-1 support.
  • Talk to someone who understands what you’re going through.
  • Take the next step and talk to a Community Liaison.
  • Connect with your local Community Liaison.
View / Download

Handoff: September 2025

view | download
Tracking
  • (GA) ?utm_campaign=RBCLConnect&utm_medium=email&utm_source=CEFD&utm_content=rbcl&utm_id=nmtDC00008058
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-gt-and-factor-vii-rbcl  
  • n7-gt-and-factor-vii-rbcl.html
  • US25NSVN00046   September 2025
  • Last updated: 2025-12-11 18:32:01

  • Version: 12

Subject Line
  • 🩸 Looking for info about your rare bleeding disorder?

  • You don’t have to navigate rare bleeding disorders alone.

  • 👋 Where are you in your rare bleeding disorder journey?

  • Rare bleeding disorders can feel overwhelming at times.

  • Searching for fast bleed control when you need it?

  • Interested in resources for Glanzmann's Thrombasthenia or Factor 7 Deficiency?

Preheader
  • Our community team is here to help.
  • Get one-on-one support and guidance.
  • Connect with our Community Liaisons for 1-1 support.
  • Talk to someone who understands what you’re going through.
  • Take the next step and talk to a Community Liaison.
  • Connect with your local Community Liaison.
View / Download

Handoff: September 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=rbcl&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-gt-and-factor-vii-ii  
  • n7-gt-and-factor-vii-ii.html
  • US25NSVN00035   September 2025
  • Last updated: 2025-12-10 23:13:27

  • Version: 5

Subject Line
  • 🩸Questions about bleeds or treatment? Start here.

  • ✨Treatment insights. Real support. All in one place.

  • 🙋 Let’s talk about managing bleeds—together.

  • 💛 There’s more support for bleeding disorders than you might think.

  • Why do so many people trust this bleed control option?

  • Seeking support for Glanzmann’s thrombasthenia when platelets don’t work or Factor 7 deficiency?

  • 👋 Hello there, have you met your Community Liaison yet?

Preheader
  • Get 1-1 support on taking charge of your care.
  • Learn who can provide 1-1 support.
  • Take the next step. Speak with a bleeding disorders expert.
  • Connect with a Community Liaison today.
  • See what’s possible with decades of research and innovation.
  • Talk to a rare bleeding disorders expert.
  • Find resources, info on local events, and more!
View / Download

Handoff: September 2025

view | download
Tracking
  • (GA) ?utm_campaign=<%= message.delivery.operation.label %>&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=rbcl&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-gt-and-factor-vii  
  • n7-gt-and-factor-vii.html
  • US25NSVN00046   September 2025
  • Last updated: 2025-09-19 17:30:20

  • Version: 7

Subject Line
  • 🩸 Looking for info about your rare bleeding disorder?

  • You don’t have to navigate rare bleeding disorders alone.

  • 👋 Where are you in your rare bleeding disorder journey?

  • Rare bleeding disorders can feel overwhelming at times.

  • Searching for fast bleed control when you need it?

  • Interested in resources for Glanzmann's Thrombasthenia or Factor 7 Deficiency?

Preheader
  • Our community team is here to help.
  • Get one-on-one support and guidance.
  • Connect with our Community Liaisons for 1-1 support.
  • Talk to someone who understands what you’re going through.
  • Take the next step and talk to a Community Liaison.
  • Connect with your local Community Liaison.
View / Download

Handoff: September 2025

view | download
Tracking
  • (GA) ?utm_campaign=Hospital+Pharmacy&utm_medium=email&utm_source=NNI&utm_content=Feiba+Comparison&utm_id=N7RXJYE6_FEIBADefense_24
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-feiba-defense-pharmacy (Pharmacy Version)
  • n7-hsp-feiba-defense-pharmacy.html
  • US24NSVN00078   December 2024
  • Last updated: 2025-01-14 16:12:38

  • Version: 1

Subject Line
  • A1 Let’s see the key differences between rFVIIa and pd-aPCC products

  • A2 Have you seen the key differences between rFVIIa and pd-aPCC products?

  • B1 Have you compared infusion times of bleeding disorders treatments?

  • B2 How important are fast infusions for your hospital?

  • C1 Could you help more patients with this single treatment?

Preheader
  • A1 Review the main components of each treatment.
  • A2 Review the main components of each treatment.
  • B1 Explore differences between products.
  • B2 Explore differences between products.
  • C1 Learn the differences between this rFVIIa and pd-aPCC.
View / Download

Handoff: January 14, 2025

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Hospital+Pharmacy&utm_medium=email&utm_source=NNI&utm_content=Feiba+Comparison&utm_id=N7RXJYE6_FEIBADefense_24
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-feiba-defense-hospital (Hospital Version)
  • n7-hsp-feiba-defense-hospital.html
  • US24NSVN00078   December 2024
  • Last updated: 2025-01-13 23:43:27

  • Version: 5

Subject Line
  • A1 See key differences between rFVIIa and pd-aPCC products →

  • A2 Have you seen the key differences between rFVIIa and pd-aPCC products?

  • B1 Have you compared infusion times of bleeding disorders treatments?

  • B2 How many components are in your patients&rsquo; bleeding disorder treatment?

  • C1 How important is a fast infusion for your patients?

Preheader
  • A1 Learn the main components of each treatment.
  • A2 Learn the main components of each treatment.
  • B1 Learn the differences between products.
  • B2 Learn the differences between products.
  • C1 Learn the differences between rFVIIa and pd-aPCC products.
View / Download

Handoff: January 12, 2025

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Hospital+Pharmacy&utm_medium=email&utm_source=NNI&utm_content=Feiba+Comparison&utm_id=N7HSPJYE9_FEIBADefense_24
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-track-record (Preliminary handoff. Waiting on final GA tagging)
  • n7-patient-track-record.html
  • US24NSVN00057   October 2024
  • Last updated: 2025-01-15 00:43:06

  • Version: 4

Subject Line
  • A1 We’re here to support you

  • A2 We’re dedicated to your treatment needs

  • B1 Shining a spotlight on hemophilia B with inhibitors

  • B2 Hear from the hemophilia B with inhibitors community

Preheader
  • A1 See how to reach out for help or more product information.
  • A2 Discover ways to connect for support and guidance.
  • B1 Listen to one patient’s journey with a rare diagnosis.
  • B2 One patient shares his experience and treatment journey.
View / Download

Handoff: October 2024

(Preliminary handoff. Waiting on final GA tagging)

view | download
Tracking
  • (Google Analytics) Waiting on Final GA tagging
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-gt-journey-identify-channel-partner (version for Channel Partner: Medscape)
  • n7-hcp-gt-journey-identify.html
  • US22NSVN00060   October 2022
  • Last updated: 2024-12-03 14:30:27

  • Version: 1

Subject Line
  • A1 (Name:) Curated educational resources for you

  • A2 Tools and resources for identifying Glanzmann's Thrombasthenia

  • B1 Identifying this rare bleeding disorder presents multiple challenges

  • B2 (Name:) Did you know this rare bleeding disorder is often misdiagnosed?

  • C1 Could one of your patients have this often misdiagnosed rare bleeding disorder?

Preheader
  • A1 Are you prepared to diagnose this rare bleeding disorder?
  • A2 Are you prepared to diagnose this rare bleeding disorder?
  • B1 Explore Glanzmann's Thrombasthenia educational resources.
  • B2 Explore Glanzmann's Thrombasthenia educational resources.
  • C2 Learn how to spot the signs of Glanzmann's Thrombasthenia.
View / Download

Handoff: December 03, 2024

(Version for channel partner deployment: Medscape)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=GT+Journey&utm_medium=email&utm_source=NNI&utm_content=GT+Diagnosis&utm_id=N7GTJourney_GTID_EM1
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-promotional-hem-b-inhibitors-rbcl-update
  • n7-patient-promotional-hem-b-inhibitors-rbcl-update.html
  • US24NSVN00006   April 2024
  • Last updated: 2024-05-23 21:07:34

  • Version: 3

Subject Line
  • (A) [FirstName], your experiences living with hemophilia B with inhibitors are different than others

  • (B) [FirstName], you deserve more than just a treatment

  • (C) Novo Nordisk has resources available just for people living with hemophilia B with inhibitors

  • (D) Connect with resources curated for the hemophilia B with inhibitors community

Preheader
  • (A) Novo Nordisk has resources available just for you.
  • (B) Connect to resources created especially for you and your hemophilia B with inhibitors community.
  • (C) Get the support you deserve.
  • (D) Novo Nordisk has resources just for you.
View / Download

Handoff: May 23, 2024

view | download
Tracking
  • (Google Analytics)
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-urgency-to-treat-2023
  • n7-hcp-urgency-to-treat-2023.html
  • US23NSVN00041   September 2023
  • Last updated: 2023-09-12 15:44:15

  • Version: 4

Subject Line
  • A1 When do acute bleeds require urgent action?

  • A2 How urgently should you treat acute bleeds?

  • B1 Breakthrough bleeds happen. Make sure your patients are prepared.

  • B2 Are your patients prepared for breakthrough bleeds?

Preheader
  • A1 Explore real-world data.
  • A2 Explore real-world data.
  • B1 See why treating quickly makes a difference.
  • B2 See why treating quickly makes a difference.
View / Download

Handoff: September 2023

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=Urgency+to+treat&utm_id=<%= message.delivery.deliverycode %>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-pt-gt-CHES Updated Version for CHES
  • n7-pt-gt-CHES.html
  • US19NSVN00138   September 2020
  • Last updated: 2023-7-11 10:30:26

  • Version: 4

Subject Line
  • A1 Want to take a short quiz about life with Glanzmann’s thrombasthenia?

  • A2 Who’s the expert on life with Glanzmann’s thrombasthenia?

  • B1 A short quiz about life with Glanzmann’s thrombasthenia

  • B2 5 questions about life with Glanzmann’s thrombasthenia

Preheader
  • A1 Start by answering this true or false question.
  • A2 Answer some true or false questions about possible symptoms.
  • B1 Which of these questions are true or false?
  • B2 Take this short true or false quiz about treating related symptoms.
View / Download

Handoff: July 11, 2023

(Updated Version for CHES with updated GA Tagging, footer copy updates, replaced footer logo, removed NovoSecure Slab section, and other misc. QA fixes/updates)

view | download
Tracking
  • ?utm_medium=email&utm_source=CPHE&utm_campaign=GT&utm_content=GT&utm_id=nmtDC00003834
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-track-record-CHES Version for CHES
  • n7-patient-track-record-CHES.html
  • US20NSVN00094   October 2020
  • Last updated: 2023-07-07 11:30:05

  • Version: 2

Subject Line
  • A1 We’re here to support you

  • A2 We’re dedicated to your treatment needs

  • B1 Shining a spotlight on hemophilia B with inhibitors

  • B2 Hear from the hemophilia B with inhibitors community

Preheader
  • A1 See how to reach out for help or more product information.
  • A2 Discover ways to connect for support and guidance.
  • B1 Listen to one patient’s journey with a rare diagnosis.
  • B2 One patient shares his experience and treatment journey.
View / Download

Handoff: July 07, 2023

(Version for CHES with updated GA Tagging, footer and other misc. updates)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=CPHE&utm_campaign=CHBwI&utm_content=migpatstory&utm_id=nmtDC00003835
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-seventfact-chapter-CHBwI-audience-CHES (Version for CHES)
  • n7-patient-seventfact-chapter-CHBwI-audience-CHES.html
  • US20NSVN00137   November 2020
  • Last updated: 2023-06-28 17:28:28

  • Version: 2

Subject Line
  • A1 See why we’re trusted by people like you

  • A2 👀 See why we’re trusted by people like you

  • B1 4 great reasons to feel good about this therapy

  • B2 A few great reasons to feel good about this therapy

Preheader
  • A1 Decades of experience, strong patient support, and more.
  • A2 Decades of experience, strong patient support, and more.
  • B1 See how our experience supports you.
  • B2 See how our experience supports you.
View / Download

Handoff: June 28, 2023

(Updated GA tags, NovoCare, and other misc updates)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=CHES&utm_campaign=NovoSeven&utm_content=30+years+experience&utm_id=nmtDC00003668
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-connect-with-hcl
  • n7-patient-connect-with-hcl.html
  • US21NSVN00088   January 2022
  • Last updated: 2023-03-17 17:01:14

  • Version: 2

Subject Line
  • A1 Get the personalized support you deserve.

  • A2 [NAME], have you met your HCL?

  • B1 Stay connected to the bleeding disorders community.

  • B2 Looking for new resources, [NAME]?

Preheader
  • A1 Our team can help, [NAME].
  • A2 Your Hemophilia Community Liaison is here for you.
  • B1 Our team is here to support you, [NAME].
  • B2 Meet your local Hemophilia Community Liaison.
View / Download

Handoff: January 2022

(N7 Patient Journey CHAwI)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-hem-a-standard-of-care-refresh
  • n7-patient-hem-a-standard-of-care-refresh.html
  • US22NSVN00012   May 2022
  • Last updated: 2023-03-17 15:17:00

  • Version: 4

Subject Line
  • A1 [FirstName], are you prepared when a bleed happens unexpectedly?

  • A2 [FirstName], bleeds should be treated urgently

  • B1 [FirstName], are you using a trusted treatment option when a bleed happens?

  • B2 If you live with hemophilia with inhibitors, you need fast bleed control

  • (Alt Subject Line 1) How can people with hemophilia with inhibitors quickly resolve unexpected bleeds?

Preheader
  • A1 Discover a treatment option for sudden bleeds.
  • A2 See why people with hemophilia with inhibitors should consider this treatment option.
  • B1 Consider an option that comes with an established safety profile.
  • B2 This recombinant treatment option has been trusted for more than 30 years.
  • (Alt Preheader 1) Consider the established safety profile of this recombinant treatment.
View / Download

Handoff: May 2022

(N7 Patient Journey CHAwI)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-seventfact
  • n7-patient-seventfact.html
  • US20NSVN00137   November 2020
  • Last updated: 2023-03-16 20:57:34

  • Version: 15

Subject Line
  • A1 See why we’re trusted by people like you

  • A2 👀 See why we’re trusted by people like you

  • B1 Here are some reasons to feel good about this therapy

  • B2 A few great reasons to feel good about this therapy

Preheader
  • A1 Decades of experience, strong patient support, and more.
  • A2 Decades of experience, strong patient support, and more.
  • B1 See how our experience supports you.
  • B2 See how our experience supports you.
View / Download

Handoff: November 2020

(N7 Patient Journey CHAwI)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-pt-gt-email-1
  • n7-pt-gt-email-1.html
  • US19NSVN00138   September 2020
  • Last updated: 2023-03-13 21:38:44

  • Version: 8

Subject Line
  • A1 Want to take a short quiz about life with Glanzmann’s thrombasthenia?

  • A2 Who’s the expert on life with Glanzmann’s thrombasthenia?

  • B1 A short quiz about life with Glanzmann’s thrombasthenia

  • B2 5 questions about life with Glanzmann’s thrombasthenia

Preheader
  • A1 Start by answering this true or false question.
  • A2 Answer some true or false questions about possible symptoms.
  • B1 Which of these questions are true or false?
  • [object Object]
View / Download

Handoff: September 2020

(N7 Patient Journey GT)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-pt-talk-to-your-doctor
  • n7-pt-talk-to-your-doctor.html
  • US19NSVN00139   October 2020
  • Email on Acid
  • Last updated: 2023-03-09 20:51:29

  • Version: 15

Subject Line
  • A1 What GT treatment questions should you ask your doctor?

  • A2 Make the most of your next doctor’s appointment

  • B1 Is your treatment for Glanzmann’s thrombasthenia doing the job?

  • B2 A doctor discussion guide specific to Glanzmann’s thrombasthenia

Preheader
  • A1 Our discussion guide for Glanzmann’s thrombasthenia can help.
  • A2 Download our discussion guide for Glanzmann’s thrombasthenia.
  • B1 If you haven’t taken this quiz, you may be missing answers.
  • B2 Download the guide to make the most of your next visit
View / Download

Handoff: October 2020

(N7 Patient Journey GT)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-sevenfact-defensive-messaging
  • n7-patient-sevenfact-defensive-messaging.html
  • US21NSVN00090   December 2021
  • Last updated: 2023-03-06 18:25:55

  • Version: 1

Subject Line
  • A1 Comparing rFVIIa treatments?

  • A2 Looking for an established treatment?

  • B1 Real patients, real stories

  • B2 What's Miguel’s rFVIIa choice?

  • C1 Only one rFVIIa has 30 years of experience and trust

  • C2 Which rFVIIa comes with 30 years of experience and trust?

  • D1 Choosing an rFVIIa treatment?

  • D2 Get the facts about an rFVIIa treatment choice

Preheader
  • A1 Follow the facts.
  • A2 One rFVIIa comes with 30 years of experience.
  • B1 What does Miguel expect from his rFVIIa treatment?
  • B2 Get the facts about an rFVIIa with 30 years of experience.
  • C1 Get the facts about treatment options.
  • C2 Get the facts about treatment options.
  • D1 Find out why other patients choose this one.
  • D2 Learn how other patients made their decision.
View / Download

Handoff: December 2021

(N7 Patient Journey CHBwI)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-rare-bleeding-disorders-education
  • n7-hsp-rare-bleeding-disorders-education.html
  • US22NSVN00038   July 2022
  • Last updated: 2023-02-07 14:26:12

  • Version: 4

Subject Line
  • A1 Explore resources for treating hemophilia and other rare bleeding disorders

Preheader
  • A1 Take a look around the novoMEDLINK™ experience.
View / Download

Handoff: July 2022

(Outlook for Mac table align fix)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=RBD&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-global-campaign-hospital-series (Hospital Version)
  • n7-global-campaign-hospital-series.html
  • US22NSVN00058   August 2022
  • Last updated: 2022-02-08 11:25:16

  • Version: 6

Subject Line
  • A1 30+ years of effective bleed control

Preheader
  • A1 See why patients and professionals rely on this rFVIIa treatment.
View / Download

Handoff: August 2022

(Outlook for Mac table align fix)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=Why+NovoSeven&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-global-campaign-pharmacy-series (Pharmacy Version)
  • n7-global-campaign-pharmacy-series.html
  • US22NSVN00059   August 2022
  • Last updated: 2023-02-08 11:50:10

  • Version: 5

Subject Line
  • A1 30+ years of effective bleed control

Preheader
  • A1 See why patients and professionals rely on this rFVIIa treatment.
View / Download

Handoff: August 2022

(Outlook for Mac table align fix)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=Why+NovoSeven&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-sevenfact-defense
  • n7-hcp-sevenfact-defense.html
  • US21NSVN00105   December 2021
  • Last updated: 2023-02-08 13:35:24

  • Version: 11

Subject Line
  • A1 Looking for an established treatment for your patients with bleeding disorders?

  • A2 Trust comes from experience when treating patients with rare bleeding disorders

  • B1 Consider prescribing an established rFVIIa for your patients

  • B2 No two rFVIIa products are the same

  • C1 How do these two rFVIIa products stack up?

  • C2 Which rFVIIa do you prescribe for rare bleeding disorders?

Preheader
  • A1 See how these rFVIIa treatments stack up.
  • A2 See which rFVIIa is right for your patients.
  • B1 See the clinical data.
  • B2 Explore the clinical data for this rFVIIa.
  • C1 See which is right for your patients.
  • C2 See which is right for your patients.
View / Download

Handoff: December 2022

(Outlook for Mac table align fix)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=Competitive&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-CFVIId (HSP Hospital Version)
  • n7-hsp-CFVIId.html
  • US22NSVN00068   November 2022
  • Last updated: 2023-02-09 10:44:17

  • Version: 6

Subject Line
  • HCP Subject Lines
  • A1: Are you prepared to help your patients with CFVIId?
  • A2: Are you prepared? How to treat patients with CFVIId
  • B1: Why early treatment for CFVIId is important
  • B2: CFVIId: early treatment is important
  • HSP Subject Lines
  • A1: How to prepare your hospital team for patients with CFVIId
  • A2: Is your hospital team prepared? Treating patients with CFVIId
  • B1: Why preparing to treat CFVIId urgently is important for your hospital team
  • B2: CFVIId? Preparing your hospital team to urgently treat it is important
  • HCP Phrasee Subject Lines
  • 1: **For HCPs ** Timely intervention is important for patients with CFVIId.
  • 2: Attention, health care providers: discover the importance of early treatment for CFVIId
  • 3: Early CFVIId treatment = essential.
  • 4: [[ CFVIId ]] Identification and treatment is best done early
  • 5: 📩 Your CFVIId informational email | Top reasons why treatment should start early
  • 6: Are you prepared to treat this bleeding disorder?
  • 7: Early intervention for CFVIId is VITAL >>>
  • 8: Click here to learn more about early treatment for CFVIId
  • 9: Have patients with CFVIId? Here's why early treatment is important
  • HSP Phrasee Subject Lines
  • 1: Prepared to treat patients with CFVIId? Here's what you should know
  • 2: (( Stay up to date )) Be sure that your hospital team has everything it needs
  • 3: Health care providers, this is for YOU - learn more about treating patients with CFVIId
  • 4: Does your hospital team take care of patients with CFVIId? >> You should check this out...
  • 5: Here's some information on treating patients with CFVIId
  • 6: This info could be useful for your hospital team ▶
  • 7: Get your hospital team ready for treating patients with CFVIId
  • 8: Get the info you need to care for patients with CFVIId - we think this may interest you
  • 9: 👋 Don't miss this - make sure you have all the necessary information
  • 10: For you and your hospital team: read more about treating patients with CFVIId
Preheader
  • HCP Preheaders
  • A1: See why early treatment is crucial.
  • A2: See why early treatment is crucial.
  • B1: Discover a product that offers bleed control for patients with CFVIId.
  • B2: Discover a product that offers bleed control for patients with CFVIId.
  • HSP Preheaders
  • A1: Learn about the crucial need for early treatment.
  • A2: Learn about the crucial need for early treatment.
  • B1: Discover a product that offers bleed control for patients with CFVIId.
  • B2: Discover a product that offers bleed control for patients with CFVIId.
View / Download

Handoff: November 2022

(Outlook for Mac table align fix)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=Efficacy+FVIId&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-CFVIId (HCP Healthcare Version)
  • n7-hcp-CFVIId.html
  • US22NSVN00068   November 2022
  • Last updated: 2023-02-08 14:53:17

  • Version: 6

Subject Line
  • HCP Subject Lines
  • A1: Are you prepared to help your patients with CFVIId?
  • A2: Are you prepared? How to treat patients with CFVIId
  • B1: Why early treatment for CFVIId is important
  • B2: CFVIId: early treatment is important
  • HSP Subject Lines
  • A1: How to prepare your hospital team for patients with CFVIId
  • A2: Is your hospital team prepared? Treating patients with CFVIId
  • B1: Why preparing to treat CFVIId urgently is important for your hospital team
  • B2: CFVIId? Preparing your hospital team to urgently treat it is important
  • HCP Phrasee Subject Lines
  • 1: **For HCPs ** Timely intervention is important for patients with CFVIId.
  • 2: Attention, health care providers: discover the importance of early treatment for CFVIId
  • 3: Early CFVIId treatment = essential.
  • 4: [[ CFVIId ]] Identification and treatment is best done early
  • 5: 📩 Your CFVIId informational email | Top reasons why treatment should start early
  • 6: Are you prepared to treat this bleeding disorder?
  • 7: Early intervention for CFVIId is VITAL >>>
  • 8: Click here to learn more about early treatment for CFVIId
  • 9: Have patients with CFVIId? Here's why early treatment is important
  • HSP Phrasee Subject Lines
  • 1: Prepared to treat patients with CFVIId? Here's what you should know
  • 2: (( Stay up to date )) Be sure that your hospital team has everything it needs
  • 3: Health care providers, this is for YOU - learn more about treating patients with CFVIId
  • 4: Does your hospital team take care of patients with CFVIId? >> You should check this out...
  • 5: Here's some information on treating patients with CFVIId
  • 6: This info could be useful for your hospital team ▶
  • 7: Get your hospital team ready for treating patients with CFVIId
  • 8: Get the info you need to care for patients with CFVIId - we think this may interest you
  • 9: 👋 Don't miss this - make sure you have all the necessary information
  • 10: For you and your hospital team: read more about treating patients with CFVIId
Preheader
  • HCP Preheaders
  • A1: See why early treatment is crucial.
  • A2: See why early treatment is crucial.
  • B1: Discover a product that offers bleed control for patients with CFVIId.
  • B2: Discover a product that offers bleed control for patients with CFVIId.
  • HSP Preheaders
  • A1: Learn about the crucial need for early treatment.
  • A2: Learn about the crucial need for early treatment.
  • B1: Discover a product that offers bleed control for patients with CFVIId.
  • B2: Discover a product that offers bleed control for patients with CFVIId.
View / Download

Handoff: November 2022

(Outlook for Mac table align fix)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=Efficacy+FVIId&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-chwi-overview-refresh
  • n7-hsp-chwi-overview-refresh.html
  • US22NSVN00039   August 2022
  • Last updated: 2023-02-09 13:21:52

  • Version: 5

Subject Line
  • A1 CHwI patients can experience breakthrough bleeds

Preheader
  • A1 Treat them quickly with this rFVIIa
View / Download

Handoff: August 2022

(Outlook for Mac table align fix)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=Efficacy+CHABwI&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-gt-overview-refresh
  • n7-hsp-gt-overview-refresh.html
  • US22NSVN00056   September 2022
  • Last updated: 2023-02-09 13:54:14

  • Version: 4

Subject Line
  • A1 Looking to learn more about diagnosing Glanzmann’s thrombasthenia?

  • A2 Diagnostic and treatment considerations for Glanzmann’s thrombasthenia

  • B1 Is your hospital prepared to treat Glanzmann’s thrombasthenia patients?

  • B2 Make sure your hospital is prepared to treat Glanzmann’s thrombasthenia patients

  • C1 Explore diagnostic resources for Glanzmann’s thrombasthenia

  • C2 Is your hospital prepared to diagnose and treat rare bleeding disorders?

  • D1 Have you encountered this one-in-a-million bleeding disorder?

  • D2 Can you spot the signs of this rare bleeding disorder?

Preheader
  • A1 Resources and data curated for you.
  • A2 Resources and data curated for you.
  • B1 Consider this treatment option for patients with refractoriness to platelets.
  • B2 Consider this treatment option for patients with refractoriness to platelets.
  • C1 Learn more about a recombinant treatment option.
  • C2 Learn more about a recombinant treatment option for Glanzmann’s thrombasthenia.
  • D1 Diagnosing this rare disease can be challenging.
  • D2 Diagnosing this rare disease can be challenging.
View / Download

Handoff: September 2022

(Outlook for Mac table align fix)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=GT+Diagnosis&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-ah-overview
  • n7-hsp-ah-overview.html
  • US22NSVN00072   November 2022
  • Last updated: 2023-01-30 19:52:16

  • Version: 6

Subject Line
  • A1 Explore acquired hemophilia and the importance of early diagnosis and treatment
  • A2 Acquired hemophilia: the importance of early diagnosis
  • B1 See why a delayed diagnosis of acquired hemophilia can put patients at risk
  • B2 Your patients with acquired hemophilia: see the dangers of a delayed diagnosis
Preheader
  • A1 Get the facts about treatment.
  • A2 Get the facts about treatment.
  • B1 Learn more about a first-line treatment.
  • B2 Learn more about a first-line treatment.
View / Download

Handoff: November 2022

(Added padding fix to "Key Facts..." section)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=email&utm_source=ADBE&utm_content=Hospital+AH
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-storage-and-infusion-refresh
  • n7-hsp-storage-and-infusion-refresh.html
  • US22NSVN00055   September 2022
  • Last updated: 2022-12-14 10:15:32

  • Version: 6

Subject Line
  • A1 Your hospital team relies on you. Be prepared with this rFVIIa.

  • A2 Prepare your hospital team with this rFVIIa

  • B1 Tools for your pharmacy team

  • B2 Curated for you: try this dosing calculator

  • C1 Tools for your hospital team

  • C2 Curated resources for you

Preheader
  • A1 Learn more about its compact packaging and bleed control.
  • A2 Learn more about its compact packaging and bleed control.
  • B1 Learn more about this fast and effective rFVIIa therapy.
  • B2 Learn more about this fast and effective rFVIIa therapy.
  • C1 This rFVIIa therapy contributes to hospital pharmacy efficiency.
  • C2 This rFVIIa therapy contributes to hospital pharmacy efficiency
View / Download

Handoff: September 2022

(Updated GA tagging to new HCP format)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=Dosing+Bleed+Control&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-btbs-patients
  • n7-hsp-btbs-patients.html
  • US22NSVN00069   November 2022
  • Last updated: 2022-12-13 14:08:13

  • Version: 6

Subject Line
  • HSP/HCP AUDIENCE:
  • A1: Recommendations for treatment of certain breakthrough bleeds
  • A2: Certain breakthrough bleeds in your patients? Recommendations for treatment
  • B1: Why you should treat certain breakthrough bleeds immediately
  • B2: Certain breakthrough bleeds: treating immediately is key
  • PHARMACY AUDIENCE
  • A1: Recommendations for equipping your pharmacy to treat certain breakthrough bleeds
  • A2: Certain breakthrough bleeds in your patients? Recommendations for treatment
  • B1: Why your pharmacy should be ready to treat certain breakthrough bleeds
  • B2: Certain breakthrough bleeds: is your pharmacy ready to treat them?
  • [Hospital Phrasee Subject Lines:]
  • 1: Are your patients experiencing breakthrough bleeds? Explore these treatment recommendations
  • 2: If you need guidance on dealing with your patients' breakthrough bleeds, look here 👀
  • 3: We think THIS treatment info might interest you...
  • 4: 👋 You might appreciate this - view suggestions for treating breakthrough bleeds
  • 5: For your patients with bleeding disorders: they could benefit from this
  • 6: ** Stay updated on their treatment options **
  • 7: You could be better prepared for your patients' breakthrough bleeds (see how!)
  • [Pharmacy Phrasee Subject Lines:]
  • 1: A message for you: are you prepared to treat breakthrough bleeds?
  • 2: ↪ Make sure you're prepared...
  • 3: Treating breakthrough bleeds - here's some useful information
  • 4: Want to make sure you're ready to treat breakthrough bleeds?
  • 5: Breakthrough bleeds: recommendations for your pharmacy inside
  • 6: Treatment recommendations you might be interested in 👉
  • 7: Your update: does your pharmacy have EVERYTHING it needs to treat breakthrough bleeds?
  • 8: ** For your pharmacy ** Do you have everything you need?
  • 9: Here are some recommendations for your pharmacy...
Preheader
  • HSP/HCP AUDIENCE
  • A2: See why an additional treatment can help.
  • A2: See why an additional treatment can help.
  • B1: See MASAC recommendations.
  • B2: See MASAC recommendations.
  • PHARMACY AUDIENCE
  • A1: See why an additional treatment can help.
  • A2: See why an additional treatment can help.
  • B1: Discover a MASAC recommended treatment.
  • B1: Discover a MASAC recommended treatment.
View / Download

Handoff: November 2022

(Updated GA tagging to new HCP format)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%=message.delivery.operation.label%>&utm_content=Why+NovoSeven&utm_id=<%=message.delivery.deliverycode%>
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-gt-journey-diagnose
  • n7-hcp-gt-journey-diagnose.html
  • US22NSVN00061   October 2022
  • Last updated: 2022-11-21 08:55:54

  • Version: 12

Subject Line
  • A1 (Name:) Targeted tools and education for you

  • A2 Glanzmann's Thrombasthenia tools and education

  • B1 A diagnostic algorithm for Glanzmann's Thrombasthenia (GT)

  • B2 (Name:) Try the Glanzmann's Thrombasthenia (GT) diagnostic algorithm

Preheader
  • A1 Tools to help you diagnose Glanzmann's thrombasthenia.
  • A2 Tools to help you diagnose Glanzmann's thrombasthenia.
  • B1 Could it be GT? Use these resources to learn more about GT diagnosis.
  • B2 Could it be GT? Use these resources to learn more about GT diagnosis.
View / Download

Handoff: October 2022

view | download
Tracking
  • (Google Analytics) ?utm_campaign=GT+Journey&utm_medium=email&utm_source=NNI&utm_content=GT+Algorithm&utm_id=N7GTJourney_GTDiagnose_EM2
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-gt-journey-support
  • n7-hcp-gt-journey-support.html
  • US22NSVN00066   October 2022
  • Last updated: 2022-11-21 17:21:39

  • Version: 7

Subject Line
  • A1 Prescribing this rFVIIa treatment?

  • A2 Try tools to help you calculate a dose for this rFVIIa treatment on novoMEDLINK™

  • B1 Easily calculate dosing for this rFVIIa treatment

  • B2 Have you prescribed this rFVIIa treatment?

  • PHRASEE SUBJECT LINES

  • 1 🔎 Find useful information for healthcare providers and patients 🔎

  • 2 You may find these rFVIIa treatment tools useful!

  • 3 Hello 👋 Want to learn more about this rFVIIa treatment?

  • 4 Do you have questions about prescribing or dosing for this rFVIIa treatment?

  • 5 Educational materials available | Here's what you should know about this rFVIIa treatment

  • 6 ** This info is for YOU **

  • 7 See why it may be time to think about prescribing this rFVIIa treatment (and get access to helpful information)

  • 8 Have you thought about this rFVIIa treatment for your patients?

Preheader
  • A1 Discover quick ordering options that fit your busy schedule.
  • A2 Discover quick ordering options that fit your busy schedule.
  • B1 We have resources to help you treat this bleeding disorder.
  • B2 We have resources to help you treat this bleeding disorder.
View / Download

Handoff: October 2022

view | download
Tracking
  • (Google Analytics) ?utm_campaign=GT+Journey&utm_medium=email&utm_source=NNI&utm_content=HCP Resources&utm_id=N7GTJourney_GTSupport_EM5
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-studied-with-hemlibra
  • n7-studied-with-hemlibra.html
  • US20NSVN00069   November 2020
  • Last updated: 2022-11-10 18:22:06

  • Version: 7

Subject Line
  • A1 The research behind this recombinant therapy may help your patients

  • A2 Your patients can rely on the research behind this factor therapy

  • B1 This factor therapy offers proven safety for patients with acute bleeds

  • B2 Your patients with acute bleeds can rely on these proven safety results

Preheader
  • A1 See the clinical data and safety profile.
  • A2 Explore the established bleed control and safety profile.
  • B1 See the clinical data behind this recombinant treatment.
  • B2 Explore the established bleed control and safety profile.
View / Download

Handoff: November 2020

(Updated GA tagging for Re-Deployment)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=NNI&utm_campaign=Continue+to+Lead&utm_content=HCP+Resources&utm_id=NV7AHE2AD_StudyHemlibra_Dec22
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-gt-journey-efficacy-safety
  • n7-hcp-gt-journey-efficacy-safety.html
  • US22NSVN00063   October 2022
  • Last updated: 2022-10-28 17:42:54

  • Version: 9

Subject Line
  • A1 Explore safety and efficacy data on this rFVIIa option for Glanzmann's thrombasthenia

  • A2 Learn more about a treatment option for Glanzmann's thrombasthenia

  • B1 Considering treatments for your Glanzmann's thrombasthenia (GT) patients?

  • B2 Are you prepared to treat Glanzmann's thrombasthenia (GT) patients?

Preheader
  • A1 Data and resources curated for you.
  • A2 Data and resources curated for you.
  • B1 Learn more about this treatment option for GT patients.
  • B2 Learn more about this treatment option for GT patients.
View / Download

Handoff: October 2022

view | download
Tracking
  • (Google Analytics) ?utm_campaign=GT+Journey&utm_medium=email&utm_source=NNI&utm_content=Efficacy GT&utm_id=N7GTJourney_GTTreatment_EM4
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-global-campaign-healthcare-professional-series (Healthcare Professional Version)
  • n7-global-campaign-healthcare-professional-series.html
  • US22NSVN00037   September 2022
  • Last updated: 2022-09-22 18:43:00

  • Version: 6

Subject Line
  • A1 30+ years of effective bleed control

  • A2 Trusted bleed control with established experience

  • B1 Trusted bleed control for a range of rare bleeding disorders

  • B2 A recombinant treatment for a wide range of rare bleeding disorders

Preheader
  • A1 See why patients and professionals use this rFVIIa treatment.
  • A2 See why patients and professionals use this rFVIIa treatment.
  • B1 Explore the data for this rFVIIa therapy.
  • B2 Explore the data for this rFVIIa therapy.
View / Download

Handoff: September 2022

view | download
Tracking
  • (Google Analytics) ?utm_campaign=Success+Speaks+for+Itself&utm_medium=email&utm_source=NNI&utm_content=HCP+Resources&utm_id=NV7AHE2AD_GlobalCampaign_Oct22
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-gt-journey-gt-vs-vwd
  • n7-hcp-gt-journey-gt-vs-vwd.html
  • US22NSVN00062   October 2022
  • Last updated: 2022-10-28 17:42:54

  • Version: 9

Subject Line
  • A1 (Name:) Can you spot the differences between these rare bleeding disorders?

  • A2 Can you spot the differences between Glanzmann's Thrombasthenia and von Willebrand's?

  • B2 (Name:) Tools to help avoid misdiagnosing this rare bleeding disorder

Preheader
  • A1 Explore education and tools to help prevent misdiagnosis.
  • A2 Explore education and tools to help prevent misdiagnosis.
  • B1 Glanzmann's Thrombasthenia can be easy to miss.
  • B2 Glanzmann's Thrombasthenia can be easy to miss.
View / Download

Handoff: October 2022

view | download
Tracking
  • (Google Analytics) ?utm_campaign=GT+Journey&utm_medium=email&utm_source=NNI&utm_content=GTvsvWD&utm_id=N7GTJourney_GTvonWill_EM3
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-gt-journey-identify
  • n7-hcp-gt-journey-identify.html
  • US22NSVN00060   October 2022
  • Last updated: 2022-10-24 23:38:27

  • Version: 12

Subject Line
  • A1 (Name:) Curated educational resources for you

  • A2 Tools and resources for identifying Glanzmann's Thrombasthenia

  • B1 Identifying this rare bleeding disorder presents multiple challenges

  • B2 (Name:) Did you know this rare bleeding disorder is often misdiagnosed?

  • C1 Could one of your patients have this often misdiagnosed rare bleeding disorder?

Preheader
  • A1 Are you prepared to diagnose this rare bleeding disorder?
  • A2 Are you prepared to diagnose this rare bleeding disorder?
  • B1 Explore Glanzmann's Thrombasthenia educational resources.
  • B2 Explore Glanzmann's Thrombasthenia educational resources.
  • C2 Learn how to spot the signs of Glanzmann's Thrombasthenia.
View / Download

Handoff: October 2022

view | download
Tracking
  • (Google Analytics) ?utm_campaign=GT+Journey&utm_medium=email&utm_source=NNI&utm_content=GT+Diagnosis&utm_id=N7GTJourney_GTID_EM1
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-connect-with-hcl-CHES (CHES version)
  • n7-patient-connect-with-hcl-CHES.html
  • US21NSVN00088   January 2022
  • Last updated: 2021-06-17 12:30:26

  • Version: 1

Subject Line
  • /-- PRIMARY SUBJECT LINES --/

  • A1 Get the personalized support you deserve.

  • A2 [NAME], have you met your HCL?

  • B1 Stay connected to the bleeding disorders community.

  • B2 Looking for new resources, [NAME]?

  • /-- PARTNER/NO ZIP CODE AVAILABLE SUBJECT LINES --/

  • A1 Get the personalized support you deserve.

  • A2 Have you met your HCL?

  • B1 Stay connected to the bleeding disorders community.

  • B2 Looking for new resources?

Preheader
  • /-- PRIMARY PRE-HEADERS --/

  • A1 Our team can help, [NAME].

  • A2 Your Hemophilia Community Liaison is here for you.

  • B1 Our team is here to support you, [NAME].

  • B2 Meet your local Hemophilia Community Liaison.

  • /-- PARTNER/NO ZIP CODE AVAILABLE PRE-HEADERS --/

  • A1 Our team can help.

  • A2 Your Hemophilia Community Liaison is here for you.

  • B1 Our team is here to support you.

  • B2 Meet your local Hemophilia Community Liaison.

View / Download

Handoff: June 17, 2022

(Version for CHES)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=CHES&utm_campaign=HCLConnect&utm_content=HCL&utm_id=100002601&src=100002601
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-sevenfact-defense-cardinal-health (Cardinal Health version)
  • n7-hcp-sevenfact-defense-cardinal-health.html
  • US21NSVN00105   December 2021
  • Last updated: 2022-04-08 09:54:24

  • Version: 1

Subject Line
  • A1 Looking for an established treatment for your patients with bleeding disorders?

  • A2 Trust comes from experience when treating patients with rare bleeding disorders

  • B1 Consider prescribing an established rFVIIa for your patients

  • B2 No two rFVIIa products are the same

  • C1 How do these two rFVIIa products stack up?

  • C2 Which rFVIIa do you prescribe for rare bleeding disorders?

Preheader
  • A1 See how these rFVIIa treatments stack up.
  • A2 See which rFVIIa is right for your patients.
  • B1 See the clinical data.
  • B2 Explore the clinical data for this rFVIIa.
  • C1 See which is right for your patients.
  • C2 See which is right for your patients.
View / Download

Handoff: April 8, 2022

(Created version for channel partner handoff for Cardinal Health)

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoseven%20contlead &utm_medium=email &utm_source=nniemail_th &utm_content=EffSafCHABwI
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • novomedlink-knee-bleed-video-outlook-email-b (Outlook email, Version B)
  • novomedlink-knee-bleed-video-outlook-email-b.oft
  • US21HRBD00240   February 2022
  • Last updated: 2022-03-23 5:02:28

  • Version: 1

Subject Line
  • Engage patients with an interactive hemophilia resource

Preheader
  •  
View / Download

Handoff: March 23, 2022

view | download
Tracking
  • (Google Analytics) ?utm_source=nniemail_th&utm_medium=email&utm_content=ClinEd&utm_campaign=novoseven%20contlead
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-sevenfact-defensive-messaging-la-kelley-v2
  • n7-sevenfact-defensive-messaging-la-kelley-v2
  • US21NSVN00090   December 2021
  • Last updated: 2022-02-08 09:12:53

  • Version: 2

Subject Line
  • A1: Comparing rFVIIa treatments?

  • A2: Looking for an established treatment?

  • B1: Real patients, real stories

  • B2: What's Miguel’s rFVIIa choice?

  • C1: Only one rFVIIa has 30 years of experience and trust

  • C2: Which rFVIIa comes with 30 years of experience and trust?

  • D1: Choosing an rFVIIa treatment?

  • D2: Get the facts about an rFVIIa treatment choice

Preheader
  • A1: Follow the facts.
  • A2: One rFVIIa comes with 30 years of experience.
  • B1: What does Miguel expect from his rFVIIa treatment?
  • B2: Get the facts about an rFVIIa with 30 years of experience.
  • C1: Get the facts about treatment options.
  • C2: Get the facts about treatment options.
  • D1: Find out why other patients choose this one.
  • D2: Learn how other patients made their decision.
View / Download

Handoff: 02/08/2022

(Completed some HTML QA updates. Renamed file to v2)

view | download
Tracking
  • (Google Analytics) ?utm_medium=email&utm_source=LAKelly&utm_campaign=Competitive&utm_content=Sevenfact&utm_id=100002503&src=100002503
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-nml-launch-announcement
  • n7-hcp-nml-launch-announcement.html
  • US21NSVN00081   December 2021
  • Last updated: 2021-12-16 19:21:39

  • Version: 2

Subject Line
  • A1 Explore our resources for professionals who treat certain rare bleeding disorders

  • A2 All of our rare bleeding disorders content, all in one place

  • A3 Multiple bleeding disorders, one place for resources

  • B1 Your time is important—that’s where novoMEDLINK™ comes in

  • B2 Finding resources shouldn’t take long—introducing novoMEDLINK™

  • B3 One efficient place for more resources—that’s novoMEDLINK™

Preheader
  • A1 Take a look around the new novoMEDLINK™ experience.
  • A2 Take a look around the new novoMEDLINK™ experience.
  • A3 Take a look around the new novoMEDLINK™ experience.
  • B1 Find treatment info for your patients with certain rare bleeding disorders.
  • B2 Find treatment info for your patients with certain rare bleeding disorders.
  • B3 Find treatment info for your patients with certain rare bleeding disorders.
View / Download

Handoff: December 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoseven%20contlead &utm_medium=email &utm_source=nniemail_th &utm_content=RBDHome
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-nml-launch-announcement
  • n7-hsp-nml-launch-announcement.html
  • US21NSVN00081   December 2021
  • Last updated: 2021-12-15 20:46:53

  • Version: 1

Subject Line
  • A1 Explore our resources for professionals who treat certain rare bleeding disorders

  • A2 All of our rare bleeding disorders content, all in one place

  • A3 Multiple bleeding disorders, one place for resources

  • B1 Your time is important—that’s where novoMEDLINK™ comes in

  • B2 Finding resources shouldn’t take long—introducing novoMEDLINK™

  • B3 One efficient place for more resources—that’s novoMEDLINK™

Preheader
  • A1 Take a look around the new novoMEDLINK™ experience.
  • A2 Take a look around the new novoMEDLINK™ experience.
  • A3 Take a look around the new novoMEDLINK™ experience.
  • B1 Find treatment info for your patients with certain rare bleeding disorders.
  • B2 Find treatment info for your patients with certain rare bleeding disorders.
  • B3 Find treatment info for your patients with certain rare bleeding disorders.
View / Download

Handoff: December 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoseven%20contlead &utm_medium=email &utm_source=nniemail_th &utm_content=RBDHome
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • novomedlink-knee-bleed-video-outlook-email-a (Outlook email)
  • novomedlink-knee-bleed-video-outlook-email-a.oft
  • US21HRBD00226   November 2021
  • Last updated: 2021-11-18 11:29:28

  • Version: 1

Subject Line
  • Educate patients on the need to treat joint bleeds quickly

Preheader
  •  
View / Download

Handoff: November 18, 2021

view | download
Tracking
  • (Google Analytics) ?utm_source=nniemail_th&utm_medium=email&utm_content=ClinEd&utm_campaign=novoseven%20contlead
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-urgency-to-treat
  • n7-hcp-urgency-to-treat.html
  • US21NSVN00065   October 2021
  • Email on Acid
  • Last updated: 2021-10-05 21:52:40

  • Version: 6

Subject Line
  • HCPs-A1 For acute bleeds, treating early is critical

  • HCPs-A2 Your first choice for breakthrough bleeds

  • HCPs-A3 For acute bleeds, don’t watch and wait

  • Nurses-A1 When your patients have an acute bleed, treat immediately

  • [object Object]

  • Nurses-A3 Support patients with acute bleeds

Preheader
  • HCPs-A1 See what MASAC recommends.
  • HCPs-A2 See the data.
  • HCPs-A3 See what MASAC recommends.
  • Nurses-A1 See what MASAC recommends.
  • Nurses-A2 Support your patients.
  • Nurses-A3 Don’t watch and wait.
View / Download

Handoff: October 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoseven%20contlead &utm_medium=email &utm_source=nniemail_th &utm_content=CDCHABwI
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-established-experienced-effective-la-kelley (Version for LA Kelley)
  • n7-patient-established-experienced-effective-la-kelley.html
  • US20NSVN00025   March 2020
  • Last updated: 2021-08-20 13:12:43

  • Version: 2

Subject Line
  • 3 reasons why this recombinant therapy may be the right choice for you

  • 3 reasons to consider this recombinant therapy for hemophilia with inhibitors

  • 3 reasons to consider this recombinant therapy for GT with resistance to platelets

  • 3 reasons to consider this recombinant therapy for Factor VII deficiency

  • Established, Experienced, Effective: This recombinant therapy is all 3

  • An established, experienced, and effective therapy for hemophilia with inhibitors

  • An established, experienced, and effective therapy for GT with resistance to platelets

  • An established, experienced, and effective therapy for Factor VII deficiency

Preheader
  • More about our commitment to your treatment journey.
  • Explore the dedication behind this treatment option.
View / Download

Handoff: August 20, 2021

(Updated GA tags)

view | download
Tracking
  • (Google Analytics) ?utm_source=LAK&utm_medium=Email&utm_campaign=acquisition&utm_term=US20NSVN00025&utm_content=
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-sevenfact-competitive-rm-PDQ
  • n7-hsp-sevenfact-competitive-rm-PDQ.html
  • US20NSVN00115   February 2021
  • Last updated: 2021-06-02 10:12:43

  • Version: 1

Subject Line
  • C1 Is your hospital prepared for bleeds in CHwI patients under age 12?

  • C2 Is your ED team prepared for bleeds in CHwI patients under age 12?

  • D1 Prepare your staff to treat the most severe bleeds in CHwI patients

  • D2 Prepare your staff to treat the most severe bleeds in CHwI patients

Preheader
  • C1 Learn which bypassing agent is indicated for all ages.
  • C2 Learn which bypassing agent is indicated for all ages.
  • D1 Choose a bypassing agent that is proven in these patients.
  • D2 Choose a bypassing agent with proven efficacy.
View / Download

Handoff: June 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoseven%20contlead &utm_medium=email &utm_source=nniemail_th &utm_content=SevenFACT-Competitive
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-be-the-face-CHES
  • n7-patient-be-the-face-CHES.html
  • US21NSVN00001   February 2021
  • Last updated: 2021-04-08 12:23:18

  • Version: 1



  • emoji codes:
    📸 U+1F4F8
    📣 U+1F4E3
Subject Line
  • A1 📸 Your story should take center stage

  • A2 📸 Shining the spotlight on your story

  • B1 📣 Here’s your chance to “Be the Face” of the bleeding disorders community

  • B2 📣 Here’s an exciting opportunity to “Be the Face” for those with a bleeding disorder

Preheader
  • A1 See how to share your experience with the community.
  • A2 Ready to inspire others with your experience?
  • B1 Inspire others by sharing your story.
  • B2 Learn how you could inspire the community.
View / Download

Handoff: April 08, 2021

view | download
Tracking
  • (Google Analytics) ?utm_source=CHES&utm_medium=Email&utm_campaign=acquisition&utm_term=US21NSVN00001
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-consumer-council-follow-up-outlook
  • n7-consumer-council-follow-up-outlook.html
  • US20NSVN00062   October 2020
  •  
  •  
Subject Line
  •  

Preheader
  •  
View / Download

Handoff: April 05, 2021

view | download
 
  •  
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-consumer-council-thank-you-outlook
  • n7-consumer-council-thank-you-outlook.html
  • US20NSVN00061   June 2020
  •  
  •  
Subject Line
  •  

Preheader
  •  
View / Download

Handoff:  

view
Tracking
  •  
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-sevenfact-competitive-rm-asd
  • n7-hsp-sevenfact-competitive-rm-asd.html
  • US20NSVN00115   February 2021
  • Last updated: 2021-03-08 19:20:55

  • Version: 1

Subject Line
  • C1 Is your hospital prepared for bleeds in CHwI patients under age 12?

  • C2 Is your ED team prepared for bleeds in CHwI patients under age 12?

  • D1 Prepare your staff to treat the most severe bleeds in CHwI patients

  • D2 Prepare your staff to treat the most severe bleeds in CHwI patients

Preheader
  • C1 Learn which bypassing agent is indicated for all ages.
  • C2 Learn which bypassing agent is indicated for all ages.
  • D1 Choose a bypassing agent that is proven in these patients.
  • D2 Choose a bypassing agent with proven efficacy.
View / Download

Handoff: February 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoseven%20contlead &utm_medium=email &utm_source=asdhealthcare_nnio &utm_content=HospPharm
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-sevenfact-competitive-rm-mckesson
  • n7-hsp-sevenfact-competitive-rm-mckesson.html
  • US20NSVN00115   February 2021
  • Last updated: 2021-03-03 21:41:33

  • Version: 4

Subject Line
  • Is your ED ready for CHwI patients of all ages?

  • Treating CHwI in the ED: Trials and efficacy

  • With CHwI, emergent bleeds need informed decisions

Preheader
  •  
View / Download

Handoff: February 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoseven%20contlead &utm_medium=email &utm_source=mckesson_th &utm_content=SevenFACT_Competitive
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-sevenfact-competitive-rm
  • n7-hsp-sevenfact-competitive-rm.html
  • US20NSVN00115   February 2021
  • Last updated: 2022-05-25 10:12:43

  • Version: 6

Subject Line
  • C1 Is your hospital prepared for bleeds in CHwI patients under age 12?

  • C2 Is your ED team prepared for bleeds in CHwI patients under age 12?

  • D1 Prepare your staff to treat the most severe bleeds in CHwI patients

  • D2 Prepare your staff to treat the most severe bleeds in CHwI patients

Preheader
  • C1 Learn which bypassing agent is indicated for all ages.
  • C2 Learn which bypassing agent is indicated for all ages.
  • D1 Choose a bypassing agent that is proven in these patients.
  • D2 Choose a bypassing agent with proven efficacy.
View / Download

Handoff: May 2022

(Updated GA tagging) view | download
Tracking
  • (Google Analytics) utm_medium=email&utm_source=NNI&utm_campaign=Continue+to+Lead&utm_content=Efficacy+CHABwI&utm_id=NV7AHE2AD_SevenFACT_Jul22
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-sevenfact-competitive-rm
  • n7-hcp-sevenfact-competitive-rm.html
  • US20NSVN00115   February 2021
  • Last updated: 2021-04-30 10:12:43

  • Version: 7

Subject Line
  • A1 How do you treat bleeds in CHwI patients under age 12?

  • A2 When choosing a bypassing agent, think about range

  • B1 How do you treat bleeds in pediatric CHwI patients?

  • B2 When choosing a bypassing agent, think about range

Preheader
  • A1 Know which bypassing agent is indicated for all ages.
  • A2 Learn which agent treats a broad range of patients.
  • B1 Learn which bypassing agent is indicated for all ages.
  • B2 Learn which agent has the most indications in rare bleeding disorders.
View / Download

Handoff: February 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoseven%20contlead &utm_medium=email &utm_source=nniemail_th &utm_content=SevenFACT_Competitive
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-pt-be-the-face-outlook
  • n7-pt-be-the-face-outlook.html
  • US21NSVN00008   February 2021
  • Last updated: 2021-02-18 13:11:18

  • Version: 3

Subject Line
  • A: Your story may help others with a bleeding disorder feel less alone

  • B: I think your inspiring experience will help the bleeding disorders community

  • C: Your story is powerful, and I know it will inspire others.

  • D: It was so great to talk to you and hear your story

  • E: Here’s more info about the “Be the Face” campaign I mentioned

  • F: Following up from our introduction with an exciting opportunity!

  • H: I’ve always thought you had a powerful story that should be shared

  • I: Your story is perfect for the “Be the Face” campaign I mentioned

  • J: Sharing your experience could really inspire others

Preheader
  • N/A
View / Download

Handoff: February 2021

view | download
Tracking
  • (Google Analytics) ?utm_source=nniemail_th&utm_medium=email&utm_content=BeTheFaceHCLOutlook&utm_campaign=novoseven-pt-betheface
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-be-the-face-la-kelley
  • n7-patient-be-the-face-la-kelley.html
  • US21NSVN00001   February 2021
  • email on acid
  • Last updated: 2021-03-09 19:33:18

  • Version: 1



  • emoji codes:
    📸 U+1F4F8
    📣 U+1F4E3
Subject Line
  • A1 📸 Your story should take center stage

  • A2 📸 Shining the spotlight on your story

  • B1 📣 Here’s your chance to “Be the Face” of the bleeding disorders community

  • B2 📣 Here’s an exciting opportunity to “Be the Face” for those with a bleeding disorder

Preheader
  • A1 See how to share your experience with the community.
  • A2 Ready to inspire others with your experience?
  • B1 Inspire others by sharing your story.
  • B2 Learn how you could inspire the community.
View / Download

Handoff: March 2021

view | download
Tracking
  • (Google Analytics) ?utm_source=LA Kelly&utm_medium=Email&utm_campaign=acquisition&utm_term=US20NSVN00195
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-patient-be-the-face
  • n7-patient-be-the-face.html
  • US21NSVN00001   February 2021
  • email on acid
  • Last updated: 2021-02-11 19:33:18

  • Version: 2



  • emoji codes:
    📸 U+1F4F8
    📣 U+1F4E3
Subject Line
  • A1 📸 Your story should take center stage

  • A2 📸 Shining the spotlight on your story

  • B1 📣 Here’s your chance to “Be the Face” of the bleeding disorders community

  • B2 📣 Here’s an exciting opportunity to “Be the Face” for those with a bleeding disorder

Preheader
  • A1 See how to share your experience with the community.
  • A2 Ready to inspire others with your experience?
  • B1 Inspire others by sharing your story.
  • B2 Learn how you could inspire the community.
View / Download

Handoff: February 2021

view | download
Tracking
  • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • N7-PT-GT-2-TalkingtoYourDoctor-CHES
  • N7-PT-GT-2-TalkingtoYourDoctor-CHES.html
  • US19NSVN00139   October 2020
  • Last updated: 2020-12-22 11:43:00

  • Version: 2

Subject Line
  • A1 What GT treatment questions should you ask your doctor?

  • A2 Make the most of your next doctor’s appointment

  • B1 Is your treatment for Glanzmann’s thrombasthenia doing the job?

  • B2 A doctor discussion guide specific to Glanzmann’s thrombasthenia

Preheader
  • A1 Our discussion guide for Glanzmann’s thrombasthenia can help.
  • A2 Download our discussion guide for Glanzmann’s thrombasthenia.
  • B1 If you haven’t taken this quiz, you may be missing answers.
  • B2 Download the guide to make the most of your next visit
View / Download

Handoff: December 2020

view | download
Tracking
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hcp-standard-of-care
  • n7-hcp-standard-of-care.html
  • US20NSVN00114   December 2020
  • Email on Acid
  • Last updated: 2020-12-11 19:17:06

  • Version: 4

Subject Line
  • A1 Which bypassing agent do providers choose for breakthrough bleeds?

  • A2 Refine your standard of care for CHAwI patients on emicizumab

  • B1 Which bypassing agent do providers choose for breakthrough bleeds?

  • B2 Refine your standard of care for breakthrough bleeds

Preheader
  • A1 Review what clinical trials show about usage with emicizumab.
  • A2 Know the safety and dosing information for treating bleeds.
  • B1 Review the safety data for your patients.
  • B2 Know the safety and dosing information for different treatment options.
View / Download

Handoff: December 2020

view | download
Tracking
  • (Google Analytics) ?utm_campaign=novoseven%20contlead&utm_medium=email&utm_source=nniemail_th&utm_content=Soc_Real_World
Title / HTML Filename / PRB# Dissemination Date / Litmus
Subject Line
Preheader
View / Download
Title / HTML Filename / PRB# Dissemination Date / Litmus
  • n7-hsp-htm-sevenfact
  • n7-hsp-htm-sevenfact.html
  • US20NSVN00158   November 2020
  • Email on Acid
  • Last updated: 2020-12-01 01:17:12

  • Version: 4

Subject Line
  • A: Meeting request: Consider the benefits of this recombinant factor therapy

  • B: Let’s discuss the key benefits of this recombinant factor therapy

  • C: Let’s talk about how this recombinant factor therapy can support your patients

  • D: Meeting request: How could this recombinant factor therapy support your patients?

Preheader
    View / Download

    Handoff: November 2020

    view | download
    Tracking
    • (Google Analytics) ?utm_campaign=novoseven%20n720keymess &utm_medium=email &utm_source=nniemail_th &utm_content=SevenFactHTMOutlook
    Title / HTML Filename / PRB# Dissemination Date / Litmus
    Subject Line
    Preheader
    View / Download
    Title / HTML Filename / PRB# Dissemination Date / Litmus
    • n7-hsp-hiam-sevenfact
    • n7-hsp-hiam-sevenfact.html
    • US20NSVN00116   November 2020
    • Email on Acid
    • Last updated: 2020-12-04 15:11:20

    • Version: 2

    Subject Line
    • A: Meeting request: Consider the features of this recombinant factor therapy

    • B: Which recombinant factor therapy do you keep on hand for patients?

    • C: Let’s talk about updated discounts for this recombinant factor therapy

    • D: Meeting request: How could this recombinant factor therapy support your patients?

    • E: Get additional discounts on this recombinant factor therapy

    • F: Let me know if you have questions about ordering this recombinant factor therapy

    Preheader
      View / Download

      Handoff: November 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=novoseven%20n720hspkey &utm_medium=email &utm_source=nniemail_th &utm_content=SevenFactHIAMOutlook
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-hcp-diagnostic-algorithm
      • n7-hcp-diagnostic-algorithm.html
      • US20NSVN000113   December 2020
      • Email on Acid
      • Last updated: 2020-12-14 03:16:50

      • Version: 5

      Subject Line
      • A1 How is Glanzmann’s thrombasthenia different from other disorders?

      • A2 Diagnostic and treatment considerations for Glanzmann’s thrombasthenia

      • B1 How is Glanzmann’s thrombasthenia different from von Willebrand disease?

      • B2 Explore diagnostic resources for Glanzmann’s thrombasthenia

      Preheader
      • A1 Review the signs of this rare disease.
      • A2 GT can be mistaken for other disorders.
      • B1 Review the signs of GT.
      • B2 GT can be mistaken for other disorders.
      View / Download

      Handoff: December 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=novoseven%20n720rrbldngdisd &utm_medium=email &utm_source=nniemail_th &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-patient-seventfact-chapter
      • n7-patient-seventfact-chapter.html
      • US20NSVN00137   November 2020
      • Last updated: 2021-02-03 00:11:28

      • Version: 1

      Subject Line
      • A1 See why we’re trusted by people like you

      • A2 👀 See why we’re trusted by people like you

      • B1 4 great reasons to feel good about this therapy

      • B2 A few great reasons to feel good about this therapy

      Preheader
      • A1 Decades of experience, strong patient support, and more.
      • A2 Decades of experience, strong patient support, and more.
      • B1 See how our experience supports you.
      • B2 See how our experience supports you.
      View / Download

      Handoff: February 2021

      view | download
      Tracking
      • (Google Analytics) campaign=N7-SevenFact&utm_campaign=NovoSeven&utm_medium=email&utm_source=chapter&utm_content=[CTA-Title]
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-hcp-gt-algorithm
      • n7-hcp-gt-algorithm.html
      • US20NSVN00121   September 2020
      • Last updated: 2020-09-18 4:04:22

      • Version: 2

      Subject Line
      • A Meeting request: Let’s walk through the diagnostic steps for Glanzmann’s thrombasthenia with refractoriness to platelets

      • B I’d like to show you a diagnostic algorithm for Glanzmann’s thrombasthenia with refractoriness to platelets

      • C Looking for resources to help patients with Glanzmann’s thrombasthenia with refractoriness to platelets?

      • D Meeting request: Algorithm for diagnosing and treating Glanzmann’s thrombasthenia with refractoriness to platelets

      Preheader
      View / Download

      Handoff: September 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_source=nniemail_th &utm_medium=email &utm_content=GTDiagnosticOutlook &utm_campaign=novoseven%20n720hcprsrcs
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-hsp-masac-in-the-er-asd
      • n7-hsp-masac-in-the-er-asd.html
      • US20NSVN00065   October 2020
      • Last updated: 2021-2-05 10:42:58

      • Version: 3

      Subject Line
      • A1 MASAC recommends treating acute bleeds within 1 hour

      • A2 When to treat acute bleeds for CHAwI patients on emicizumab

      • B1 Recommended treatment for hemophilia patients with inhibitors in the ED

      • B2 Hospitals should have this bypassing agent ready for acute bleeds

      Preheader
      • A1 Emicizumab patients with inhibitors have unique needs.
      • A2 Review MASAC guidelines for patients on emicizumab in the ED.
      • B1 Do you have the right bypassing agent on hand?
      • B2 Recommended treatment shouldn&rsquo;t wait for test results and other steps.
      View / Download

      Handoff: February 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_source=asdhealthcare_nnio&utm_medium=email&utm_content=HospPharm_HemHCPCore&utm_campaign=novoseven%20contlead
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-hsp-masac-in-the-er-PDQ-PT
      • n7-hsp-masac-in-the-er-PDQ-PT.html
      • US20NSVN00065   October 2020
      • Last updated: 2021-06-16 10:42:58

      • Version: 1

      Subject Line
      • A1 MASAC recommends treating acute bleeds within 1 hour

      • A2 When to treat acute bleeds for CHAwI patients on emicizumab

      • B1 Recommended treatment for hemophilia patients with inhibitors in the ED

      • B2 Hospitals should have this bypassing agent ready for acute bleeds

      Preheader
      • A1 Emicizumab patients with inhibitors have unique needs.
      • A2 Review MASAC guidelines for patients on emicizumab in the ED.
      • B1 Do you have the right bypassing agent on hand?
      • B2 Recommended treatment shouldn&rsquo;t wait for test results and other steps.
      View / Download

      Handoff: October 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=novoseven%20n720hspcptmssg &utm_medium=email &utm_source=nniemail_th &utm_content=MASAC_For_ER
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-hsp-masac-in-the-er
      • n7-hsp-masac-in-the-er.html
      • US20NSVN00065   October 2020
      • Last updated: 2020-09-28 10:42:58

      • Version: 2

      Subject Line
      • A1 MASAC recommends treating acute bleeds within 1 hour

      • A2 When to treat acute bleeds for CHAwI patients on emicizumab

      • B1 Recommended treatment for hemophilia patients with inhibitors in the ED

      • B2 Hospitals should have this bypassing agent ready for acute bleeds

      Preheader
      • A1 Emicizumab patients with inhibitors have unique needs.
      • A2 Review MASAC guidelines for patients on emicizumab in the ED.
      • B1 Do you have the right bypassing agent on hand?
      • B2 Recommended treatment shouldn&rsquo;t wait for test results and other steps.
      View / Download

      Handoff: October 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=novoseven%20n720hspcptmssg &utm_medium=email &utm_source=nniemail_th &utm_content=MASAC_For_ER
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-hcp-30-years-experience
      • n7-hcp-30-years-experience.html
      • US20NSVN00068   September 2020
      • Email on Acid
      • Last updated: 2020-12-07 14:16:13

      • Version: 1

      Subject Line
      • A1 30+ years of effective bleed control

      • A2 30+ years: A recombinant treatment with established experience for a wide range of patients

      • B1 30+ years of effective bleed control for indicated patients with rare bleeding disorders

      • B2 30+ years of bleed control: A recombinant treatment for a wide range of indicated rare bleeding disorders

      Preheader
      • A1 See why patients and professionals can rely on this recombinant treatment.
      • A2 Explore the clinical data and established safety profile of this product.
      • B1 Review the clinical data for this recombinant treatment.
      • B2 Explore the established experience of this recombinant therapy.
      View / Download

      Handoff: (Updated)
      December 07 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=novoseven%20n720rrbldngdisd &utm_medium=email &utm_source=nniemail_th &utm_content=30_years_experience
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-hcp-30-years-experience-pdq
      • n7-hcp-30-years-experience-pdq.html
      • US20NSVN00068   September 2020
      • Email on Acid
      • Last updated: 2021-2-24 14:16:13

      • Version: 1

      Subject Line
      • A1 30+ years of effective bleed control

      • A2 30+ years: A recombinant treatment with established experience for a wide range of patients

      • B1 30+ years of effective bleed control for indicated patients with rare bleeding disorders

      • B2 30+ years of bleed control: A recombinant treatment for a wide range of indicated rare bleeding disorders

      Preheader
      • A1 See why patients and professionals can rely on this recombinant treatment.
      • A2 Explore the clinical data and established safety profile of this product.
      • B1 Review the clinical data for this recombinant treatment.
      • B2 Explore the established experience of this recombinant therapy.
      View / Download

      Handoff: (Updated)
      February 24 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_source=pdq_th&utm_medium=email&utm_content=30_years_experience&utm_campaign=novoseven%20contlead
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-pt-gt-GT-audience-CHES
      • n7-pt-gt-GT-audience-CHES.html
      • US19NSVN00138   September 2020
      • Last updated: 2021-06-16 18:03:26

      • Version: 1

      Subject Line
      • A1 Want to take a short quiz about life with Glanzmann’s thrombasthenia?

      • A2 Who’s the expert on life with Glanzmann’s thrombasthenia?

      • B1 A short quiz about life with Glanzmann’s thrombasthenia

      • B2 5 questions about life with Glanzmann’s thrombasthenia

      Preheader
      • A1 Start by answering this true or false question.
      • A2 Answer some true or false questions about possible symptoms.
      • B1 Which of these questions are true or false?
      • [object Object]
      View / Download

      Handoff: September 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_source=CHES&utm_medium=Email&utm_campaign=acquisition&utm_term=US19NSVN00138
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-hcp-are-you-ready-for-rbd
      • n7-hcp-are-you-ready-for-rbd.html
      • US20NSVN00067   August 2020
      • Email on Acid
      • Last updated: 2022-05-11 16:35:24

        (New tracking UTMs completed for email Re-Deployment)
      • Version: 5

      Subject Line
      • A1 Spot the signs and symptoms of these rare bleeding disorders

      • A2 Explore a treatment option for patients with these rare bleeding disorders

      • B1 Spot the signs and symptoms of factor VII deficiency and Glanzmann’s thrombasthenia

      • B2 Explore a treatment option for factor VII deficiency and Glanzmann’s thrombasthenia

      Preheader
      • A1 Discover recombinant treatment for rare patients
      • A2 Review the signs and symptoms you may see.
      • B1 Learn about one of the only recombinant treatment options for these rare patients
      • B2 Do you see patients with these signs and symptoms?
      View / Download

      Handoff: August 2020

      view | download
      Tracking
      • (Google Analytics) utm_medium=email&utm_source=NNI&utm_campaign=Continue+to+Lead&utm_content=Why+NovoSeven&utm_id=NV7AHE2AD_AreYouPreparedRBD_May22
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-VWD-email-la-kelly
      • n7-VWD-email-la-kelly.html
      • US19NSVN00140   September 2020
      • Email on Acid
      • Last updated: 2020-09-02 23:32:52

      • Version: 9

      Subject Line
      • A1 Are your symptoms different from others with VWD?

      • A2 When von Willebrand disease is the wrong diagnosis

      • B1 How do your bleeds compare to others with VWD?

      • B2 How does your VWD experience compare to others?

      • C1 Could VWD be the wrong diagnosis?

      • C2 Living with VWD but battling the bleed?

      Preheader
      • A1 This short quiz may help answer that.
      • A2 It can happen. Take a short quiz to find out more.
      • B1 These true or false questions can provide insight.
      • B2 It might be time to reassess w/your doctor. This quiz can help.
      • C1 A quiz to help you assess your VWD experience.
      • C2 Here’s a quiz to help guide your next doctor discussion.
      View / Download

      Handoff: September 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=retention&utm_medium=email&utm_source=lak&utm_content=CTA-NAME
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-VWD-email-h4h
      • n7-VWD-email-h4h.html
      • US19NSVN00140   September 2020
      • Email on Acid
      • Last updated: 2020-09-02 23:32:52

      • Version: 9

      Subject Line
      • A1 Are your symptoms different from others with VWD?

      • A2 When von Willebrand disease is the wrong diagnosis

      • B1 How do your bleeds compare to others with VWD?

      • B2 How does your VWD experience compare to others?

      • C1 Could VWD be the wrong diagnosis?

      • C2 Living with VWD but battling the bleed?

      Preheader
      • A1 This short quiz may help answer that.
      • A2 It can happen. Take a short quiz to find out more.
      • B1 These true or false questions can provide insight.
      • B2 It might be time to reassess w/your doctor. This quiz can help.
      • C1 A quiz to help you assess your VWD experience.
      • C2 Here’s a quiz to help guide your next doctor discussion.
      View / Download

      Handoff: September 2020

      view | download
      Tracking
      • (Google Analytics) utm_campaign=retention&utm_medium=email&utm_source=h4h&utm_content=CTA-NAME
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-VWD-email-CHES
      • n7-VWD-email-CHES.html
      • US19NSVN00140   September 2020
      • Email on Acid
      • Last updated: 2020-09-02 23:32:52

      • Version: 9

      Subject Line
      • A1 Are your symptoms different from others with VWD?

      • A2 When von Willebrand disease is the wrong diagnosis

      • B1 How do your bleeds compare to others with VWD?

      • B2 How does your VWD experience compare to others?

      • C1 Could VWD be the wrong diagnosis?

      • C2 Living with VWD but battling the bleed?

      Preheader
      • A1 This short quiz may help answer that.
      • A2 It can happen. Take a short quiz to find out more.
      • B1 These true or false questions can provide insight.
      • B2 It might be time to reassess w/your doctor. This quiz can help.
      • C1 A quiz to help you assess your VWD experience.
      • C2 Here’s a quiz to help guide your next doctor discussion.
      View / Download

      Handoff: September 2020

      view | download
      Tracking
      • (Google Analytics) utm_campaign=retention&utm_medium=email&utm_source=ches&utm_content=CTA-NAME
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-VWD-email-bens-friends
      • n7-VWD-email-bens-friends.html
      • US19NSVN00140   September 2020
      • Email on Acid
      • Last updated: 2020-09-02 23:32:52

      • Version: 9

      Subject Line
      • A1 Are your symptoms different from others with VWD?

      • A2 When von Willebrand disease is the wrong diagnosis

      • B1 How do your bleeds compare to others with VWD?

      • B2 How does your VWD experience compare to others?

      • C1 Could VWD be the wrong diagnosis?

      • C2 Living with VWD but battling the bleed?

      Preheader
      • A1 This short quiz may help answer that.
      • A2 It can happen. Take a short quiz to find out more.
      • B1 These true or false questions can provide insight.
      • B2 It might be time to reassess w/your doctor. This quiz can help.
      • C1 A quiz to help you assess your VWD experience.
      • C2 Here’s a quiz to help guide your next doctor discussion.
      View / Download

      Handoff: September 2020

      view | download
      Tracking
      • (Google Analytics) utm_campaign=retention&utm_medium=email&utm_source=bf&utm_content=CTA-NAME
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • n7-VWD-email
      • n7-VWD-email.html
      • US19NSVN00140   September 2020
      • Email on Acid
      • Last updated: 2020-09-02 23:32:52

      • Version: 9

      Subject Line
      • A1 Are your symptoms different from others with VWD?

      • A2 When von Willebrand disease is the wrong diagnosis

      • B1 How do your bleeds compare to others with VWD?

      • B2 How does your VWD experience compare to others?

      • C1 Could VWD be the wrong diagnosis?

      • C2 Living with VWD but battling the bleed?

      Preheader
      • A1 This short quiz may help answer that.
      • A2 It can happen. Take a short quiz to find out more.
      • B1 These true or false questions can provide insight.
      • B2 It might be time to reassess w/your doctor. This quiz can help.
      • C1 A quiz to help you assess your VWD experience.
      • C2 Here’s a quiz to help guide your next doctor discussion.
      View / Download

      Handoff: September 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • N7 HCP Professional Resources
      • n7-hcp-professional-resources.html
      • US20NSVN00124   August 2020
      • Last updated: 2020-09-17 10:32:17

      • Version: 2

      Subject Line
      • A1 Listen to our latest educational materials for health professionals

      • A2 Educational podcasts and webinars available to stream on our site

      • B1 Looking for educational resources to share with your team?

      • B2 Educational resources you can download or order for your office

      • C1 Looking for educational resources to share with your patients?

      • C2 Educational resources for patients you can download or order

      Preheader
      • A1 Check out webinars and podcasts featuring key opinion leaders.
      • A2 Play the latest content for health professionals.
      • B1 Discover content for health professionals about recombinant FVIIa.
      • B2 Find materials for health professionals about recombinant FVIIa.
      • C1 Discover content for patients about recombinant FVIIa.
      • C2 Find indication-specific materials about recombinant FVIIa.
      View / Download

      Handoff: September 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_source=nniemail_th&utm_medium=email&utm_content=Professional_Resources_Bracketed&utm_campaign=novoseven%20n720hcprsrcs
      rebinyn Emails
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-ppx-cbdr-competitive-messaging
      • rebinyn-hcp-ppx-cbdr-competitive-messaging.html
      • US23REB00003   September 2023
      • Last updated: 2023-10-16 23:04:33

      • Version: 7

      Subject Line
      • SL1 See the data for this PPx Factor IX therapy

      • SL2 View efficacy data for this hemophilia B therapy

      • SL3 View the real-world efficacy data for this hemophilia B therapy

      • SL4 Could your hemophilia B patients benefit from a switch?

      • SL5 See real-world efficacy data about this PPx treatment

      Preheader
      • PH1 Find out more about this treatment.
      • PH2 Learn more about this PPx treatment.
      • PH3 Learn more about this PPx treatment.
      • PH4 See the real-world efficacy data for this PPx treatment.
      • PH5 Your hemophilia B patients may be ready for a switch.
      View / Download

      Handoff: September 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=Efficacy+Prophylaxis&utm_id=<%= message.delivery.deliverycode %>
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-competitive-messaging-refresh
      • rebinyn-hcp-competitive-messaging-refresh.html
      • US23REB00003   September 2023
      • Last updated: 2023-10-16 19:03:35

      • Version: 1

      Subject Line
      • SL1 See the data for this PPx Factor IX therapy

      • SL2 View efficacy data for this hemophilia B therapy

      • SL3 View the real-world efficacy data for this hemophilia B therapy

      • SL4 Could your hemophilia B patients benefit from a switch?

      • SL5 See real-world efficacy data about this PPx treatment

      Preheader
      • PH1 Find out more about this treatment.
      • PH2 Learn more about this PPx treatment.
      • PH3 Learn more about this PPx treatment.
      • PH4 See the real-world efficacy data for this PPx treatment.
      • PH5 Your hemophilia B patients may be ready for a switch.
      View / Download

      Handoff: September 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=email&utm_source=ADBE&utm_content=Efficacy+Prophylaxis
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-competitive-pk-2023
      • rebinyn-hcp-competitive-pk-2023.html
      • US23REB00004   September 2023
      • Last updated: 2023-09-15 21:22:39

      • Version: 6

      Subject Line
      • A1 High Factor IX levels for longer

      • A2 Your patients could achieve high FIX levels for longer

      • A3 Do your hemophilia B patients have questions about switching to a prophylaxis treatment?

      • A4 Your patients with hemophilia B have treatment options

      • A5 Interested in ambitious prophylaxis?

      • A6 Reach for ambitious prophylaxis

      Preheader
      • A1 Compare this hemophilia B therapy with other treatments.
      • A2 Compare this hemophilia B therapy with other treatments.
      • A3 Find out more about this therapy option.
      • A4 See how this hemophilia B therapy compares to other SHL and EHL treatments.
      • A5 This may be an option for your patients.
      • A6 Have you considered this option for your hemophilia B patients?
      View / Download

      Handoff: September 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=PK+Comparisons&utm_id=<%= message.delivery.deliverycode %>
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-label-email-02
      • rebinyn-patient-ppx-label-email-02.html
      • US22REB00021   October 2022
      • Last updated: 2023-08-16 17:09:06

      • Version: 6

      Subject Line
      • A1 Once-weekly prophylaxis can reduce bleeding episodes

      • B1 Could once-weekly prophylaxis dosing be right for you?

      • A2 Once-weekly prophylaxis treatment for hemophilia B

      • B2 Is a once-weekly prophylaxis treatment right for you?

      • A3 Be ready for the unexpected with once-weekly prophylaxis dosing

      • B3 Could once-weekly prophylaxis dosing help you be ready for the unexpected?

      Preheader
      • A1 Spend more time in the non-hemophilia range.
      • B1 Spend more time in the non-hemophilia range.
      • A2 Spend more time in the non-hemophilia range.
      • B2 Spend more time in the non-hemophilia range.
      • A3 Spend more time in the non-hemophilia range.
      • B3 Spend more time in the non-hemophilia range.
      View / Download

      Handoff: August 16, 2023

      (Rebinyn Patient GA Tagging Updates)

      view | download
      Tracking
      • (Google Analytics)
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-day-0
      • rebinyn-patient-ppx-day-0.html
      • US22REB00022   August 2022
      • Last updated: 2023-08-24 20:02:21

      • Version: 19

      Subject Line
      • A1: [Now approved:] Once-weekly prophylaxis dosing

      • A2: [Now FDA-approved:] Prophylaxis

      • A3: Once-weekly prophylaxis dosing [now FDA-approved]

      • B1: [Latest] FDA approval for Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated

      • B2: [Now approved for prophylaxis]

      • C1: A once-weekly prophylaxis treatment for hemophilia B

      • C2: A [new] once-weekly prophylaxis dosing schedule?!

      Preheader
      • A1: Check out what’s new with this factor IX treatment.
      • A2: Check out what’s new with this factor IX treatment.
      • A3: Check out what’s new with this factor IX treatment.
      • B1: Learn more about this treatment option.
      • B2: Learn more about this hemophilia B treatment option.
      • C1: [The latest news]
      • C2: [The latest news]
      View / Download

      Handoff: August 24, 2023

      (Rebinyn Patient GA Tagging Updates)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-timothy-refresh
      • rebinyn-patient-timothy-refresh.html
      • US22REB00197   February 2023
      • Last updated: 2023-08-17 23:13:58

      • Version: 5

      Subject Line
      • A1 Are you considering other hemophilia B therapy choices?

      • B1 Timothy has a success story to share about his hemophilia B treatment

      • A2 Hi, [Name]! I'm Timothy—and we may have something in common

      • B2 Timothy has an inspiring hemophilia B story to share

      • A3 From the hemophilia community: Why Timothy chose this Factor 9

      • B3 Timothy is a dad, a tailor, a volunteer, and a hemophilia B advocate

      Preheader
      • A1 Learn why Timothy chose this once-weekly Factor 9 therapy.
      • B1 Learn more about his experience with a once-weekly Factor 9 therapy.
      • A2 Find out why I chose this once-weekly Factor 9 therapy.
      • B2 Timothy uses a once-weekly Factor 9 therapy.
      • A3 He’s a dad, a tailor, a volunteer, and a hemophilia B advocate.
      • B3 Hear Timothy's inspiring hemophilia B story.
      View / Download

      Handoff: August 17, 2023

      (Rebinyn Patient GA Tagging Updates)

      view | download
      Tracking
      • (Google Analytics)
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-alprolix-comparison-refresh
      • rebinyn-patient-alprolix-comparison-refresh.html
      • US22REB00198   February 2023
      • Last updated: 2023-08-18 15:30:14

      • Version: 2

      Subject Line
      • A1 Higher factor levels for longer with this Factor 9 therapy

      • B1 ❓Which Factor 9 therapy provided higher factor levels for longer?

      • A2 ✅ Compare factor levels and storage for 2 EHL recombinant Factor 9 therapies

      • B2 Let’s compare 2 EHL recombinant Factor 9 therapies

      Preheader
      • A1 Explore your options to see what works for you.
      • B1 Explore your options to see what works for you.
      • A2 Talk to your doctor about your options.
      • B2 Talk to your doctor about your options.
      View / Download

      Handoff: August 18, 2023

      (Rebinyn Patient GA Tagging Updates)

      view | download
      Tracking
      • (Google Analytics)
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-alprolix-comparison-2-refresh
      • rebinyn-patient-alprolix-comparison-2-refresh.html
      • US22REB00202   February 2023
      • Last updated: 2023-08-18 17:39:49

      • Version: 6

      Subject Line
      • A1 Looking for high factor levels? Check out this rFIX therapy.

      • A2 Meet Emili, mom of Xander who lives with hemophilia B

      • B1 👉🏽 Check out the higher factor levels achieved by this rFIX therapy

      • B2 See what’s important to Emili, mom of Xander who lives with hemophilia B

      Preheader
      • A1 Get information to help you choose a hemophilia B treatment.
      • A2 Learn her story and why she chose this Factor 9 treatment.
      • B1 Find out more about a hemophilia B treatment option.
      • B2 Find out why she chose this hemophilia B treatment.
      View / Download

      Handoff: August 18, 2023

      (Rebinyn Patient GA Tagging Updates)

      view | download
      Tracking
      • (Google Analytics)
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-caregiver-abdiel-refresh
      • rebinyn-patient-caregiver-abdiel-refresh.html
      • US22REB00201   February 2023
      • Last updated: 2023-08-18 19:18:04

      • Version: 4



      • emoji codes:
        🎥 U+1F3A5
      Subject Line
      • (Caregiver)

      • A1: Meet Abdiel, a hemophilia B community advocate

      • B1: I’m Abdiel, a hemophilia B community advocate

      • A2: A real-life story from the hemophilia B community: Meet Abdiel

      • B2: Meet Abdiel: A real-life story from the hemophilia B community

      • (Patient)

      • A1: [Name,] My name is Abdiel and I live with hemophilia B, too

      • B1: Hello [Name]. My name is Abdiel and I live with hemophilia B, too

      • A2: Abdiel believes in sharing experiences to learn from each other

      • B2: 🎥 Abdiel believes in sharing experiences to learn from each other

      Preheader
      • (Caregiver)
      • A1: Watch this video to learn about his experience.
      • B1: Watch this video to learn about my experience.
      • A2: Hear why he chose this extended half-life therapy.
      • B2: Hear why he chose this extended half-life therapy.
      • (Patient)
      • A1: Watch my story to find out more about me and why I chose this Factor 9 therapy.
      • B1: Watch my story to find out more about me and why I chose this Factor 9 therapy.
      • A2: Watch his story on growing up with hemophilia B.
      • B2: Watch his story on growing up with hemophilia B.
      View / Download

      Handoff: August 18, 2023

      (Rebinyn Patient GA Tagging Updates)

      view | download
      Tracking
      • (Google Analytics)
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-caregiver-emili-refresh
      • rebinyn-patient-caregiver-emili-refresh.html
      • US22REB00200   February 2023
      • Last updated: 2023-08-21 14:48:55

      • Version: 8

      Subject Line
      • A1 A story from the hemophilia community: Why Emili chose this Factor 9 for her son

      • A2 🎥 from the hemophilia community: Why Emili chose this Factor 9 for her son

      • B1 Emili’s hemophilia B story includes her dad, her children, and advocacy

      • B2 This hemophilia B story includes Emili’s dad, her children, and advocacy

      Preheader
      • A1 This advocate and mom of two has a long history with hemophilia.
      • A2 This advocate and mom of two has a long history with hemophilia.
      • B1 Learn why she says the community has come a long way.
      • B2 Learn why she says the community has come a long way.
      View / Download

      Handoff: August 21, 2023

      (Rebinyn Patient GA Tagging Updates)

      view | download
      Tracking
      • (Google Analytics)
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-connect-with-hcl
      • rebinyn-patient-connect-with-hcl.html
      • US22REB00199   February 2023
      • Last updated: 2023-08-21 17:22:43

      • Version: 15

      Subject Line
      • A1 Learn what Hemophilia Community Liaisons can do for you

      • A2 Find support when you need it

      • B1 Do you know what a Hemophilia Community Liaison does?

      • B2 💌 Get 1:1 support

      Preheader
      • A1 See all the ways you can get support.
      • A2 Connect with your Hemophilia Community Liaison.
      • B1 See all the ways you can get support.
      • B2 Connect with your Hemophilia Community Liaison.
      View / Download

      Handoff: August 21, 2023

      (Rebinyn Patient GA Tagging Updates)

      view | download
      Tracking
      • (Google Analytics)
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-timothy-refresh-la-kelley Version for LA Kelly
      • rebinyn-patient-timothy-refresh-la-kelley.html
      • US22REB00197   February 2023
      • Last updated: 2023-07-31 18:29:38

      • Version: 2

      Subject Line
      • A1 Are you considering other hemophilia B therapy choices?

      • B1 Timothy has a success story to share about his hemophilia B treatment

      • A2 Hi, [Name]! I'm Timothy—and we may have something in common

      • B2 Timothy has an inspiring hemophilia B story to share

      • [object Object]

      • B3 Timothy is a dad, a tailor, a volunteer, and a hemophilia B advocate

      Preheader
      • A1 Learn why Timothy chose this once-weekly Factor 9 therapy.
      • B1 Learn more about his experience with a once-weekly Factor 9 therapy.
      • A2 Find out why I chose this once-weekly Factor 9 therapy.
      • B2 Timothy uses a once-weekly Factor 9 therapy.
      • A3 He’s a dad, a tailor, a volunteer, and a hemophilia B advocate.
      • B3 Hear Timothy's inspiring hemophilia B story.
      View / Download

      Handoff: February 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=PatientStories&utm_medium=email&utm_source=LA&utm_content=timothystory&utm_id=nmtDC00003997
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-alprolix-comparison-2-refresh-h4h Version for H4H
      • rebinyn-patient-alprolix-comparison-2-refresh-h4h.html
      • US22REB00202   February 2023
      • Last updated: 2023-07-07 16:36:32

      • Version: 1

      Subject Line
      • A1 Looking for high factor levels? Check out this rFIX therapy.

      • A2 Meet Emili, mom of Xander who lives with hemophilia B

      • B1 👉🏽 Check out the higher factor levels achieved by this rFIX therapy

      • B2 See what&rsquo;s important to Emili, mom of Xander who lives with hemophilia B

      Preheader
      • A1 Get information to help you choose a hemophilia B treatment.
      • A2 Learn her story and why she chose this Factor 9 treatment.
      • B1 Find out more about a hemophilia B treatment option.
      • B2 Find out why she chose this hemophilia B treatment.
      View / Download

      Handoff: July 07 2023

      (Channel partner version for H4H. Added GA tagging, hosted images, updated footer)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=PatientStories&utm_medium=email&utm_source=H4H&utm_content=Compare&utm_id=nmtDC00003837
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-alprolix-comparison-2-refresh-chb Version for CHB
      • rebinyn-patient-alprolix-comparison-2-refresh-chb.html
      • US22REB00202   February 2023
      • Last updated: 2023-06-16 18:05:41

      • Version: 2

      Subject Line
      • A1 Looking for high factor levels? Check out this rFIX therapy.

      • A2 Meet Emili, mom of Xander who lives with hemophilia B

      • B1 👉🏽 Check out the higher factor levels achieved by this rFIX therapy

      • B2 See what&rsquo;s important to Emili, mom of Xander who lives with hemophilia B

      Preheader
      • A1 Get information to help you choose a hemophilia B treatment.
      • A2 Learn her story and why she chose this Factor 9 treatment.
      • B1 Find out more about a hemophilia B treatment option.
      • B2 Find out why she chose this hemophilia B treatment.
      View / Download

      Handoff: February 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=PatientStories&utm_content=Compare&utm_id=nmtDC00003837
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-timothy-refresh-chb (Version for CHB)
      • rebinyn-patient-timothy-refresh-chb.html
      • US22REB00197   February 2023
      • Last updated: 2023-03-02 17:36:52

      • Version: 1

      Subject Line
      • A1 Are you considering other hemophilia B therapy choices?

      • B1 Timothy has a success story to share about his hemophilia B treatment

      • A2 Hi, [Name]! I'm Timothy—and we may have something in common

      • B2 Timothy has an inspiring hemophilia B story to share

      • [object Object]

      • B3 Timothy is a dad, a tailor, a volunteer, and a hemophilia B advocate

      Preheader
      • A1 Learn why Timothy chose this once-weekly Factor 9 therapy.
      • B1 Learn more about his experience with a once-weekly Factor 9 therapy.
      • A2 Find out why I chose this once-weekly Factor 9 therapy.
      • B2 Timothy uses a once-weekly Factor 9 therapy.
      • A3 He’s a dad, a tailor, a volunteer, and a hemophilia B advocate.
      • B3 Hear Timothy's inspiring hemophilia B story.
      View / Download

      Handoff: February 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=HCLconnect&utm_content=HCL&utm_id=nmtDC00003572
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-timothy-refresh-h4h (Version for H4H)
      • rebinyn-patient-timothy-refresh-h4h.html
      • US22REB00197   February 2023
      • Last updated: 2023-03-01 22:48:51

      • Version: 1

      Subject Line
      • A1 Are you considering other hemophilia B therapy choices?

      • B1 Timothy has a success story to share about his hemophilia B treatment

      • A2 Hi, [Name]! I'm Timothy—and we may have something in common

      • B2 Timothy has an inspiring hemophilia B story to share

      • [object Object]

      • B3 Timothy is a dad, a tailor, a volunteer, and a hemophilia B advocate

      Preheader
      • A1 Learn why Timothy chose this once-weekly Factor 9 therapy.
      • B1 Learn more about his experience with a once-weekly Factor 9 therapy.
      • A2 Find out why I chose this once-weekly Factor 9 therapy.
      • B2 Timothy uses a once-weekly Factor 9 therapy.
      • A3 He’s a dad, a tailor, a volunteer, and a hemophilia B advocate.
      • B3 Hear Timothy's inspiring hemophilia B story.
      View / Download

      Handoff: February 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=H4H&utm_campaign=HCLconnect&utm_content=HCL&utm_id=nmtDC00003572
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-label-email-02-la-kelley
      • rebinyn-patient-ppx-label-email-02-la-kelley.html
      • US22REB00021   October 2022
      • Last updated: 2023-02-17 20:49:57

      • Version: 5

      Subject Line
      • (Set 1)

      • A) Once-weekly prophylaxis can reduce bleeding episodes

      • B) Could once-weekly prophylaxis dosing be right for you?

      • (Set 2)

      • A) Once-weekly prophylaxis treatment for hemophilia B

      • B) Is a once-weekly prophylaxis treatment right for you?

      • (Set 3)

      • A) Be ready for the unexpected with once-weekly prophylaxis dosing

      • B) Could once-weekly prophylaxis dosing help you be ready for the unexpected?

      Preheader
      • (Set 1)
      • A) Spend more time in the non-hemophilia range.
      • B) Spend more time in the non-hemophilia range.
      • (Set 2)
      • A) Spend more time in the non-hemophilia range.
      • B) Spend more time in the non-hemophilia range.
      • (Set 3)
      • A) Spend more time in the non-hemophilia range.
      • B) Spend more time in the non-hemophilia range.
      View / Download

      Handoff: October 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=LA&utm_campaign=Prophy+indication&utm_content=CoreProphyStory&utm_id=nmtDC00003556
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-ppx-competitive-pk
      • rebinyn-hcp-ppx-competitive-pk.html
      • US22REB00177   January 2023
      • Last updated: 2023-02-08 00:44:44

      • Version: 2

      Subject Line
      • A1 High Factor IX levels for longer

      • A2 Your patients could achieve high FIX levels for longer

      Preheader
      • A1 Compare this hemophilia B therapy with other treatments.
      • A2 Compare this hemophilia B therapy with other treatments.
      View / Download

      Handoff: January 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=email&utm_source=ADBE&utm_content=PK+Comparisons
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-timothy
      • rebinyn-patient-timothy.html
      • US22REB00046   July 2022
      • Last updated: 2022-12-08 16:24:07

      • Version: 1

      Subject Line
      • A1 Are you considering other hemophilia B therapy choices?

      • B1 Timothy has a success story to share about his hemophilia B treatment

      • A2 Hi, [Name]! I'm Timothy—and we may have something in common

      • B2 Timothy has an inspiring hemophilia B story to share

      • [object Object]

      • B3 Timothy is a dad, a tailor, a volunteer, and a hemophilia B advocate

      Preheader
      • A1 Learn why Timothy chose this Factor IX therapy.
      • B1 Learn more about his experience with Rebinyn [Coagulation Factor IX (Recombinant), GlycoPEGylated].
      • A2 Find out why I chose this Factor IX therapy.
      • B2 Timothy uses Rebinyn [Coagulation Factor IX (Recombinant), GlycoPEGylated].
      • A3 He’s a dad, a tailor, a volunteer, and a hemophilia B advocate.
      • B3 Hear Timothy's inspiring hemophilia B story.
      View / Download

      Handoff: July 2022

      (This email fileset was uploaded to Veeva only. Not to be deployed since the ISI will be updated in future refresh fileset)

      view
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-ppx-competitive-messaging
      • rebinyn-hcp-ppx-competitive-messaging.html
      • US22REB00147   November 2022
      • Last updated: 2022-11-23 21:47:40

      • Version: 2

      Subject Line
      • A1 See the data for this PPx Factor IX therapy

      • B1 See the data for this hemophilia B PPx therapy

      • A2 View efficacy data for this hemophilia B therapy

      • B2 View the real-world efficacy data for this hemophilia B therapy

      Preheader
      • A1 Find out more about this treatment.
      • B1 Find out more about this treatment.
      • A2 Learn more about this PPx treatment.
      • B2 Learn more about this PPx treatment.
      View / Download

      Handoff: November 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=Prophylaxis&utm_medium=email&utm_source=NNI&utm_content=Efficacy+Prophylaxis&utm_id=RebAHE2AD_PPxCBDR_Dec22
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-day-0-outlook-email (First Handoff Version)
      • rebinyn-patient-ppx-day-0-outlook-email.oft
      • US22REB00168   November 2022
      • Last updated: 2022-11-23 09:58:28

      • Version: 1

      Subject Line
      • [Now approved:] Have you considered once-weekly prophylaxis?

      • [Now FDA-approved:] Could once-weekly prophylaxis be right for you?

      • See what once-weekly prophylaxis could mean for you

      • Imagine infusing just once weekly for hemophilia B

      • Imagine only infusing once a week

      Preheader
      •  
      View / Download

      Handoff: November 23, 2022

      (First handoff version)

      view | download
      Tracking
      • (Google Analytics) None
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-day-0-outlook-email-later-version ("NOW APPROVED FOR" text removed)
      • rebinyn-patient-ppx-day-0-outlook-email-later-version.oft
      • US22REB00168   November 2022
      • Last updated: 2022-11-23 09:58:28

      • Version: 1

      Subject Line
      • Have you considered once-weekly prophylaxis?

      • Could once-weekly prophylaxis be right for you?

      • See what once-weekly prophylaxis could mean for you

      • Imagine infusing just once weekly for hemophilia B

      • Imagine only infusing once a week

      Preheader
      •  
      View / Download

      Handoff: November 23, 2022

      (Later version handoff)
      "NOW APPROVED FOR" text removed from main headline. This version is built for a later handoff

      view | download
      Tracking
      • (Google Analytics) None
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-label-email-02-h4h (Version for H4H)
      • rebinyn-patient-ppx-label-email-02-h4h.html
      • US22REB00021   October 2022
      • Last updated: 2022-11-17 09:45:28

      • Version: 1

      Subject Line
      • (Set 1)

      • A) Once-weekly prophylaxis can reduce bleeding episodes

      • B) Could once-weekly prophylaxis dosing be right for you?

      • (Set 2)

      • A) Once-weekly prophylaxis treatment for hemophilia B

      • B) Is a once-weekly prophylaxis treatment right for you?

      • (Set 3)

      • A) Be ready for the unexpected with once-weekly prophylaxis dosing

      • B) Could once-weekly prophylaxis dosing help you be ready for the unexpected?

      Preheader
      • (Set 1)
      • A) Spend more time in the non-hemophilia range.
      • B) Spend more time in the non-hemophilia range.
      • (Set 2)
      • A) Spend more time in the non-hemophilia range.
      • B) Spend more time in the non-hemophilia range.
      • (Set 3)
      • A) Spend more time in the non-hemophilia range.
      • B) Spend more time in the non-hemophilia range.
      View / Download

      Handoff: November 17, 2022

      (Version for H4H channel partner)
      Hosted images, updated GA tags, removed unsubscribe language in footer

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=H4H&utm_campaign=Prophy+indication&utm_content=CoreProphyStory&utm_id=nmtDC00003119
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-label-email-02-chb (Version for CHB)
      • rebinyn-patient-ppx-label-email-02-chb.html
      • US22REB00021   October 2022
      • Last updated: 2022-11-16 17:02:28

      • Version: 3

      Subject Line
      • (Set 1)

      • A) Once-weekly prophylaxis can reduce bleeding episodes

      • B) Could once-weekly prophylaxis dosing be right for you?

      • (Set 2)

      • A) Once-weekly prophylaxis treatment for hemophilia B

      • B) Is a once-weekly prophylaxis treatment right for you?

      • (Set 3)

      • A) Be ready for the unexpected with once-weekly prophylaxis dosing

      • B) Could once-weekly prophylaxis dosing help you be ready for the unexpected?

      Preheader
      • (Set 1)
      • A) Spend more time in the non-hemophilia range.
      • B) Spend more time in the non-hemophilia range.
      • (Set 2)
      • A) Spend more time in the non-hemophilia range.
      • B) Spend more time in the non-hemophilia range.
      • (Set 3)
      • A) Spend more time in the non-hemophilia range.
      • B) Spend more time in the non-hemophilia range.
      View / Download

      Handoff: November 16, 2022

      (Version for CHB channel partner)
      Hosted images, added CHB Header text, updated GA tags, removed unsubscribe language in footer

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=Prophy+indication&utm_content=CoreProphyStory&utm_id=nmtDC00003119
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-day-0-la-kelley (Version for LA Kelley)
      • rebinyn-patient-ppx-day-0-la-kelley.html
      • US22REB00022   August 2022
      • Last updated: 2022-11-16 10:50:35

      • Version: 1

      Subject Line
      • A1 Now approved: Once-weekly prophylaxis dosing

      • B1 Latest FDA approval for Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated

      Preheader
      • A1 Check out what’s new with this factor IX treatment.
      • B1 Learn more about this treatment option.
      View / Download

      Handoff: November 16, 2022

      (Updated: Fixed broken ISI link)

      view | download
      Tracking
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-ppx-launch
      • rebinyn-hcp-ppx-launch.html
      • US22REB00073   September 2022


      • (Removed now approved headline)
      • Last updated: 2023-06-13 02:42:22

      • Version: 8

      Subject Line
      • A1 What’s your first choice for hem B prophylactic treatment?

      • A2 Prophylactic treatment for your hem B patients

      • B1 What are your treatment goals for hemophilia B patients?

      • B2 More time in the non-hemophilia range? It’s possible with this Factor IX treatment

      • C1 [Now] FDA approved: hemophilia B prophylactic treatment bleed protection

      • C2 Prophylactic treatment with bleed protection

      Preheader
      • A1 See what high Factor IX levels could mean for your patients.
      • A2 See what high Factor IX levels could mean for your patients.
      • B1 Keep your hemophilia B patients in the non-hemophilia range for longer.
      • B2 Keep your hemophilia B patients in the non-hemophilia range.
      • C1 Higher Factor IX levels and simple, once-weekly dosing.
      • C2 Higher Factor IX levels and simple, once-weekly dosing.
      View / Download

      Handoff: September 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=Prophylaxis&utm_medium=email&utm_source=NNI&utm_content=Now+Approved+Prophylaxis+Indication&utm_id=RebAHE2AD_PPxLaunch_Sep22
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-day-0-h4h (Version for Hope for Hemophilia)
      • rebinyn-patient-ppx-day-0-h4h
      • US22REB00022   August 2022
      • Last updated: 2022-09-19 12:25:35

      • Version: 1

      Subject Line
      • A1 Now approved: Once-weekly prophylaxis dosing

      • B1 Latest FDA approval for Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated

      Preheader
      • A1 Check out what’s new with this factor IX treatment.
      • B1 Learn more about this treatment option.
      View / Download

      Handoff: September 19, 2022

      (Version for Hope for Hemophilia channel partner)
      Updated GA tags, removed unsubscribe language in footer, Images hosted

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=H4H&utm_campaign=Prophy+indication&utm_content=Now+approved+prophy&utm_id=100002754&src=100002754
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-ppx-day-0-chb (Version for CHB)
      • rebinyn-patient-ppx-day-0-chb.html
      • US22REB00022   August 2022
      • Last updated: 2022-08-25 10:38:35

      • Version: 2

      Subject Line
      • A1 Now approved: Once-weekly prophylaxis dosing

      • B1 Latest FDA approval for Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated

      Preheader
      • A1 Check out what’s new with this factor IX treatment.
      • B1 Learn more about this treatment option.
      View / Download

      Handoff: August 25, 2022

      (Version for CHB channel partner)
      Added CHB Header text, Updated GA tags, removed unsubscribe language in footer

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=Prophy+indication&utm_content=Now+approved+prophy&utm_id=100002754&src=100002754
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-ppx-now-approved
      • rebinyn-hcp-ppx-now-approved.html
      • US22REB00072   August 2022
      • Last updated: 2022-08-01 16:58:33

      • Version: 33

      Subject Line
      • A1 Now FDA approved: prophylactic hemophilia B treatment

      Preheader
      • A1 Once-weekly Factor IX therapy for your hemophilia B patients.
      View / Download

      Handoff: August 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=PPx&utm_medium=email&utm_source=NNI&utm_content=Now+Approved+Prophylaxis+Indication&utm_id=RebAHE2AD_NowApproved_Aug22
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-incremental-recovery
      • rebinyn-hcp-incremental-recovery.html
      • US22REB00025   June 2022
      • Last updated: 2022-06-14 19:54:31

      • Version: 1

      Subject Line
      • A1 More time in the non-hemophilia range

      • A2 Could your patients spend more time in the non-hemophilia range?

      • B1 Higher Factor IX levels for longer

      • B2 Your patients could achieve higher FIX levels for longer

      Preheader
      • A1 This Factor IX therapy can help your patients achieve higher PK levels for longer.
      • A2 This Factor IX therapy can help your patients achieve higher PK levels for longer.
      • B1 See what this hemophilia B therapy could mean for your patients.
      • B2 See what this hemophilia B therapy could mean for your patients.
      View / Download

      Handoff: June 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=PK+Preference&utm_medium=email&utm_source=NNI&utm_content=PK+Comparisons&utm_id=RebAHE2ADIncrementRecoverJun22
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-5x-greater-cure-3 (Email Re-Deployment)
      • rebinyn-patient-5x-greater-cure-3.html
      • US20REB00044   August 2020
      • Last updated: 2020-03-31 10:30:46

      • Version: 12

      Subject Line
      • A1 An extended half-life that extends your bleed protection?

      • A2 😎 We’re illuminating the benefits of extended half-life therapy

      • B1 An extended half-life could extend your bleed protection.

      • B2 We’re illuminating the benefits of extended half-life therapy

      • C1 With an extended half-life this factor IX stands out

      • C2 Explore this factor IX with an extended half-life

      Preheader
      • A1 See how this factor IX could help you. - A2 Imagine what it could do for you. - B1 See how this factor IX could help you. - B2 Imagine what it could do for you. - C1 See how this treatment could help you. - C2 See how this treatment could help you.
      View / Download

      Handoff: March 31, 2022

      (QA updates fixes completed for email Re-Deployment)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-5x-greater-cure-1-chb (Version for CHB)
      • rebinyn-patient-5x-greater-cure-1-chb.html
      • US20REB00015   August 2020
      • Last updated: 2022-03-03 14:02:48

      • Version: 1

      Subject Line
      • A1 You know what 5x more fuel does for your road trip

      • A2 5x more fuel means your car runs longer

      • B1 What can 5x longer bleed protection do for you?

      • B2 What could 5x longer bleed protection mean for you?

      Preheader
      • A1 Imagine what 5x longer bleed protection could do for you.
      • A2 Imagine what 5x longer bleed protection could mean for you.
      • B1 It’s like having 5x more fuel to keep your car running longer.
      • B2 It’s like having 5x more fuel to keep your car running longer.
      View / Download

      Handoff: March 3, 2022

      (Handoff for CHB. Updated GA tagging)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=5xgreater&utm_content=5xgasgauge&utm_id=100002501&src=100002501
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-alprolix-2-update
      • rebinyn-hcp-alprolix-2-update.html
      • US21REB00055   December 2021
      • Last updated: 2021-11-23 17:50:42

      • Version: 1

      Subject Line
      • A1 See features of FIX products

      • A2 Check out rFIX product data

      Preheader
      • A1 Learn what makes 1 stand out.
      • A2 Have you reviewed the latest data on Rebinyn® Coagulation Factor IX - (Recombinant), GlycoPEGylated?
      View / Download

      Handoff: December 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=rebinyn%20pkpref &utm_medium=email &utm_source=nniemail_th &utm_content=pharmaco
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-5x-greater-cure-1
      • rebinyn-patient-5x-greater-cure-1.html
      • US20REB00015   August 2020
      • Last updated: 2021-11-12 10:25:48

      • Version: 14

      Subject Line
      • A1 You know what 5x more fuel does for your road trip

      • A2 5x more fuel means your car runs longer

      • B1 What can 5x longer bleed protection do for you?

      • B2 What could 5x longer bleed protection mean for you?

      Preheader
      • A1 Imagine what 5x longer bleed protection could do for you.
      • A2 Imagine what 5x longer bleed protection could mean for you.
      • B1 It’s like having 5x more fuel to keep your car running longer.
      • B2 It’s like having 5x more fuel to keep your car running longer.
      View / Download

      Handoff: November 12, 2021

      (Some email QA updates for redeployment)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-5x-greater-cure-2
      • rebinyn-patient-5x-greater-cure-2.html
      • US20REB00016   August 2020
      • Last updated: 2021-12-03 08:35:47

      • Version: 13

      Subject Line
      • A1 You know what 5x longer battery life does for your phone

      • A2 5x longer battery life means your phone can last longer

      • B1 Who wouldn’t choose a battery that lasts 5x longer?

      • B2 Would you choose a battery that lasts 5x longer?

      Preheader
      • A1 Imagine what 5x longer bleed protection could do for you.
      • A2 Imagine what 5x longer bleed protection could mean for you.
      • B1 You can choose a factor IX that does, too.
      • B2 Consider a factor IX that lasts 5x longer than the leading standard half-life.
      View / Download

      Handoff: December 03, 2021

      (Added BeneFIX text back in email)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-reveal-quiz-la-kelly (Version for LA Kelly)
      • rebinyn-patient-reveal-quiz-la-kelly.html
      • US21REB00017   July 2021
      • Last updated: 2021-11-09 13:35:38

      • Version: 1

      Subject Line
      • A1 It’s quiz time: Is product A or product B a better fit for you?

      • A2 Are you ready to take the PK Challenge?

      • A3 The big reveal: Take the PK Challenge

      • A4 Have you heard of the PK Challenge?

      Preheader
      • A1 Take the PK Challenge today.
      • A2 See how the PK profiles popular hemophilia B treatments compare.
      • A3 How do the PK profiles of these treatments compare?
      • A4 Find out which treatment is the better fit for you.
      View / Download

      Handoff: November 9, 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_source=LA%20Kelly&utm_medium=Email&utm_campaign=acquisition&utm_term=US21REB00017&utm_content=[Unique to each Link]&src=100002418
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-high-factor-levels-update
      • rebinyn-hcp-high-factor-levels-update.html
      • US21REB00018   September 2021
      • Last updated: 2021-08-12 18:21:30

      • Version: 5

      Subject Line
      • A1 Which Factor IX therapy would you choose for your patients?

      • B1 See how the PK profiles of Factor IX therapies compare

      • C1 How do the PK profiles of popular hemophilia B treatments compare?

      Preheader
      • A1 Compare AUCs to find the answer.
      • B1 Choose the right one for your patients.
      • C1 Find the right fit for your patients.
      View / Download

      Handoff: September 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=rebinyn%20pkpref &utm_medium=email &utm_source=nniemail_th &utm_content=Pharmaco
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-reveal-quiz-chb (Version for CHB)
      • rebinyn-patient-reveal-quiz-chb.html
      • US21REB00017   July 2021
      • Last updated: 2021-08-20 13:35:38

      • Version: 2

      Subject Line
      • A1 It’s quiz time: Is product A or product B a better fit for you?

      • A2 Are you ready to take the PK Challenge?

      • A3 The big reveal: Take the PK Challenge

      • A4 Have you heard of the PK Challenge?

      Preheader
      • A1 Take the PK Challenge today.
      • A2 See how the PK profiles popular hemophilia B treatments compare.
      • A3 How do the PK profiles of these treatments compare?
      • A4 Find out which treatment is the better fit for you.
      View / Download

      Handoff: August 20, 2021

      (Updated GA tags)

      view | download
      Tracking
      • (Google Analytics) ?utm_source=CHB&utm_medium=Email&utm_campaign=acquisition&utm_term=US21REB00017&utm_content=
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-pk-tool-announcement
      • rebinyn-hcp-pk-tool-announcement.html
      • US21REB00019   August 2021
      • Last updated: 2021-08-03 16:02:08

      • Version: 2

      Subject Line
      • A1 Hemophilia B PK profiles at the touch of a button

      • B1 Compare PK of hemophilia B treatments in just a few clicks

      • C1 Try this tool to compare PK profiles of Factor IX therapies

      Preheader
      • A1 Predict FIX PK profiles of SHL and EHL products.
      • B1 Try our PK comparison tool for Factor IX therapies.
      • C1 It only takes a few clicks.
      View / Download

      Handoff: August 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=rebinyn%20pkpref &utm_medium=email &utm_source=nniemail_th &utm_content=Pharmaco
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-reveal-quiz
      • rebinyn-patient-reveal-quiz.html
      • US21REB00017   July 2021
      • Last updated: 2021-07-22 17:00:38

      • Version: 4

      Subject Line
      • A1 It’s quiz time: Is product A or product B a better fit for you?

      • A2 Are you ready to take the PK Challenge?

      • A3 The big reveal: Take the PK Challenge

      • A4 Have you heard of the PK Challenge?

      Preheader
      • A1 Take the PK Challenge today.
      • A2 See how the PK profiles popular hemophilia B treatments compare.
      • A3 How do the PK profiles of these treatments compare?
      • A4 Find out which treatment is the better fit for you.
      View / Download

      Handoff: July 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-5x-greater-cure-30-Hem-B-audience-CHB
      • rebinyn-patient-5x-greater-cure-30-Hem-B-audience-CHB.html
      • US20REB00044   August 2020
      • Last updated: 2021-06-16 16:20:46

      • Version: 1

      Subject Line
      • A1 An extended half-life that extends your bleed protection?

      • A2 😎 We’re illuminating the benefits of extended half-life therapy

      • B1 An extended half-life could extend your bleed protection.

      • B2 We’re illuminating the benefits of extended half-life therapy

      • C1 With an extended half-life this factor IX stands out

      • C2 Explore this factor IX with an extended half-life

      Preheader
      • A1 See how this factor IX could help you. - A2 Imagine what it could do for you. - B1 See how this factor IX could help you. - B2 Imagine what it could do for you. - C1 See how this treatment could help you. - C2 See how this treatment could help you.
      View / Download

      Handoff: July 19, 2021

      (Completed Some QA fixes)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-pk-data-update
      • rebinyn-hcp-pk-data-update.html
      • US21REB00013   July 2021
      • Last updated: 2021-07-16 15:50:41

      • Version: 4

      Subject Line
      • A1 PK simulation data for EHL Factor IX products

      • B1 PK simulation data for EHL Factor IX therapy

      • A2 Comparing PK simulation data for hem B treatments

      • B2 Comparing PK data for hem B treatments for on-demand and surgery

      Preheader
      • A1 See and compare PK results for bleed control.
      • B1 See and compare PK results for bleed control.
      • A2 PK simulation data shows results for EHL and SHL products.
      • B2 PK simulation data shows results for EHL and SHL products.
      View / Download

      Handoff: July 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=rebinyn%20pkpref &utm_medium=email &utm_source=nniemail_th &utm_content=Pharmaco
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-pk-data-update-pdq (Version for PDQ)
      • rebinyn-hcp-pk-data-update-pdq.html
      • US21REB00013   July 2021
      • Last updated: 2021-07-16 16:01:41

      • Version: 4

      Subject Line
      • A1 PK simulation data for EHL Factor IX products

      • B1 PK simulation data for EHL Factor IX therapy

      • A2 Comparing PK simulation data for hem B treatments

      • B2 Comparing PK data for hem B treatments for on-demand and surgery

      Preheader
      • A1 See and compare PK results for bleed control.
      • B1 See and compare PK results for bleed control.
      • A2 PK simulation data shows results for EHL and SHL products.
      • B2 PK simulation data shows results for EHL and SHL products.
      View / Download

      Handoff: July 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=rebinyn%20pkpref &utm_medium=email &utm_source=nniemail_th &utm_content=Pharmaco
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-pediatric-data-pdq
      • rebinyn-hcp-pediatric-data-pdq.html
      • US20REB00046   February 2021
      • Last updated: 2021-02-25 20:30:11

      • Version: 7

      Subject Line
      • A1 Advocate and parent Emili chose this Factor IX for her child

      • B1 Understand why advocate and parent Emili chose this Factor IX for her child

      • A2 Learn why Emili&mdash;advocate and parent&mdash;chose this FIX for her son

      • B2 Emili&mdash;advocate and parent&mdash;chose this FIX for her son

      • A3 Explore the pediatric data behind this FIX therapy

      • B3 Explore the pediatric data supporting this FIX therapy

      Preheader
      • A1 See the data that helped her decide.
      • B1 See the data that helped her decide.
      • A2 Explore the compelling data that helped her decide.
      • B2 Explore the compelling data that helped her decide.
      • A3 Learn why advocate and parent Emili, chose this treatment for her son.
      • B3 Learn why advocate and parent Emili, chose this treatment for her son.
      View / Download

      Handoff: February 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=rebinyn%20pkpref &utm_medium=email &utm_source=pdq_th &utm_content=Emili&Xander
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-hcp-pediatric-data
      • rebinyn-hcp-pediatric-data.html
      • US20REB00046   February 2021
      • Last updated: 2022-05-11 16:25:18

        (New tracking UTMs completed for email Re-Deployment)
      • Version: 5

      Subject Line
      • A1 Advocate and parent Emili chose this Factor IX for her child

      • B1 Understand why advocate and parent Emili chose this Factor IX for her child

      • A2 Learn why Emili&mdash;advocate and parent&mdash;chose this FIX for her son

      • B2 Emili&mdash;advocate and parent&mdash;chose this FIX for her son

      • A3 Explore the pediatric data behind this FIX therapy

      • B3 Explore the pediatric data supporting this FIX therapy

      Preheader
      • A1 See the data that helped her decide.
      • B1 See the data that helped her decide.
      • A2 Explore the compelling data that helped her decide.
      • B2 Explore the compelling data that helped her decide.
      • A3 Learn why advocate and parent Emili, chose this treatment for her son.
      • B3 Learn why advocate and parent Emili, chose this treatment for her son.
      View / Download

      Handoff: February 2021

      view | download
      Tracking
      • (Google Analytics) utm_medium=email&utm_source=NNI&utm_campaign=PK+Preference&utm_content=PK+Comparisons&utm_id=RebAHE2AD_PediatricData_May22
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-5x-greater-cure-1-la-kelley
      • rebinyn-patient-5x-greater-cure-1-la-kelley.html
      • US20REB00015   August 2020
      • Last updated: 2021-03-04 16:20:48

      • Version: 1

      Subject Line
      • A1 You know what 5x more fuel does for your road trip

      • A2 5x more fuel means your car runs longer

      • B1 What can 5x longer bleed protection do for you?

      • B2 What could 5x longer bleed protection mean for you?

      Preheader
      • A1 Imagine what 5x longer bleed protection could do for you.
      • A2 Imagine what 5x longer bleed protection could mean for you.
      • B1 It’s like having 5x more fuel to keep your car running longer.
      • B2 It’s like having 5x more fuel to keep your car running longer.
      View / Download

      Handoff: March 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_source=LA%20Kelly&utm_medium=Email&utm_campaign=acquisition&utm_term=%20US20REB00015
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rebinyn-patient-5x-greater-cure-2-chb
      • rebinyn-patient-5x-greater-cure-2-chb.html
      • US20REB00016   June 20222
      • Email on Acid
      • Last updated: 2022-06-29 16:20:47

      • Version: 13

      Subject Line
      • A1 You know what 5x longer battery life does for your phone

      • A2 5x longer battery life means your phone can last longer

      • B1 Who wouldn’t choose a battery that lasts 5x longer?

      • B2 Would you choose a battery that lasts 5x longer?

      Preheader
      • A1 Imagine what 5x longer bleed protection could do for you.
      • A2 Imagine what 5x longer bleed protection could mean for you.
      • B1 You can choose a factor IX that does, too.
      • B2 Consider a factor IX that lasts 5x longer than the leading standard half-life.
      View / Download

      Handoff: June 2022

      (Updates to tracking UTMs)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=5xgreater&utm_content=5xbattery&utm_id=100002602&src=100002602
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rm-template-patient
      • rm-template-patient.html
      • US19ESP00150   April 2020
      • Last updated: 2020-07-01 18:28:13

      • Version: 0

      Subject Line
      • A1 Subject Line One

      • A2 Subject Line Two

      • B1 Subject Line Three

      Preheader
      • A1 Preheader Line One.
      • A2 Preheader Line Two.
      • B1 Preheader Line Three.
      View / Download

      Handoff: April 2020

      view
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      esperoct Emails
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-women-in-hemo-self-advocacy-email-h4h   (Version for Hope for Hemophilia with updated GA tagging, footer, images hosted)
      • esperoct-pt-women-in-hemo-self-advocacy-email-h4h.html
      • US24ESP00101   March 2025
      • Last updated: 2025-11-14 20:40:10

      • Version: 4

      Subject Line
      • 1) 👩🏻 Women with hemophilia A deserve to be seen and heard

      • 2) Your needs as a woman with hemophilia A are important 🌸

      • 3) Get the treatment options women like you deserve 💃💫

      • 4) 😟 Many women with hemophilia A feel ignored by their doctors

      • 5) 👫Are women and men with hemophilia A treated the same?

      • 6) 👜 💄Women like you are discovering Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] and Novoeight® (antihemophilic factor, recombinant)

      Preheader
      • 1) Learn how to become your own best advocate.
      • 2) Get tools for finding the treatment you deserve.
      • 3) Help your doctor understand your hemophilia A symptoms.
      • 4) You have treatment options.
      • 5) Stand up for the treatment you deserve.
      • 6) Get tools for talking to your doctor and finding treatment options.
      View / Download

      Handoff: November 14, 2025

      (Version for Hope for Hemophilia with updated GA tagging, footer, images hosted)

      view | download
      Tracking
      • (GA) ?utm_campaign=Women+in+hemophilia&utm_medium=email&utm_source=H4H&utm_content=womeninhemophilia&utm_id=nmtDC00008117
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-patient-vaughn-h4h   (Version for H4H)
      • esperoct-patient-vaughn-h4h.html
      • US24ESP00106   March 2025
      • Last updated: 2025-08-13 21:35:24

      • Version: 6

      Subject Line
      • A Vaughn has hemophilia A

      • B Vaughn is a pretty active guy

      • C Have you heard about this flexibility factor?

      • D Have you heard of Esperoct® [antihemophilic factor (recombinant), glycopegylatedexei]?

      • E Consider Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      Preheader
      • A Do you know what factor he uses?
      • B Can his factor 8 treatment keep up with him?
      • C See how it might work for your lifestyle.
      • D Vaughn would like to introduce you.
      • E Could this treatment be right for you?
      View / Download

      Handoff: August 13, 2025

      (Version for H4H)

      view | download
      Tracking
      • (GA) ?utm_campaign=Flexibility+Factor&utm_medium=email&utm_source=H4H&utm_content=vaughnsstory&utm_id=nmtDC00007648
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-women-in-hemo-self-advocacy-email-la-kelley   (Version for LA Kelley)
      • esperoct-pt-women-in-hemo-self-advocacy-email-la-kelley.html
      • US24ESP00101   March 2025
      • Last updated: 2025-05-21 23:06:49

      • Version: 14

      Subject Line
      • 1) 👩🏻 Women with hemophilia A deserve to be seen and heard

      • 2) Your needs as a woman with hemophilia A are important 🌸

      • 3) Get the treatment options women like you deserve 💃💫

      • 4) 😟 Many women with hemophilia A feel ignored by their doctors

      • 5) 👫Are women and men with hemophilia A treated the same?

      • 6) 👜 💄Women like you are discovering Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] and Novoeight® (antihemophilic factor, recombinant)

      Preheader
      • 1) Learn how to become your own best advocate.
      • 2) Get tools for finding the treatment you deserve.
      • 3) Help your doctor understand your hemophilia A symptoms.
      • 4) You have treatment options.
      • 5) Stand up for the treatment you deserve.
      • 6) Get tools for talking to your doctor and finding treatment options.
      View / Download

      Handoff: May 21, 2025

      (Version for LA Kelley, Updated header, footer, GA tagging)

      view | download
      Tracking
      • (GA) ?utm_campaign=Women+with+Hemophilia+&utm_medium=email&utm_source=LA&utm_content=womenwhemophilia&utm_id=nmtDC00006962
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-women-in-hemo-product-email-h4h   (Version for Hope for Hemophilia)
      • esperoct-pt-women-in-hemo-product-email-h4h.html
      • US24ESP00100   March 2025
      • Last updated: 2025-05-21 22:00:07

      • Version: 14

      Subject Line
      • 1) Are these the FleXXibility factors for women like you? 👜💄

      • 2) Searching for a hemophilia A treatment that fits your lifestyle? 💃✨

      • 3) 👩🏻 Are you a woman with hemophilia A looking for treatment?

      • 4) Get bleed protection for women like you 👠💕

      • 5) 🌸 Get the hemophilia A treatment women deserve

      • 6) 👗👒Yes, women can have hemophilia A, too

      Preheader
      • 1) Explore 2 treatment options for hemophilia A.
      • 2) These resources help women discover their options.
      • 3) Learn more about 2 flexible options.
      • 4) Learn about 2 hemophilia A treatment options.
      • 5) Could these options be right for you?
      • 6) Discover treatment options that fit your busy lifestyle.
      View / Download

      Handoff: May 21, 2025

      (Version for Hope for Hemophilia, Updated header, footer, GA tagging, hosted images)

      view | download
      Tracking
      • (GA) ?utm_campaign=Women+with+Hemophilia+&utm_medium=email&utm_source=H4H&utm_content=womenwhemophilia&utm_id=nmtDC00006963
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-flexibility-factor-la-kelley (LA Kelley Version)
      • esperoct-pt-flexibility-factor-la-kelley.html
      • US24ESP00081   November 2024
      • Last updated: 2025-02-14 19:56:47

      • Version: 3

      Subject Line
      • A1 Consider Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • A2 Check out Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • B1 Discover Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • B2 Have you heard about this flexibility factor?

      Preheader
      • A1 Could this treatment be right for you?
      • A2 Could this treatment be right for you?
      • B1 See how it might work for your lifestyle.
      • B2 See how it might work for your lifestyle.
      View / Download

      Handoff: February 14, 2025

      Updated for LA Kelley. Updated hero, RBCLs, added header/footer updates, updated GA tagging.

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-flexibility-factor-hfa (Hem Federation of America Version)
      • esperoct-pt-flexibility-factor-hfa.html
      • US24ESP00081   November 2024
      • Last updated: 2025-02-14 21:18:39

      • Version: 1

      Subject Line
      • A1 Consider Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • A2 Check out Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • B1 Discover Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • B2 Have you heard about this flexibility factor?

      Preheader
      • A1 Could this treatment be right for you?
      • A2 Could this treatment be right for you?
      • B1 See how it might work for your lifestyle.
      • B2 See how it might work for your lifestyle.
      View / Download

      Handoff: February 14, 2025

      Updated for Hem Federation of America. Updated hero, RBCLs, added header/footer updates, updated GA tagging.

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=HFA&utm_campaign=Flexibility+Factor+Refresh&utm_content=flexibilityfactor&utm_id=nmtDC00006275
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-flexibility-factor-h4h (Hope for Hemophilia Version)
      • esperoct-pt-flexibility-factor-h4h.html
      • US24ESP00081   November 2024
      • Last updated: 2025-01-24 17:54:11

      • Version: 9

      Subject Line
      • A1 Consider Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • A2 Check out Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • B1 Discover Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • B2 Have you heard about this flexibility factor?

      Preheader
      • A1 Could this treatment be right for you?
      • A2 Could this treatment be right for you?
      • B1 See how it might work for your lifestyle.
      • B2 See how it might work for your lifestyle.
      View / Download

      Handoff: January 24, 2025

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=Flexibility+Factor&utm_medium=email&utm_source=H4H&utm_content=Flexibility&utm_id=nmtDC00006134
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-severe-to-mild-h4h (Hope for Hemophilia Version)
      • esperoct-pt-severe-to-mild-h4h.html
      • US20ESP00119   January 2021
      • Last updated: 2024-12-06 21:09:24

      • Version: 2

      Subject Line
      • Patients

      • A1 [Name,] This Treatment Could Make a Difference for You

      • B1 [Name,] Could This Treatment Make A Difference for You?

      • A2 From Severe to Mild.

      • B2 From Severe to Mild. It’s Time for a Change.

      • A3 Severe, Moderate, or Mild?

      • B3 Severe, Moderate, or Mild. It’s Time for a Change.

      • Caregivers

      • A1 See What Could be Achieved with a Longer Half-life

      • B1 Could a Longer Half-life Help You Achieve High Factor Levels?

      • A2 [Name,] Could This Treatment Deliver the Change You Need?

      • B2 [Name,] This Factor Could Deliver the Change You Need

      • Channel Partners

      • A1 Mild, Moderate, or Severe?

      • B1 Mild, Moderate, or Severe? It’s Time for a Change

      • A2 Level Up Your Factor

      • B2 Time to Level Up

      Preheader
      • Patients
      • A1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • B1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • A2 See what you could achieve with this extended half-life treatment.
      • B2 See what you could achieve with this extended half-life treatment.
      • A3 See what you could achieve with this extended half-life treatment.
      • B3 See what you could achieve with this extended half-life treatment.
      • Caregivers
      • A1 Explore this treatment.
      • B1 Explore this treatment.
      • A2 Learn more about this extended half-life treatment now.
      • B2 Learn more about this extended half-life treatment now.
      • Channel Partners
      • A1 Explore this extended half-life therapy.
      • B1 Explore this extended half-life therapy.
      • A2 Explore this hemophilia A therapy now.
      • B2 Explore this hemophilia A therapy now.
      View / Download

      Handoff: January 2021

      Updated GA tagging, images already hosted from a previous handoff, updated footer

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=H4H&utm_campaign=Esperoct&utm_content=Severe+to+mild&utm_id=nmtDC00006018
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-patient-bradley-h4h (Hope for Hemophilia Version)
      • esperoct-patient-bradley-h4h.html
      • US22ESP00025   August 2022
      • Last updated: 2024-11-01 16:42:37

      • Version: 2

      Subject Line
      • A1 Hi, [Name]! I’m Bradley O.—and we may have something in common

      • B1 Where do you find inspiration?

      • C1 Bradley O. has an inspiring story to share

      • D1 Want to hear an inspiring story?

      • E1 A new home, a new beginning, and a different treatment

      • F1 Learn more about this advocate’s journey

      • G1 How do you make decisions about hemophilia A treatment?

      Preheader
      • A2 Learn more about my hemophilia A story.
      • B2 Bradley O. has a hemophilia A success story to share.
      • C2 Bradley uses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • D2 Bradley uses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • E2 Bradley O. has an inspiring story to share about Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • F2 Bradley O. has an inspiring story to share about Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • G2 Bradley O. turned to his support team and asked a lot of questions.
      View / Download

      Handoff: November 1 2024

      Updated GA tagging, images already hosted from a previous handoff

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=H4H&utm_campaign=Inspire&utm_content=Sucessstory&utm_id=nmtDC00005947
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-flexibility-factor
      • esperoct-pt-flexibility-factor.html
      • US24ESP00081   October 2024
      • Last updated: 2024-10-17 21:08:01

      • Version: 3

      Subject Line
      • A1 Consider Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • A2 Check out Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • B1 Discover Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • B2 Have you heard about this flexibility factor?

      Preheader
      • A1 Could this treatment be right for you?
      • A2 Could this treatment be right for you?
      • B1 See how it might work for your lifestyle.
      • B2 See how it might work for your lifestyle.
      View / Download

      Handoff: October 17, 2024

      Updates still a work in progress, more edits still coming

      view
      Tracking
      •  
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-patient-bradley-la-kelley (Version for LA Kelley)
      • esperoct-patient-bradley-la-kelley.html
      • US22ESP00025   August 2022
      • Last updated: 2024-05-01 21:24:25

      • Version: 2

      Subject Line
      • A1 Hi, [Name]! I’m Bradley O.—and we may have something in common

      • B1 Where do you find inspiration?

      • C1 Bradley O. has an inspiring story to share

      • D1 Want to hear an inspiring story?

      • E1 A new home, a new beginning, and a different treatment

      • F1 Learn more about this advocate’s journey

      • G1 How do you make decisions about hemophilia A treatment?

      Preheader
      • A2 Learn more about my hemophilia A story.
      • B2 Bradley O. has a hemophilia A success story to share.
      • C2 Bradley uses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • D2 Bradley uses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • E2 Bradley O. has an inspiring story to share about Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • F2 Bradley O. has an inspiring story to share about Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • G2 Bradley O. turned to his support team and asked a lot of questions.
      View / Download

      Handoff: May, 1 2024

      (Version for LA Kelley, GA tagging updates, header/footer updates)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=LA&utm_campaign=Inspire&utm_content=Sucessstory&utm_id=nmtDC00005340
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-flexibility-factor
      • esperoct-hcp-flexibility-factor.html
      • US23ESP00012   September 2023
      • Last updated: 2023-11-07 22:44:12

      • Version: 5

      Subject Line
      • A1 Hemophilia A treatment that won’t hold them back

      • A2 It’s time to give this hemophilia A treatment another look

      • B1 Are your patients asking for more treatment flexibility?

      • B2 Your patients expect flexibility

      • C1 How important is portability for your patients?

      • C2 A treatment that goes where your patients go

      • D1 For wherever their day takes them.

      Preheader
      • A1 Flexibility for your patients’ busy lifestyles.
      • A2 Flexibility for your patients’ busy lifestyles.
      • B1 Consider this hemophilia A treatment.
      • B2 Consider this hemophilia A treatment.
      • C1 Prescribe the flexible hemophilia A treatment patients deserve.
      • C2 Prescribe the flexible hemophilia A treatment patients deserve.
      • D1 Make the switch to Esperoct® antihemophilic factor (recombinant) glycopegylated-exei.
      View / Download

      Handoff: September 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=Flexibility&utm_id=<%= message.delivery.deliverycode %>
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-least-switch-aways-h4h-header-2 (version for H4H)
      • esperoct-pt-least-switch-aways-h4h-header-2.html
      • US22ESP00032   July 2022
      • Last updated: 2023-10-06 10:20:14

      • Version: 1

      Subject Line
      • A1 Why does Bradley choose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]?

      • B1 Why do I choose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]?

      • C1 Which rFVIII treatment keeps up with this recent college grad?

      • D1 Bradley O. is starting his next chapter

      • E1 Why are people switching to this rFVIII?

      • F1 Considering hemophilia A treatment options?

      • G1 Bradley O. made the switch and he's sticking with it.

      Preheader
      • A2 There are several reasons why it's been the right rFVIII option for him.
      • B2 “There are several reasons why it's been the right rFVIII option for me.”
      • C2 Bradley O. chooses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • D2 He chooses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • E2 Here is why Bradley O. chose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • F2 Bradley O. made the switch and he's sticking with it.
      • G2 Learn more about why he chooses Esperoct® [antihemophilic factor(recombinant), glycopegylated-exei]
      View / Download

      Handoff: July 2022

      (GA Tagging update 10/06/23)

      view | download
      Tracking
      • (GA Tagging) ?utm_medium=email&utm_source=H4H&utm_campaign=Esperoct&utm_content=Sucessstory&utm_id=nmtDC00004172
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-temperature-stability-la-kelley (Version for LA Kelley)
      • esperoct-pt-temperature-stability-la-kelley.html
      • US21ESP00041   June 2021
      • Last updated: 2023-06-08 08:10:40

      • Version: 3

      Subject Line
      • A1 From coast to coast, discover the factor that can take the heat.

      • A2 When the weather heats up, can your factor handle it?

      • A3 How does your factor treatment handle hot temperatures?

      • A4 90°F in Alaska? 300 days of sun in the Northwest?

      • A5 From Hawaii to New York, we’re talking temperatures

      Preheader
      • A1 Get to know highest-storage temperature Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]
      • A2 Get to know highest-storage temperature Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]
      • A3 Discover the factor that handles temperatures over 86°F
      • A4 Discover the factor that handles temperatures up to 104°F
      • A5 Discover the factor that handles temperatures up to 104°F
      View / Download

      Handoff: June 2023

      (Added Version for LA Kelley)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=LA&utm_campaign=Tempstability&utm_content=Beyond86degrees&utm_id=nmtDC00003836
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-HCP-chowdary-email
      • esperoct-HCP-chowdary-email.html
      • US20ESP00078   July 2020
      • Last updated: 2023-05-22 19:28:49

      • Version: 25

      Subject Line
      • A1 Exciting PK data for this hemophilia A treatment

      • A2 Intriguing PK data for this hemophilia A treatment

      • B1 Hemophilia A treatment PK data for adults, adolescents, and children

      • B2 PK data for adults, adolescents, and children in this hemophilia A treatment

      Preheader
      • A1 View the data for Esperoct® (antihemophilic factor [recombinant], glycopegylated-exei).
      • A2 View the data for Esperoct® (antihemophilic factor [recombinant], glycopegylated-exei).
      • B1 See what prophylaxis can achieve.
      • B2 See what prophylaxis can achieve.
      View / Download

      Handoff: May 2023

      (Updated GA tagging, URLs, footer logo, and other misc. updates.)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=Efficacy&utm_id=<%= message.delivery.deliverycode %>
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-least-switch-aways-la-kelley (Version for LA Kelley)
      • esperoct-pt-least-switch-aways.html
      • US22ESP00032   July 2022
      • Last updated: 2022-01-30 15:42:48

      • Version: 1

      Subject Line
      • A1 Why does Bradley choose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]?

      • B1 Why do I choose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]?

      • C1 Which rFVIII treatment keeps up with this recent college grad?

      • D1 Bradley O. is starting his next chapter

      • E1 Why are people switching to this rFVIII?

      • F1 Considering hemophilia A treatment options?

      • G1 Bradley O. made the switch and he's sticking with it.

      Preheader
      • A2 There are several reasons why it's been the right rFVIII option for him.
      • B2 “There are several reasons why it's been the right rFVIII option for me.”
      • C2 Bradley O. chooses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • D2 He chooses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • E2 Here is why Bradley O. chose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • F2 Bradley O. made the switch and he's sticking with it.
      • G2 Learn more about why he chooses Esperoct® [antihemophilic factor(recombinant), glycopegylated-exei]
      View / Download

      Handoff: January 30, 2023

      (Added Version for LA Kelley)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=LA&utm_campaign=Inspire&utm_content=Sucessstory&utm_id=nmtDC00003553
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-post-hoc-analysis
      • esperoct-hcp-post-hoc-analysis.html
      • US22ESP00022   October 2022
      • Last updated: 2022-11-21 12:36:51

      • Version: 6

      Subject Line
      • A1 [NEW:] Post-hoc data analysis on Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • A2 [NEW:] Post-hoc data analysis on an EHL rFVIII treatment

      • B1 [NEW:] 5+ years of data on Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • B2 [NEW:] Data from a 5+ year clinical trial of a recombinant factor VIII product

      • C1 Long-term trial results for Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • C2 EHL rFVIII long-term clinical trial results

      Preheader
      • A1 Have you reviewed the [latest] findings?
      • A2 Have you reviewed the [latest] findings?
      • B1 Have you reviewed the [latest] long-term data?
      • B2 Have you reviewed the[latest] long-term data?
      • C1 See the data.
      • C2 See the data.
      View / Download

      Handoff: November 2022

      (Updated DOFU to October, Removed 2 instances of the word [NEW], Updated Preheader to remove the word [latest])

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=SHL+Switch&utm_medium=email&utm_source=NNI&utm_content=HCP+Resources&utm_id=EspAHE2AD_PostHoc_Nov22
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-least-switch-aways
      • esperoct-pt-least-switch-aways.html
      • US22ESP00032   July 2022
      • Last updated: 2022-11-15 23:39:48

      • Version: 13

      Subject Line
      • A1 Why does Bradley choose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]?

      • B1 Why do I choose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]?

      • C1 Which rFVIII treatment keeps up with this recent college grad?

      • D1 Bradley O. is starting his next chapter

      • E1 Why are people switching to this rFVIII?

      • F1 Considering hemophilia A treatment options?

      • G1 Bradley O. made the switch and he's sticking with it.

      Preheader
      • A2 There are several reasons why it's been the right rFVIII option for him.
      • B2 “There are several reasons why it's been the right rFVIII option for me.”
      • C2 Bradley O. chooses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • D2 He chooses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • E2 Here is why Bradley O. chose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • F2 Bradley O. made the switch and he's sticking with it.
      • G2 Learn more about why he chooses Esperoct® [antihemophilic factor(recombinant), glycopegylated-exei]
      View / Download

      Handoff: November 15, 2022

      (Added HTML comment tags to variable sections)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-n8-hcp-kogenate-switch
      • esperoct-n8-hcp-kogenate-switch.html
      • US22ESP00064   November 2022
      • Last updated: 2022-11-08 09:12:48

      • Version: 3

      Subject Line
      • A1 Kogenate® FS is being discontinued

      • B1 It’s time to consider a change for patients on Kogenate® FS

      • C1 Review treatment options for hemophilia A patients

      • D1 Seeking alternatives for your patients on Kogenate® FS?

      • E1 Kogenate® FS is being discontinued

      Preheader
      • A1 SHL and EHL rFVIII options for your hemophilia A patients.
      • B1 SHL and EHL rFVIII options for your hemophilia A patients.
      • C1 Help your patients make choices that fit their lifestyles.
      • D1 Help your hemophilia A patients make choices that fit their lifestyles.
      • E1 Make the switch with Novo Nordisk.
      View / Download

      Handoff: November 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=SHL+Switch&utm_medium=email&utm_source=NNI&utm_content=Kogenate&utm_id=EspAHE2AD_KogenateSwitch_Nov22
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-patient-bradley
      • esperoct-patient-bradley.html
      • US22ESP00025   August 2022
      • Last updated: 2022-08-30 22:41:46

      • Version: 1

      Subject Line
      • A1 Hi, [Name]! I’m Bradley O.—and we may have something in common

      • B1 Where do you find inspiration?

      • C1 Bradley O. has an inspiring story to share

      • D1 Want to hear an inspiring story?

      • E1 A new home, a new beginning, and a different treatment

      • F1 Learn more about this advocate’s journey

      • G1 How do you make decisions about hemophilia A treatment?

      Preheader
      • A2 Learn more about my hemophilia A story.
      • B2 Bradley O. has a hemophilia A success story to share.
      • C2 Bradley uses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • D2 Bradley uses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • E2 Bradley O. has an inspiring story to share about Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • F2 Bradley O. has an inspiring story to share about Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • G2 Bradley O. turned to his support team and asked a lot of questions.
      View / Download

      Handoff: August 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-fewest-switch-aways
      • esperoct-hcp-fewest-switch-aways.html
      • US22ESP00036   July 2022
      • Last updated: 2022-09-26 15:21:55

      • Version: 14

      Subject Line
      • A1 Your patients deserve more than standard

      • B1 Are your hemophilia A patients asking about their treatment options?

      • C1 More hemophilia A patients stay with this rFVIII treatment

      • D1 Fewer patients switch away from this rFVIII treatment

      • PHRASEE SUBJECT LINES

      • 1 This rFVIII treatment helped hemophilia A patients achieve these results ➡️ (U+27A1)

      • 2 How does this rFVIII treatment stack up against the competition?

      • 3 Learn more about the rFVIII treatment that's helping patients achieve high trough levels

      • 4 Have you considered this rFVIII treatment for your hemophilia A patients?

      Preheader
      • A2 More patients stay on this rFVIII treatment
      • B2 More patients stay on this rFVIII treatment
      • C2 Compare treatments for hemophilia A.
      • D2 Compare treatments for hemophilia A.
      View / Download

      Handoff: July 2022

      (Hero update to replace background image with foreground image, other misc. updates.)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=SHL+Switch&utm_medium=email&utm_source=NNI&utm_content=Efficacy&utm_id=EspAHE2AD_fewestswitch_Sep22
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-least-switch-aways-h4h-header-1
      • esperoct-pt-least-switch-aways-h4h-header-1.html
      • US22ESP00032   July 2022
      • Last updated: 2022-08-29 17:09:14

      • Version: 1

      Subject Line
      • A1 Why does Bradley choose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]?

      • B1 Why do I choose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]?

      • C1 Which rFVIII treatment keeps up with this recent college grad?

      • D1 Bradley O. is starting his next chapter

      • E1 Why are people switching to this rFVIII?

      • F1 Considering hemophilia A treatment options?

      • G1 Bradley O. made the switch and he's sticking with it.

      Preheader
      • A2 There are several reasons why it's been the right rFVIII option for him.
      • B2 “There are several reasons why it's been the right rFVIII option for me.”
      • C2 Bradley O. chooses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • D2 He chooses Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • E2 Here is why Bradley O. chose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • F2 Bradley O. made the switch and he's sticking with it.
      • G2 Learn more about why he chooses Esperoct® [antihemophilic factor(recombinant), glycopegylated-exei]
      View / Download

      Handoff: July 2022

      view | download
      Tracking
      • (Google Analytics) utm_medium=email utm_source=NNIO utm_campaign=Esperoct utm_content=Switch utm_id=nmtDC00002644
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-success-with-esperoct-la-kelley (LA Kelley Version)
      • esperoct-pt-success-with-esperoct-la-kelley.html
      • US21ESP00122   March 2022
      • Last updated: 2022-04-15 20:12:22

      • Version: 1

      Subject Line
      • A1 Inspire others with your hemophilia A story

      • A2 Ready to share your story?

      • B1 Tell us your hemophilia A story

      • B2 What’s your hemophilia A success story?

      Preheader
      • A1 Your experience may help the hemophilia A community.
      • A2 Learn more about reaching the hemophilia A community.
      • B1 Ready to inspire the hemophilia A community?
      • B2 Learn how to share your uniquely inspiring experience.
      View / Download

      Handoff: April 15, 2022

      (Channel Partner handoff for LA Kelley)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=LA%20Kelley&utm_campaign=Inspire&utm_content=Sucessstory&utm_id=nmtDC00002348
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-success-with-esperoct-h4h (Hope for Hemophilia Version)
      • esperoct-pt-success-with-esperoct-h4h.html
      • US21ESP00122   March 2022
      • Last updated: 2022-04-15 16:57:25

      • Version: 1

      Subject Line
      • A1 Inspire others with your hemophilia A story

      • A2 Ready to share your story?

      • B1 Tell us your hemophilia A story

      • B2 What’s your hemophilia A success story?

      Preheader
      • A1 Your experience may help the hemophilia A community.
      • A2 Learn more about reaching the hemophilia A community.
      • B1 Ready to inspire the hemophilia A community?
      • B2 Learn how to share your uniquely inspiring experience.
      View / Download

      Handoff: April 15, 2022

      (Channel Partner handoff for Hope for Hemophilia, with hosted images)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=H4H&utm_campaign=Inspire&utm_content=Sucessstory&utm_id=nmtDC00002347
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-persona-quiz
      • esperoct-pt-persona-quiz.html
      • US20ESP00141   April 2021
      • Last updated: 2022-05-10 11:28:03

      • Version: 5

      Subject Line
      • /-- Existing Partners --/

      • A1 [Name!] Your treatment personality can impact your hemophilia A journey

      • A2 Your treatment personality can impact your hemophilia A journey, [Name!]

      • B1 How can your treatment personality impact your hemophilia A journey?

      • B2 Your treatment personality impacts your hemophilia A journey

      • A3 Quiz! Learn how your treatment personality impacts your hemophilia A journey

      • B3 Learn how your treatment personality impacts your hemophilia A journey

      • /-- Channel Partners --/

      • A1 Your treatment personality can impact your hemophilia A journey

      • B1 How can your treatment personality impact your hemophilia A journey?

      • A2 Quiz! Discover your treatment personality and learn why it matters.

      • B2 Discover your treatment personality and learn why it matters in this quiz

      Preheader
      • /-- Existing Partners --/
      • A1 Take this quiz and learn how.
      • A2 Take this quiz and learn how.
      • B1 Take this quiz and learn more.
      • B2 Take this quiz and learn more.
      • A3 And get your personalized guide to treatment.
      • B3 And get your personalized guide to treatment.
      • /-- Channel Partners --/
      • A1 Take this quiz and see.
      • B1 Take this quiz and see.
      • A2 Receive your personalized guide to treatment.
      • B2 Receive your personalized guide to treatment.
      View / Download

      Handoff: May 10, 2022

      (Updates to replace NovoSecure with NovoCare in body copy, GA tagging, footer)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-success-with-esperoct
      • esperoct-pt-success-with-esperoct.html
      • US21ESP00122   March 2022
      • Last updated: 2022-03-10 23:58:42

      • Version: 2

      Subject Line
      • A1 Inspire others with your hemophilia A story

      • A2 Ready to share your story?

      • B1 Tell us your hemophilia A story

      • B2 What’s your hemophilia A success story?

      Preheader
      • A1 Your experience may help the hemophilia A community.
      • A2 Learn more about reaching the hemophilia A community.
      • B1 Ready to inspire the hemophilia A community?
      • B2 Learn how to share your uniquely inspiring experience.
      View / Download

      Handoff: March 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-meet-your-pathfinder-h4h
      • esperoct-pt-meet-your-pathfinder-h4h
      • US20ESP00095   April 2021
      • Last updated: 2022-02-07 10:02:03

      • Version: 1

      Subject Line
      • A1 Use a personalized discussion guide to talk with your doctor

      • A2 Talking to your doc about treatment? Get a discussion guide

      • B1 Why take this personality quiz?

      • B2 Quiz time! Take this 5-question hemophilia A personality quiz

      • C1 How do your personality traits impact your hemophilia A treatment?

      • C2 Could your personality traits impact how you manage your hemophilia A?

      Preheader
      • A1 Take our quick quiz to get your guide.
      • A2 Take our quick quiz to get your guide.
      • B1 Get a personalized discussion guide for hemophilia A.
      • B2 Get a personalized discussion guide for talking to your doctor.
      • C1 Find out with this quick quiz.
      • C2 Find out with this quick quiz.
      View / Download

      Handoff: 02/07/2022

      (Hope for Hemophilia version with hosted images)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=H4H&utm_campaign=Esperoct&utm_content=Pathfinder&utm_id=100002497&src=100002497
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-connect-with-hcl-refresh
      • esperoct-pt-connect-with-hcl-refresh.html
      • US21ESP00083   December 2021
      • Last updated: 2022-02-03 19:06:48

      • Version: 1

      Subject Line
      • A1 Get the personalized support you deserve

      • A2 [NAME], have you met your local HCL?

      • B1 Stay connected to the hemophilia A community

      • B2 Looking for new resources, [NAME]?

      • [NO ZIP CODE Available Subject Line Options below]

      • A1 Get the personalized support you deserve

      • A2 Have you met your local HCL?

      • B1 Stay connected to the hemophilia A community

      • B2 Looking for new resources?

      Preheader
      • A1 Our team can help, [NAME].
      • A2 Your Hemophilia Community Liaison is here for you.
      • B1 Our team is here to support you, [NAME].
      • B2 Meet your local Hemophilia Community Liaison.
      • [NO ZIP CODE Available Preheader Options below]
      • A1 Our team can help.
      • A2 Your Hemophilia Community Liaison is here for you.
      • B1 Our team is here to support you.
      • B2 Meet your local Hemophilia Community Liaison.
      View / Download

      Handoff: December 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-persona-quiz-la-kelly (Version for LA Kelly)
      • esperoct-pt-persona-quiz-la-kelly.html
      • US20ESP00141   April 2021
      • Last updated: 2021-10-28 10:22:03

      • Version: 4

      Subject Line
      • /-- Existing Partners --/

      • A1 [Name!] Your treatment personality can impact your hemophilia A journey

      • A2 Your treatment personality can impact your hemophilia A journey, [Name!]

      • B1 How can your treatment personality impact your hemophilia A journey?

      • B2 Your treatment personality impacts your hemophilia A journey

      • A3 Quiz! Learn how your treatment personality impacts your hemophilia A journey

      • B3 Learn how your treatment personality impacts your hemophilia A journey

      • /-- Channel Partners --/

      • A1 Your treatment personality can impact your hemophilia A journey

      • B1 How can your treatment personality impact your hemophilia A journey?

      • A2 Quiz! Discover your treatment personality and learn why it matters.

      • B2 Discover your treatment personality and learn why it matters in this quiz

      Preheader
      • /-- Existing Partners --/
      • A1 Take this quiz and learn how.
      • A2 Take this quiz and learn how.
      • B1 Take this quiz and learn more.
      • B2 Take this quiz and learn more.
      • A3 And get your personalized guide to treatment.
      • B3 And get your personalized guide to treatment.
      • /-- Channel Partners --/
      • A1 Take this quiz and see.
      • B1 Take this quiz and see.
      • A2 Receive your personalized guide to treatment.
      • B2 Receive your personalized guide to treatment.
      View / Download

      Handoff: October 28, 2021

      (Removed footer Unsubscribe language)

      view | download
      Tracking
      • (Google Analytics) ?utm_source=LA%20Kelly&utm_medium=Email&utm_campaign=acquisition&utm_term=US20ESP00141&utm_content=
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-three-ways
      • esperoct-hcp-three-ways.html
      • US21ESP00061   September 2021
      • Last updated: 2021-09-17 19:38:14

      • Version: 1

      Subject Line
      • A1 Why choose this hemophilia A treatment

      • B1 Why choose Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      • C1 Make a clear choice with Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

      Preheader
      • A2 See the latest data.
      • B2 See the latest data.
      • C2 Learn more about this treatment.
      View / Download

      Handoff: September 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=esperoct%20shlswch &utm_medium=email &utm_source=nniemail_th &utm_content=EffProphy
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-efficacy-across-age-groups-refresh-PDQ
      • esperoct-hcp-efficacy-across-age-groups-refresh-PDQ.html
      • US21ESP00047   June 2021
      • Last updated: 2021-07-12 13:20:35

      • Version: 1

      Subject Line
      • A1 Studies reveal the latest data for Esperoct antihemophilic factor (recombinant), glycopegylated-exei

      • B1 The latest trial data is available for Esperoct® antihemophilic factor (recombinant), glycopegylated-exei

      • A2 Studies reveal the latest data for an EHL product for hemophilia A

      • B2 The latest trial data is available for an EHL product for hemophilia A

      Preheader
      • A1 See the results from the clinical trials.
      • B1 Explore efficacy information for your patients.
      • A2 See the results from the clinical trials.
      • B2 Explore efficacy information for your patients.
      View / Download

      Handoff: July 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=esperoct%20shlswch &utm_medium=email &utm_source=nniemail_th &utm_content=EffProphy
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-efficacy-across-age-groups-refresh
      • esperoct-hcp-efficacy-across-age-groups-refresh.html
      • US21ESP00047   June 2021
      • Last updated: 2021-07-12 16:21:35

      • Version: 1

      Subject Line
      • A1 Studies reveal the latest data for Esperoct antihemophilic factor (recombinant), glycopegylated-exei

      • B1 The latest trial data is available for Esperoct® antihemophilic factor (recombinant), glycopegylated-exei

      • A2 Studies reveal the latest data for an EHL product for hemophilia A

      • B2 The latest trial data is available for an EHL product for hemophilia A

      Preheader
      • A1 See the results from the clinical trials.
      • B1 Explore efficacy information for your patients.
      • A2 See the results from the clinical trials.
      • B2 Explore efficacy information for your patients.
      View / Download

      Handoff: July 2021

      (Bold text copy fix)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=esperoct%20shlswch &utm_medium=email &utm_source=nniemail_th &utm_content=EffProphy
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-temperature-stability-H4H
      • esperoct-pt-temperature-stability-H4H.html
      • US21ESP00041   April 2022
      • Last updated: 2022-05-31 21:46:40

      • Version: 2

      Subject Line
      • A1 From coast to coast, discover the factor that can take the heat.

      • A2 When the weather heats up, can your factor handle it?

      • A3 How does your factor treatment handle hot temperatures?

      • A4 90°F in Alaska? 300 days of sun in the Northwest?

      • A5 From Hawaii to New York, we’re talking temperatures

      Preheader
      • A1 Get to know highest-storage temperature Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]
      • A2 Get to know highest-storage temperature Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]
      • A3 Discover the factor that handles temperatures over 86°F
      • A4 Discover the factor that handles temperatures up to 104°F
      • A5 Discover the factor that handles temperatures up to 104°F
      View / Download

      Handoff: April 2022 (Update, images hosted)

      view | download
      Tracking
      • utm_medium=email utm_source=H4H utm_campaign=Tempstability utm_content=Beyond86degrees utm_id=nmtDC00002349
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-temperature-stability
      • esperoct-pt-temperature-stability.html
      • US21ESP00041   June 2021
      • Last updated: 2021-06-11 21:46:40

      • Version: 3

      Subject Line
      • A1 From coast to coast, discover the factor that can take the heat.

      • A2 When the weather heats up, can your factor handle it?

      • A3 How does your factor treatment handle hot temperatures?

      • A4 90°F in Alaska? 300 days of sun in the Northwest?

      • A5 From Hawaii to New York, we’re talking temperatures

      Preheader
      • A1 Get to know highest-storage temperature Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]
      • A2 Get to know highest-storage temperature Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]
      • A3 Discover the factor that handles temperatures over 86°F
      • A4 Discover the factor that handles temperatures up to 104°F
      • A5 Discover the factor that handles temperatures up to 104°F
      View / Download

      Handoff: June 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-meet-your-pathfinder-lakelley
      • esperoct-pt-meet-your-pathfinder-lakelley.html
      • US20ESP00095   April 2021
      • Last updated: 2021-06-29 23:25:03

      • Version: 1

      Subject Line
      • A1 Use a personalized discussion guide to talk with your doctor

      • A2 Talking to your doc about treatment? Get a discussion guide

      • B1 Why take this personality quiz?

      • B2 Quiz time! Take this 5-question hemophilia A personality quiz

      • C1 How do your personality traits impact your hemophilia A treatment?

      • C2 Could your personality traits impact how you manage your hemophilia A?

      Preheader
      • A1 Take our quick quiz to get your guide.
      • A2 Take our quick quiz to get your guide.
      • B1 Get a personalized discussion guide for hemophilia A.
      • B2 Get a personalized discussion guide for talking to your doctor.
      • C1 Find out with this quick quiz.
      • C2 Find out with this quick quiz.
      View / Download

      Handoff: June 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_source=LAK &utm_medium=Email &utm_campaign=acquisition &utm_term=US20ESP00095
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-meet-your-pathfinder
      • esperoct-pt-meet-your-pathfinder.html
      • US20ESP00095   April 2021
      • Last updated: 2022-08-30 23:25:03

      • Version: 10

      Subject Line
      • A1 Use a personalized discussion guide to talk with your doctor

      • A2 Talking to your doc about treatment? Get a discussion guide

      • B1 Why take this personality quiz?

      • B2 Quiz time! Take this 5-question hemophilia A personality quiz

      • C1 How do your personality traits impact your hemophilia A treatment?

      • C2 Could your personality traits impact how you manage your hemophilia A?

      Preheader
      • A1 Take our quick quiz to get your guide.
      • A2 Take our quick quiz to get your guide.
      • B1 Get a personalized discussion guide for hemophilia A.
      • B2 Get a personalized discussion guide for talking to your doctor.
      • C1 Find out with this quick quiz.
      • C2 Find out with this quick quiz.
      View / Download

      Handoff: April 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-severe-to-mild-chapter-partner-2
      • esperoct-pt-severe-to-mild-chapter-partner-2.html
      • US20ESP00119   January 2021
      • Email on Acid
      • Last updated: 2021-3-11 21:09:24

      • Version: 1

      Subject Line
      • Patients

      • A1 [Name,] This Treatment Could Make a Difference for You

      • B1 [Name,] Could This Treatment Make A Difference for You?

      • A2 From Severe to Mild.

      • B2 From Severe to Mild. It’s Time for a Change.

      • A3 Severe, Moderate, or Mild?

      • B3 Severe, Moderate, or Mild. It’s Time for a Change.

      • Caregivers

      • A1 See What Could be Achieved with a Longer Half-life

      • B1 Could a Longer Half-life Help You Achieve High Factor Levels?

      • A2 [Name,] Could This Treatment Deliver the Change You Need?

      • B2 [Name,] This Factor Could Deliver the Change You Need

      • Channel Partners

      • A1 Mild, Moderate, or Severe?

      • B1 Mild, Moderate, or Severe? It’s Time for a Change

      • A2 Level Up Your Factor

      • B2 Time to Level Up

      Preheader
      • Patients
      • A1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • B1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • A2 See what you could achieve with this extended half-life treatment.
      • B2 See what you could achieve with this extended half-life treatment.
      • A3 See what you could achieve with this extended half-life treatment.
      • B3 See what you could achieve with this extended half-life treatment.
      • Caregivers
      • A1 Explore this treatment.
      • B1 Explore this treatment.
      • A2 Learn more about this extended half-life treatment now.
      • B2 Learn more about this extended half-life treatment now.
      • Channel Partners
      • A1 Explore this extended half-life therapy.
      • B1 Explore this extended half-life therapy.
      • A2 Explore this hemophilia A therapy now.
      • B2 Explore this hemophilia A therapy now.
      View / Download

      Handoff: February 2021

      view | download
      Tracking
      • (Google Analytics) ?campaign=Esperoct-SevereToMild&utm_campaign=Esperoct&utm_medium=email&utm_source=BDAI&utm_content=[CTA-Title]
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-severe-to-mild-chapter
      • esperoct-pt-severe-to-mild-chapter.html
      • US20ESP00119   January 2021
      • Email on Acid
      • Last updated: 2021-02-10 21:09:24

      • Version: 1

      Subject Line
      • Patients

      • A1 [Name,] This Treatment Could Make a Difference for You

      • B1 [Name,] Could This Treatment Make A Difference for You?

      • A2 From Severe to Mild.

      • B2 From Severe to Mild. It’s Time for a Change.

      • A3 Severe, Moderate, or Mild?

      • B3 Severe, Moderate, or Mild. It’s Time for a Change.

      • Caregivers

      • A1 See What Could be Achieved with a Longer Half-life

      • B1 Could a Longer Half-life Help You Achieve High Factor Levels?

      • A2 [Name,] Could This Treatment Deliver the Change You Need?

      • B2 [Name,] This Factor Could Deliver the Change You Need

      • Channel Partners

      • A1 Mild, Moderate, or Severe?

      • B1 Mild, Moderate, or Severe? It’s Time for a Change

      • A2 Level Up Your Factor

      • B2 Time to Level Up

      Preheader
      • Patients
      • A1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • B1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • A2 See what you could achieve with this extended half-life treatment.
      • B2 See what you could achieve with this extended half-life treatment.
      • A3 See what you could achieve with this extended half-life treatment.
      • B3 See what you could achieve with this extended half-life treatment.
      • Caregivers
      • A1 Explore this treatment.
      • B1 Explore this treatment.
      • A2 Learn more about this extended half-life treatment now.
      • B2 Learn more about this extended half-life treatment now.
      • Channel Partners
      • A1 Explore this extended half-life therapy.
      • B1 Explore this extended half-life therapy.
      • A2 Explore this hemophilia A therapy now.
      • B2 Explore this hemophilia A therapy now.
      View / Download

      Handoff: February 2021

      view | download
      Tracking
      • (Google Analytics) ?campaign=Esperoct-SevereToMild&utm_campaign=Esperoct&utm_medium=email&utm_source=chapter&utm_content=[CTA-Title]
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-severe-to-mild
      • esperoct-pt-severe-to-mild.html
      • US20ESP00119   January 2021
      • Email on Acid
      • Last updated: 2020-12-17 21:09:24

      • Version: 4

      Subject Line
      • Patients

      • A1 [Name,] This Treatment Could Make a Difference for You

      • B1 [Name,] Could This Treatment Make A Difference for You?

      • A2 From Severe to Mild.

      • B2 From Severe to Mild. It’s Time for a Change.

      • A3 Severe, Moderate, or Mild?

      • B3 Severe, Moderate, or Mild. It’s Time for a Change.

      • Caregivers

      • A1 See What Could be Achieved with a Longer Half-life

      • B1 Could a Longer Half-life Help You Achieve High Factor Levels?

      • A2 [Name,] Could This Treatment Deliver the Change You Need?

      • B2 [Name,] This Factor Could Deliver the Change You Need

      • Channel Partners

      • A1 Mild, Moderate, or Severe?

      • B1 Mild, Moderate, or Severe? It’s Time for a Change

      • A2 Level Up Your Factor

      • B2 Time to Level Up

      Preheader
      • Patients
      • A1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • B1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • A2 See what you could achieve with this extended half-life treatment.
      • B2 See what you could achieve with this extended half-life treatment.
      • A3 See what you could achieve with this extended half-life treatment.
      • B3 See what you could achieve with this extended half-life treatment.
      • Caregivers
      • A1 Explore this treatment.
      • B1 Explore this treatment.
      • A2 Learn more about this extended half-life treatment now.
      • B2 Learn more about this extended half-life treatment now.
      • Channel Partners
      • A1 Explore this extended half-life therapy.
      • B1 Explore this extended half-life therapy.
      • A2 Explore this hemophilia A therapy now.
      • B2 Explore this hemophilia A therapy now.
      View / Download

      Handoff: January 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-pt-severe-to-mild-la-kelly
      • esperoct-pt-severe-to-mild-la-kelly.html
      • US20ESP00119   January 2021
      • Email on Acid
      • Last updated: 2020-12-17 21:09:24

      • Version: 4

      Subject Line
      • Patients

      • A1 [Name,] This Treatment Could Make a Difference for You

      • B1 [Name,] Could This Treatment Make A Difference for You?

      • A2 From Severe to Mild.

      • B2 From Severe to Mild. It’s Time for a Change.

      • A3 Severe, Moderate, or Mild?

      • B3 Severe, Moderate, or Mild. It’s Time for a Change.

      • Caregivers

      • A1 See What Could be Achieved with a Longer Half-life

      • B1 Could a Longer Half-life Help You Achieve High Factor Levels?

      • A2 [Name,] Could This Treatment Deliver the Change You Need?

      • B2 [Name,] This Factor Could Deliver the Change You Need

      • Channel Partners

      • A1 Mild, Moderate, or Severe?

      • B1 Mild, Moderate, or Severe? It’s Time for a Change

      • A2 Level Up Your Factor

      • B2 Time to Level Up

      Preheader
      • Patients
      • A1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • B1 Explore Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei].
      • A2 See what you could achieve with this extended half-life treatment.
      • B2 See what you could achieve with this extended half-life treatment.
      • A3 See what you could achieve with this extended half-life treatment.
      • B3 See what you could achieve with this extended half-life treatment.
      • Caregivers
      • A1 Explore this treatment.
      • B1 Explore this treatment.
      • A2 Learn more about this extended half-life treatment now.
      • B2 Learn more about this extended half-life treatment now.
      • Channel Partners
      • A1 Explore this extended half-life therapy.
      • B1 Explore this extended half-life therapy.
      • A2 Explore this hemophilia A therapy now.
      • B2 Explore this hemophilia A therapy now.
      View / Download

      Handoff: January 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN &utm_medium=TRACKING_MEDIUM &utm_source=TRACKING_SOURCE &utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-longest-largest-pdq
      • esperoct-hcp-longest-largest-pdq.html
      • US20ESP00054   December 2020
      • Last updated: 2021-03-12 22:22:09

      • Version: 1

      Subject Line
      • Existing Partners

      • A1 Learn why this hemophilia A clinical trial is different

      • B1 This hemophilia A clinical trial is different; learn why

      • Channel Partners

      • A1 Explore the results of this hemophilia A clinical trial

      • B1 Discover the results of this hemophilia A clinical trial

      • A2 Help your hemophilia A patients chart their treatment course

      • B2 Help your hemophilia A patients chart a different treatment course

      Preheader
      • Existing Partners
      • A1 Explore the results and see how they could impact your patients.
      • B1 Explore the results and see how they could impact your patients.
      • Channel Partners
      • A1 Learn how your hemophilia A patients could benefit.
      • B1 Learn how your hemophilia A patients could benefit.
      • A2 Explore the results of this clinical study.
      • B2 Explore the results of this clinical study.
      View / Download

      Handoff: March 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_source=pdq_th&utm_medium=email&utm_content=Longest_Largest_Trial&utm_campaign=esperoct%20shlswch
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-longest-largest
      • esperoct-hcp-longest-largest.html
      • US20ESP00054   December 2020
      • Last updated: 2021-01-04 22:22:09

      • Version: 4

      Subject Line
      • Existing Partners

      • A1 Learn why this hemophilia A clinical trial is different

      • B1 This hemophilia A clinical trial is different; learn why

      • Channel Partners

      • A1 Explore the results of this hemophilia A clinical trial

      • B1 Discover the results of this hemophilia A clinical trial

      • A2 Help your hemophilia A patients chart their treatment course

      • B2 Help your hemophilia A patients chart a different treatment course

      Preheader
      • Existing Partners
      • A1 Explore the results and see how they could impact your patients.
      • B1 Explore the results and see how they could impact your patients.
      • Channel Partners
      • A1 Learn how your hemophilia A patients could benefit.
      • B1 Learn how your hemophilia A patients could benefit.
      • A2 Explore the results of this clinical study.
      • B2 Explore the results of this clinical study.
      View / Download

      Handoff: December 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=esperoct%20shlswch &utm_medium=email &utm_source=nniemail_th &utm_content=Longest_Largest_Clinical_Trial
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-kol-video-option-b
      • esperoct-hcp-kol-video-option-b.html
      • US20ESP00091   October 2020
      • Last updated: 2020-10-21 19:05:00

      • Version: 4

      Subject Line
      • A1 KOL Dr. Tami Singleton prescribes this EHL for her hemophilia A patients

      • A2 Could your hemophilia A patients benefit from a different treatment?

      • A3 See why specialist Dr. Singleton prescribes this EHL hemophilia A therapy

      • B1 Video: KOL Dr. Tami Singleton prescribes this EHL for her hemophilia A patients

      • B2 Your hemophilia A patient’s may benefit from a different treatment

      • B3 See why KOL Dr. Singleton prescribes this EHL hemophilia A therapy

      • Channel partners alternatives

      • A1 KOL Dr. Singleton prescribes this EHL for her hemophilia A patients

      • A2 Could your hemophilia A patients benefit from a different treatment?

      • B1 Video: KOL Dr. Singleton prescribes this EHL for her hemophilia A patients

      • B2 Your hemophilia A patient’s may benefit from a different treatment

      Preheader
      • A1 Learn why.
      • A2 Video: Learn why an KOL Dr. Tami Singleton prescribes this EHL.
      • A3 Chief of Pediatric Hematology and HTC Director explains the benefits of this rFVIII.
      • B1 Learn why.
      • B2 Video: Learn why an KOL Dr. Singleton prescribes this EHL.
      • B3 Chief of Pediatric Hematology and HTC Director explains the benefits of this rFVIII.
      • Channel partners alternatives
      • A1 Learn why.
      • A2 Video: Learn why an KOL Dr. Singleton prescribes this EHL.
      • B1 Learn why.
      • B2 Video: Learn why an KOL Dr. Singleton prescribes this EHL.
      View / Download

      Handoff: October 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=esperoct%20esp20keymess &utm_medium=email &utm_source=nniemail_th &utm_content=KOL_Video_Email
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-kol-video-pdq
      • esperoct-hcp-kol-video-pdq.html
      • US20ESP00091   October 2020
      • Last updated: 2021-1-29 11:11:01

      • Version: 1

      Subject Line
      • A1 KOL Dr. Tami Singleton prescribes this EHL for her hemophilia A patients

      • A2 Could your hemophilia A patients benefit from a different treatment?

      • A3 See why specialist Dr. Singleton prescribes this EHL hemophilia A therapy

      • B1 Video: KOL Dr. Tami Singleton prescribes this EHL for her hemophilia A patients

      • B2 Your hemophilia A patient’s may benefit from a different treatment

      • B3 See why KOL Dr. Singleton prescribes this EHL hemophilia A therapy

      • Channel partners alternatives

      • A1 KOL Dr. Singleton prescribes this EHL for her hemophilia A patients

      • A2 Could your hemophilia A patients benefit from a different treatment?

      • B1 Video: KOL Dr. Singleton prescribes this EHL for her hemophilia A patients

      • B2 Your hemophilia A patient’s may benefit from a different treatment

      Preheader
      • A1 Learn why.
      • A2 Video: Learn why an KOL Dr. Tami Singleton prescribes this EHL.
      • A3 Chief of Pediatric Hematology and HTC Director explains the benefits of this rFVIII.
      • B1 Learn why.
      • B2 Video: Learn why an KOL Dr. Singleton prescribes this EHL.
      • B3 Chief of Pediatric Hematology and HTC Director explains the benefits of this rFVIII.
      • Channel partners alternatives
      • A1 Learn why.
      • A2 Video: Learn why an KOL Dr. Singleton prescribes this EHL.
      • B1 Learn why.
      • B2 Video: Learn why an KOL Dr. Singleton prescribes this EHL.
      View / Download

      Handoff: January 2021

      view | download
      Tracking
      • (Google Analytics) ?utm_source=pdq_th&utm_medium=email&utm_content=KOL_Video&utm_campaign=esperoct%20shlswch
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-kol-video
      • esperoct-hcp-kol-video.html
      • US20ESP00091   October 2020
      • Last updated: 2020-10-21 19:09:01

      • Version: 5

      Subject Line
      • A1 KOL Dr. Tami Singleton prescribes this EHL for her hemophilia A patients

      • A2 Could your hemophilia A patients benefit from a different treatment?

      • A3 See why specialist Dr. Singleton prescribes this EHL hemophilia A therapy

      • B1 Video: KOL Dr. Tami Singleton prescribes this EHL for her hemophilia A patients

      • B2 Your hemophilia A patient’s may benefit from a different treatment

      • B3 See why KOL Dr. Singleton prescribes this EHL hemophilia A therapy

      • Channel partners alternatives

      • A1 KOL Dr. Singleton prescribes this EHL for her hemophilia A patients

      • A2 Could your hemophilia A patients benefit from a different treatment?

      • B1 Video: KOL Dr. Singleton prescribes this EHL for her hemophilia A patients

      • B2 Your hemophilia A patient’s may benefit from a different treatment

      Preheader
      • A1 Learn why.
      • A2 Video: Learn why an KOL Dr. Tami Singleton prescribes this EHL.
      • A3 Chief of Pediatric Hematology and HTC Director explains the benefits of this rFVIII.
      • B1 Learn why.
      • B2 Video: Learn why an KOL Dr. Singleton prescribes this EHL.
      • B3 Chief of Pediatric Hematology and HTC Director explains the benefits of this rFVIII.
      • Channel partners alternatives
      • A1 Learn why.
      • A2 Video: Learn why an KOL Dr. Singleton prescribes this EHL.
      • B1 Learn why.
      • B2 Video: Learn why an KOL Dr. Singleton prescribes this EHL.
      View / Download

      Handoff: October 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=esperoct%20esp20keymess &utm_medium=email &utm_source=nniemail_th &utm_content=KOL_Video_Email
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-rep-to-hcp-kol-outlook
      • esperoct-rep-to-hcp-kol-outlook.html
      • US20ESP00092   September 2020
      • Last updated: 2020-10-09 12:31:09

      • Version: 3

      Subject Line
      • A1 A prescriber’s perspective on an extended half-life rFVIII

      • A2 Video: Prescriber’s perspective on an extended half-life rFVIII

      • B1 KOL Dr. Tami Singleton presents thoughts on an EHL rFVIII

      • B2 Dr. Tami Singleton presents her thoughts on an EHL rFVIII

      Preheader
      View / Download

      Handoff: September 2020

      view | download

      Without the youtube link:

      download
      Tracking
      • (Google Analytics) ?utm_source=nniemail_th &utm_medium=email &utm_content=GT Diagnostic Outlook &utm_campaign=novoseven%20n720hcprsrcs
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • esperoct-hcp-new-patients
      • esperoct-hcp-new-patients.html
      • US20ESP00053   September 2020
      • Email on Acid
      • Last updated: 2020-09-04 15:52:07

      • Version: 3

      Subject Line
      • A1 Resources to help your hemophilia A patients along their journey

      • A2 Get resources for your hemophilia A patients

      • B1 Having virtual or in-office visits? We’ve got resources for you, either way

      • B2 Whether your visits are virtual or in-office, we’ve got resources to help

      Preheader
      • A1 See the support offered with this hemophilia A treatment.
      • A2 See the support offered with this hemophilia A treatment.
      • B1 Learn about the patient support resources with this hemophilia A treatment
      • B2 Learn about the patient support resources with this hemophilia A treatment
      View / Download

      Handoff: September 2020

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=esperoct%20esp20patsprt &utm_medium=email &utm_source=nniemail_th &utm_content=New%20PT%20Onboarding
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • rm-template-hcp
      • rm-template-hcp.html
      • US19ESP00150   April 2020
      • Last updated: 2020-07-01 18:24:39

      • Version: 0

      Subject Line
      • A1 Subject Line One

      • A2 Subject Line Two

      • B1 Subject Line Three

      Preheader
      • A1 Preheader Line One.
      • A2 Preheader Line Two.
      • B1 Preheader Line Three.
      View / Download

      Handoff: April 2020

      view
      Tracking
      • (Google Analytics) ?utm_campaign=esperoct &utm_medium=email &utm_source=nniemail_th &utm_content=announcement
      novosecure Emails
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • ns-hemago-sunset
      • rm-template-hcp.html
      • US20HRBD00266   November 2020
      • Last updated: 2020-10-27 15:55:46

      • Version: 1

      Subject Line
      • HemaGo™ is going away soon

      • HemaGo™ will no longer be available in 30 days

      • Please download your data from the HemaGo™ app today

      Preheader
      • N/A
      View / Download

      Handoff: October 27, 2020

      view | download
      Unbranded Emails
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • microhealth-patient-email-h4h-12-2025   (Version for Hope for Hemophilia with updated GA tagging (December 2025))
      • microhealth-patient-email-h4h-12-2025.html
      • US23HRBD00132   September 2024
      • Last updated: 2025-11-24 20:04:45

      • Version: 3

      Subject Line
      • A) This hemophilia app keeps track of the details

      • B) Did you know there’s an app for tracking bleeds?

      • C) Have you tried Microhealth for tracking your bleeds?

      • D) Living with hemophilia? Try this useful app

      Preheader
      • A) Safe and secure, Microhealth can track your treatment details using your smartphone.
      • B) With Microhealth, you can log bleeds, set reminders, or DM your doctor — all from your phone.
      • C) The safe, secure mobile app was designed to serve those living with a bleeding disorder.
      • D) Microhealth has features that help you track each step of your treatment.
      View / Download

      Handoff: November 24, 2025

      (Version for Hope for Hemophilia with updated GA tagging (December 2025))

      view | download
      Tracking
      • (GA) ?utm_campaign=APP+Download&utm_medium=email&utm_source=H4H&utm_content=microhealthbenefits&utm_id=nmtDC00008261
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • microhealth-patient-email-ches-12-2025   (Version for CHES with updated GA tagging (December 2025))
      • microhealth-patient-email-ches-12-2025.html
      • US23HRBD00132   September 2024
      • Last updated: 2025-11-24 21:10:58

      • Version: 3

      Subject Line
      • A) This hemophilia app keeps track of the details

      • B) Did you know there’s an app for tracking bleeds?

      • C) Have you tried Microhealth for tracking your bleeds?

      • D) Living with hemophilia? Try this useful app

      Preheader
      • A) Safe and secure, Microhealth can track your treatment details using your smartphone.
      • B) With Microhealth, you can log bleeds, set reminders, or DM your doctor — all from your phone.
      • C) The safe, secure mobile app was designed to serve those living with a bleeding disorder.
      • D) Microhealth has features that help you track each step of your treatment.
      View / Download

      Handoff: November 24, 2025

      (Version for CHES with updated GA tagging (December 2025))

      view | download
      Tracking
      • (GA) ?utm_campaign=APP+Download&utm_medium=email&utm_source=CEFD&utm_content=microhealthbenefits&utm_id=nmtDC00008262
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • microhealth-patient-email-chb   (Newer version for Coalition for Hemophilia B with updated GA tagging)
      • microhealth-patient-email-chb.html
      • US23HRBD00132   September 2024
      • Last updated: 2025-10-13 21:37:33

      • Version: 6

      Subject Line
      • A) This hemophilia app keeps track of the details

      • B) Did you know there’s an app for tracking bleeds?

      • C) Have you tried Microhealth for tracking your bleeds?

      • D) Living with hemophilia? Try this useful app

      Preheader
      • A) Safe and secure, Microhealth can track your treatment details using your smartphone.
      • B) With Microhealth, you can log bleeds, set reminders, or DM your doctor — all from your phone.
      • C) The safe, secure mobile app was designed to serve those living with a bleeding disorder.
      • D) Microhealth has features that help you track each step of your treatment.
      View / Download

      Handoff: October 10, 2025

      (Newer version for Coalition for Hemophilia B with updated GA tagging)

      view | download
      Tracking
      • No Tracking
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • microhealth-patient-email-ches   (Newer version for CHES with updated GA tagging)
      • microhealth-patient-email-ches.html
      • US23HRBD00132   September 2024
      • Last updated: 2025-10-10 20:29:03

      • Version: 4

      Subject Line
      • A) This hemophilia app keeps track of the details

      • B) Did you know there’s an app for tracking bleeds?

      • C) Have you tried Microhealth for tracking your bleeds?

      • D) Living with hemophilia? Try this useful app

      Preheader
      • A) Safe and secure, Microhealth can track your treatment details using your smartphone.
      • B) With Microhealth, you can log bleeds, set reminders, or DM your doctor — all from your phone.
      • C) The safe, secure mobile app was designed to serve those living with a bleeding disorder.
      • D) Microhealth has features that help you track each step of your treatment.
      View / Download

      Handoff: October 10, 2025

      (Newer version for CHES with updated GA tagging)

      view | download
      Tracking
      • (GA) ?utm_campaign=APP+Download&utm_medium=email&utm_source=CEFD&utm_content=microhealthbenefits&utm_id=nmtDC00007968
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • microhealth-patient-email-h4h   (Newer version for Hope for Hemophilia with updated GA tagging)
      • microhealth-patient-email-h4h.html
      • US23HRBD00132   September 2024
      • Last updated: 2025-10-10 18:13:45

      • Version: 3

      Subject Line
      • A) This hemophilia app keeps track of the details

      • B) Did you know there’s an app for tracking bleeds?

      • C) Have you tried Microhealth for tracking your bleeds?

      • D) Living with hemophilia? Try this useful app

      Preheader
      • A) Safe and secure, Microhealth can track your treatment details using your smartphone.
      • B) With Microhealth, you can log bleeds, set reminders, or DM your doctor — all from your phone.
      • C) The safe, secure mobile app was designed to serve those living with a bleeding disorder.
      • D) Microhealth has features that help you track each step of your treatment.
      View / Download

      Handoff: October 10, 2025

      (Newer version for Hope for Hemophilia with updated GA tagging)

      view | download
      Tracking
      • (GA) ?utm_campaign=APP+Download&utm_medium=email&utm_source=H4H&utm_content=microhealthbenefits&utm_id=nmtDC00007967
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • microhealth-hcp-email
      • microhealth-hcp-email.html
      • US24HRBD00063   September 2024
      • Last updated: 2024-10-02 15:54:29

      • Version: 3

      Subject Line
      • A) Have you heard about Microhealth?

      • B) A tracking app for your patients with hemophilia

      • C) Want to help your patients better keep track of their bleeds?

      • D) Keep track of your patients who are using the Microhealth mobile app

      Preheader
      • A) This mobile tracking app for patients with hemophilia offers benefits for providers too.
      • B) Patients use Microhealth to log bleeds and infusions; providers use it to view patients’ treatment journey.
      • C) With Microhealth, providers can use the app to view patient bleed and infusion data.
      • D) Review your patient's treatment details and message them directly from your dashboard.
      View / Download

      Handoff: October 2, 2024

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=Conferences&utm_content=MicroHealth+Benefits&utm_id=RBD_MicrohealthApp
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-turn-the-tide-refresh-not-signedup-chb (Version for CHB)
      • unbranded-patient-turn-the-tide-refresh-not-signedup-chb.html
      • US23HRBD00110   December 2023
      • Last updated: 2024-09-24 23:31:37

      • Version: 3

      Subject Line
      • A1 Managing hemophilia can feel like riding a wave of uncertainty

      • A2 Managing hemophilia isn’t easy

      • A3 Are you struggling to manage hemophilia?

      • B1 If you’re struggling, you’re not alone

      • B2 Explore hemophilia survey data

      Preheader
      • A1 Alternate approaches are being researched…
      • A2 Alternate approaches are being researched…
      • A3 Alternate approaches are being researched…
      • B1 Discover helpful educational resources fit for you.
      • B2 Discover helpful educational resources fit for you.
      View / Download

      Handoff: September 25, 2024

      (Version for CHB, GA tagging update, Hosted images, header/footer updates.)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CHB&utm_campaign=TTT_Launch&utm_content=Research&utm_id=nmtDC00005839
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-turn-the-tide-refresh-not-signedup-la-kelley (Version for LA Kelley)
      • unbranded-patient-turn-the-tide-refresh-not-signedup-la-kelley.html
      • US23HRBD00110   December 2023
      • Last updated: 2024-09-24 15:54:23

      • Version: 4

      Subject Line
      • A1 Managing hemophilia can feel like riding a wave of uncertainty

      • A2 Managing hemophilia isn’t easy

      • A3 Are you struggling to manage hemophilia?

      • B1 If you’re struggling, you’re not alone

      • B2 Explore hemophilia survey data

      Preheader
      • A1 Alternate approaches are being researched…
      • A2 Alternate approaches are being researched…
      • A3 Alternate approaches are being researched…
      • B1 Discover helpful educational resources fit for you.
      • B2 Discover helpful educational resources fit for you.
      View / Download

      Handoff: September 24, 2024

      (Version for LA Kelley, GA tagging updates)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=LA&utm_campaign=TTT_Launch&utm_content=Research&utm_id=nmtDC00005848
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • microhealth-patient-email
      • microhealth-patient-email.html
      • US23HRBD00132   September 2024
      • Last updated: 2024-09-20 17:34:50

      • Version: 2

      Subject Line
      • A) This hemophilia app keeps track of the details

      • B) Did you know there’s an app for tracking bleeds?

      • C) Have you tried Microhealth for tracking your bleeds?

      • D) Living with hemophilia? Try this useful app

      Preheader
      • A) Safe and secure, Microhealth can track your treatment details using your smartphone.
      • B) With Microhealth, you can log bleeds, set reminders, or DM your doctor — all from your phone.
      • C) The safe, secure mobile app was designed to serve those living with a bleeding disorder.
      • D) Microhealth has features that help you track each step of your treatment.
      View / Download

      Handoff: September 2024

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-bleed-id-ches (Version for CHES)
      • unbranded-patient-bleed-id-ches.html
      • US22NSVN00026   November 2022
      • Last updated: 2024-08-21 09:33:20

      • Version: 9

      Subject Line
      • A1 Identify bleeds with the [new] Bleed ID tool!

      • A2 [NEW:] Have you tried the Bleed ID tool?

      • B1 Ready to learn how to recognize bleeds?

      • B2 Do you know all the signs and symptoms of bleeds?

      • B3 Identifying bleeds quickly is important

      • C1 Why is it important to identify bleeds urgently?

      Preheader
      • A1 Let us help you learn how to recognize when a bleed happens.
      • A2 Be prepared to identify bleeds.
      • B1 Try the [new] Bleed ID tool.
      • B2 We have a [new] Bleed ID tool to prepare you.
      • B3 Discover the [new] Bleed ID tool.
      • C1 Learn more with the [new] bleed identification tool.
      View / Download

      Handoff: August 21, 2024

      (Version for CHES, GA tagging updates, updated HCL photo)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CEFD&utm_campaign=BleedID&utm_content=BleedID&utm_id=nmtDC00005652
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-turn-the-tide-refresh-signedup-la-kelley (Version for LA Kelley)
      • unbranded-patient-turn-the-tide-refresh-signedup-la-kelley.html
      • US23HRBD00110   July 2024
      • Last updated: 2024-07-26 20:05:14

      • Version: 2

      Subject Line
      • A1 Managing hemophilia can feel like riding a wave of uncertainty

      • A2 Managing hemophilia isn’t easy

      • A3 Are you struggling to manage hemophilia?

      • B1 If you’re struggling, you’re not alone

      • B2 Explore hemophilia survey data

      Preheader
      • A1 Alternate approaches are being researched…
      • A2 Alternate approaches are being researched…
      • A3 Alternate approaches are being researched…
      • B1 Discover helpful educational resources fit for you.
      • B2 Discover helpful educational resources fit for you.
      View / Download

      Handoff: July 26, 2024

      (Version for LA Kelley, GA tagging updates, footer updates)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=LA&utm_campaign=TTT_Launch&utm_content=turnthetide&utm_id=nmtDC00005604
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-hcp-turn-the-tide-welcome
      • unbranded-hcp-turn-the-tide-welcome.html
      • US23HRBD00136   March 2024
      • Last updated: 2024-07-30 15:48:14

      • Version: 3

      Subject Line
      • SL1 Thanks for signing up

      • SL2 You signed up to, “Turn the Tide in Hemophilia”

      • SL3 You signed up for hemophilia updates

      Preheader
      • PH1 When is it time to turn the tide in hemophilia?
      • PH2 Look out for hemophilia updates.
      • PH3 We’re here for you and your patients.
      View / Download

      Handoff: July 30, 2024

      Updated logo URL

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=welcome&utm_id=<%= message.delivery.deliverycode %>
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-hcp-turn-the-tide-01
      • unbranded-hcp-turn-the-tide-01.html
      • US22HRBD00221   April 2023
      • Last updated: 2024-06-19 22:00:55

      • Version: 8

      Subject Line
      • A1 Isn’t it time to turn the tide in hemophilia?

      • A2 See the results of a new patient survey in hemophilia

      • B1 A new survey offers insight into patients’ hemophilia experiences

      • B2 New data offers insight into patients’ hemophilia experiences

      • C1 New data illustrates patients’ hemophilia experiences

      • C2 New data illustrates patients’ hemophilia experiences

      Preheader
      • A1 There’s new data on patients’ experiences.
      • A2 There’s new data on patients’ experiences.
      • B1 And there’s new research into alternate approaches to coagulation.
      • B2 And there’s new research into alternate approaches to coagulation.
      • C1 There’s also new research into alternate approaches to coagulation.
      • C2 See specifics about patient challenges
      View / Download

      Handoff: April 2023

      June 20, 2024
      - Sign Up URL Updates
      - small QA updates

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=turnthetide&utm_id=<%= message.delivery.deliverycode %>
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-turn-the-tide-refresh-not-signedup-h4h (Version for H4H Not Signed Up)
      • unbranded-patient-turn-the-tide-refresh-not-signedup-h4h.html
      • US23HRBD00110   December 2023
      • Last updated: 2024-04-09 23:27:32

      • Version: 1

      Subject Line
      • A1 Managing hemophilia can feel like riding a wave of uncertainty

      • A2 Managing hemophilia isn’t easy

      • A3 Are you struggling to manage hemophilia?

      • B1 If you’re struggling, you’re not alone

      • B2 Explore hemophilia survey data

      Preheader
      • A1 Alternate approaches are being researched…
      • A2 Alternate approaches are being researched…
      • A3 Alternate approaches are being researched…
      • B1 Discover helpful educational resources fit for you.
      • B2 Discover helpful educational resources fit for you.
      View / Download

      Handoff: April 9, 2023

      (Version for H4H Not Signed Up)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-turn-the-tide-refresh-signedup-h4h (Version for H4H Signed Up)
      • unbranded-patient-turn-the-tide-refresh-signedup-h4h.html
      • US23HRBD00110   December 2023
      • Last updated: 2024-04-09 20:17:40

      • Version: 7

      Subject Line
      • A1 Managing hemophilia can feel like riding a wave of uncertainty

      • A2 Managing hemophilia isn’t easy

      • A3 Are you struggling to manage hemophilia?

      • B1 If you’re struggling, you’re not alone

      • B2 Explore hemophilia survey data

      Preheader
      • A1 Alternate approaches are being researched…
      • A2 Alternate approaches are being researched…
      • A3 Alternate approaches are being researched…
      • B1 Discover helpful educational resources fit for you.
      • B2 Discover helpful educational resources fit for you.
      View / Download

      Handoff: April 9, 2024

      (Version for H4H Signed Up)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-turn-the-tide-refresh-not-signedup-ches (Version for CHES Not Signed Up)
      • unbranded-patient-turn-the-tide-refresh-not-signedup-ches.html
      • US23HRBD00110   December 2023
      • Last updated: 2024-03-26 17:57:08

      • Version: 5

      Subject Line
      • A1 Managing hemophilia can feel like riding a wave of uncertainty

      • A2 Managing hemophilia isn’t easy

      • A3 Are you struggling to manage hemophilia?

      • B1 If you’re struggling, you’re not alone

      • B2 Explore hemophilia survey data

      Preheader
      • A1 Alternate approaches are being researched…
      • A2 Alternate approaches are being researched…
      • A3 Alternate approaches are being researched…
      • B1 Discover helpful educational resources fit for you.
      • B2 Discover helpful educational resources fit for you.
      View / Download

      Handoff: March 26, 2024

      (Version for CHES Not Signed Up)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CEFD&utm_campaign=TTT_Launch&utm_content=turnthetide&utm_id=nmtDC00004953
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-turn-the-tide-refresh-signedup-ches (Version for CHES Signed Up)
      • unbranded-patient-turn-the-tide-refresh-signedup-ches.html
      • US23HRBD00110   December 2023
      • Last updated: 2024-03-25 13:01:48

      • Version: 7

      Subject Line
      • A1 Managing hemophilia can feel like riding a wave of uncertainty

      • A2 Managing hemophilia isn’t easy

      • A3 Are you struggling to manage hemophilia?

      • B1 If you’re struggling, you’re not alone

      • B2 Explore hemophilia survey data

      Preheader
      • A1 Alternate approaches are being researched…
      • A2 Alternate approaches are being researched…
      • A3 Alternate approaches are being researched…
      • B1 Discover helpful educational resources fit for you.
      • B2 Discover helpful educational resources fit for you.
      View / Download

      Handoff: March 26, 2024

      (Version for CHES Signed Up)

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=CEFD&utm_campaign=TTT_Launch&utm_content=turnthetide&utm_id=nmtDC00004953
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-hcp-turn-the-tide-refresh-pdq (PDQ, also removed Get Updates and Sign Up Banners)
      • unbranded-hcp-turn-the-tide-refresh-pdq.html
      • US23HCP00114   December 2023
      • Last updated: 2024-03-20 18:32:53

      • Version: 6

      Subject Line
      • A1 There's more data on patients' experiences.

      • A2 See the results of a patient survey in hemophilia

      • B1 Exciting developments in hemophilia research

      • B2 Exciting developments in hemophilia research

      • C1 A survey offers insight into patients' hemophilia experiences

      • C2 Intriguing data offers insight into patients' hemophilia experiences

      • D1 Updated data illustrates patients' hemophilia experiences

      • D2 Updated data illustrates patients' hemophilia experiences

      Preheader
      • A1 Isn't it time to turn the tide in hemophilia?
      • A2 There's more data on patients' experiences.
      • B1 Scientists are researching approaches to the coagulation cascade.
      • B2 Have you seen research on the coagulation cascade?
      • C1 And there's research into alternate approaches to coagulation.
      • C2 And there's research into alternate approaches to coagulation.
      • D1 There's also research into alternate approaches to coagulation.
      • D2 See specifics about patient challenges.
      View / Download

      Handoff: March 20, 2024

      (Version for PDQ, also removed Get Updates and Sign Up Banners)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=email&utm_source=ADBE&utm_content=turnthetide
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-turn-the-tide-refresh-signedup
      • unbranded-patient-turn-the-tide-refresh-signedup.html
      • US23HRBD00110   December 2023
      • Last updated: 2024-02-07 17:15:48

      • Version: 7

      Subject Line
      • A1 Managing hemophilia can feel like riding a wave of uncertainty

      • A2 Managing hemophilia isn’t easy

      • A3 Are you struggling to manage hemophilia?

      • B1 If you’re struggling, you’re not alone

      • B2 Explore hemophilia survey data

      Preheader
      • A1 Alternate approaches are being researched…
      • A2 Alternate approaches are being researched…
      • A3 Alternate approaches are being researched…
      • B1 Discover helpful educational resources fit for you.
      • B2 Discover helpful educational resources fit for you.
      View / Download

      Handoff: December 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=email&utm_source=ADBE&utm_content=Registration
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-turn-the-tide-refresh-not-signedup
      • unbranded-patient-turn-the-tide-refresh-not-signedup.html
      • US23HRBD00110   December 2023
      • Last updated: 2024-02-08 20:22:17

      • Version: 9

      Subject Line
      • A1 Managing hemophilia can feel like riding a wave of uncertainty

      • A2 Managing hemophilia isn’t easy

      • A3 Are you struggling to manage hemophilia?

      • B1 If you’re struggling, you’re not alone

      • B2 Explore hemophilia survey data

      Preheader
      • A1 Alternate approaches are being researched…
      • A2 Alternate approaches are being researched…
      • A3 Alternate approaches are being researched…
      • B1 Discover helpful educational resources fit for you.
      • B2 Discover helpful educational resources fit for you.
      View / Download

      Handoff: December 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=email&utm_source=ADBE&utm_content=Registration
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-hcp-turn-the-tide-refresh
      • unbranded-hcp-turn-the-tide-refresh.html
      • US23HCP00114   December 2023
      • Last updated: 2024-02-06 20:59:14

      • Version: 19

      Subject Line
      • A1 There's more data on patients' experiences.

      • A2 See the results of a patient survey in hemophilia

      • B1 Exciting developments in hemophilia research

      • B2 Exciting developments in hemophilia research

      • C1 A survey offers insight into patients' hemophilia experiences

      • C2 Intriguing data offers insight into patients' hemophilia experiences

      • D1 Updated data illustrates patients' hemophilia experiences

      • D2 Updated data illustrates patients' hemophilia experiences

      Preheader
      • A1 Isn't it time to turn the tide in hemophilia?
      • A2 There's more data on patients' experiences.
      • B1 Scientists are researching approaches to the coagulation cascade.
      • B2 Have you seen research on the coagulation cascade?
      • C1 And there's research into alternate approaches to coagulation.
      • C2 And there's research into alternate approaches to coagulation.
      • D1 There's also research into alternate approaches to coagulation.
      • D2 See specifics about patient challenges.
      View / Download

      Handoff: December 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=email&utm_source=ADBE&utm_content=turnthetide
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-hcp-turn-the-tide-02
      • unbranded-hcp-turn-the-tide-02.html
      • US22HRBD00222   April 2023
      • Last updated: 2023-05-30 16:57:02

      • Version: 5

      Subject Line
      • A1 Big news in hemophilia research

      • A2 Big news in hemophilia research

      • B1 Different approaches to the coagulation cascade are being researched

      • B2 Alternative approaches to the coagulation cascade are being researched

      • C1 Interesting new hemophilia research is being conducted

      • C2 Compelling new hemophilia research is being conducted

      Preheader
      • A1 Scientists are researching different approaches to the coagulation cascade.
      • A2 The coagulation cascade, and different approaches to it, are being researched.
      • B1 And there’s new data about patients’ hemophilia experiences, too.
      • B2 And there’s new data about patients’ hemophilia experiences, too.
      • C1 Also, a new survey illustrates patients’ hemophilia experiences.
      • C2 Also, a new survey illustrates patients’ hemophilia experiences.
      View / Download

      Handoff: April 2023

      view | download
      Tracking
      • (Google Analytics) ?utm_medium=email&utm_source=ADBE&utm_campaign=<%= message.delivery.operation.label %>&utm_content=turnthetide&utm_id=<%= message.delivery.deliverycode %>
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-bleed-id(N7 Patient Journey CHAwI)
      • unbranded-patient-bleed-id.html
      • US22NSVN00026   November 2022
      • Last updated: 2023-03-16 17:07:13

      • Version: 8

      Subject Line
      • A1 [Name:] Identify bleeds with the [new] Bleed ID tool!

      • A2 [NEW:] Have you tried the Bleed ID tool?

      • B1 [Name:] Ready to learn how to recognize bleeds?

      • B2 Do you know all the signs and symptoms of bleeds?

      • B3 Identifying bleeds quickly is important

      • C1 Why is it important to identify bleeds urgently?

      Preheader
      • A1 Let us help you learn how to recognize when a bleed happens.
      • A2 Be prepared to identify bleeds.
      • B1 Try the [new] Bleed ID tool.
      • B2 We have a [new] Bleed ID tool to prepare you.
      • B3 Discover the [new] Bleed ID tool.
      • C1 Learn more with the [new] bleed identification tool.
      View / Download

      Handoff: November 2022

      (N7 Patient Journey CHAwI)

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-hem-b-conference
      • unbranded-patient-hem-b-conference.html
      • US23HRBD00010   February 2023
      • Last updated: 2023-02-06 20:02:28

      • Version: 2

      Subject Line
      • A1 Novo Nordisk would like to meet you. Stop by booth #25!

      • A2 Going to the Coalition for Hemophilia B symposium?

      • B1 We’ll be at the Coalition for Hemophilia B symposium. Will you?

      • B2 Will we see you March 16-19 in Orlando?

      Preheader
      • A1 You could meet your local Hemophilia Community Liaison (HCL)!
      • A2 Stop by the Novo Nordisk booth #25 to connect with your local representative!
      • B1 Come see us or learn other ways to connect with our helpful resources.
      • B2 Come see us or learn other ways to connect with our helpful resources.
      View / Download

      Handoff: February 2023

      view | download
      Tracking
      • (Google Analytics) N/A
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-bleed-id-la-kelley
      • unbranded-patient-bleed-id-la-kelley.html
      • US22NSVN00026   November 2022
      • Last updated: 2024-06-25 16:38:57

      • Version: 4

      Subject Line
      • A1 [Name:] Identify bleeds with the [new] Bleed ID tool!

      • A2 [NEW:] Have you tried the Bleed ID tool?

      • B1 [Name:] Ready to learn how to recognize bleeds?

      • B2 Do you know all the signs and symptoms of bleeds?

      • B3 Identifying bleeds quickly is important

      • C1 Why is it important to identify bleeds urgently?

      Preheader
      • A1 Let us help you learn how to recognize when a bleed happens.
      • A2 Be prepared to identify bleeds.
      • B1 Try the [new] Bleed ID tool.
      • B2 We have a [new] Bleed ID tool to prepare you.
      • B3 Discover the [new] Bleed ID tool.
      • C1 Learn more with the [new] bleed identification tool.
      View / Download

      Handoff: November 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=BleedID&utm_medium=email&utm_source=LA&utm_content=BleedID&utm_id=nmtDC00005550
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • unbranded-patient-urgency-to-treat
      • unbranded-patient-urgency-to-treat.html
      • US22HRBD00175   September 2022
      • Last updated: 2022-10-05 15:27:18

      • Version: 1

      Subject Line
      • A1 Get the personalized support you deserve.

      • A2 [NAME], have you met your HCL?

      • B1 Stay connected to the bleeding disorders community.

      • B2 Looking for new resources, [NAME]?

      Preheader
      • A1 Our team can help, [NAME].
      • A2 Your Hemophilia Community Liaison is here for you.
      • B1 Our team is here to support you, [NAME].
      • B2 Meet your local Hemophilia Community Liaison.
      View / Download

      Handoff: September 2022

      view | download
      Tracking
      • (Google Analytics) ?utm_campaign=TRACKING_CAMPAIGN&utm_medium=TRACKING_MEDIUM&utm_source=TRACKING_SOURCE&utm_content=TRACKING_CONTENT
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • Outlook Template Files (Batch 3)
      • nni-hcp-bio-rep-jennifer-m-outlook / US21HCP00020 / March 2021
      • nni-hcp-bio-rep-schlander-outlook / US21HCP00019 / March 2021
      • nni-hcp-bio-rep-sherry-d-outlook / US21HRBD00032 / March 2021
      • nni-hcp-bio-rep-thomas-outlook / US21HRBD00031 / March 2021
      • Last updated: 2021-03-10 9:24:46

      • Version: 1

      Subject Line
      • Meeting request: Let’s discuss how I can best support you and your patients

      • I’d like to introduce myself as your Hemophilia Institutional Account Manager

      • Hi, I’m [Rep Name]. I look forward to supporting you as your Hemophilia Institutional Account Manager.

      • Meeting request: I’d like to introduce myself as your Hemophilia Institutional Account Manager

      Preheader
      • N/A
      View / Download

      Handoff: March 10, 2021


      jennifer m | view | download

      schlander | view | download

      sherry d | view | download

      thomas | view | download

      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • Outlook Template Files (Batch 2)
      • nni-hcp-bio-rep-eric-m-outlook / US20HRBD00288 / January 2021
      • nni-hcp-bio-rep-erik-w-outlook / US20HRBD00289 / January 2021
      • nni-hcp-bio-rep-matt-outlook / US20HRBD00290 / January 2021
      • nni-hcp-bio-rep-jennifer-b-outlook / US20HRBD00291 / January 2021
      • nni-hcp-bio-rep-kelly-outlook / US20HRBD00292 / January 2021
      • nni-hcp-bio-rep-donna-outlook / US20HRBD00293 / January 2021
      • nni-hcp-bio-rep-christine-outlook / US20HRBD00294 / October 2020
      • nni-hcp-bio-rep-carmen-outlook / US20HRBD00295 / January 2021
      • nni-hcp-bio-rep-maureen-outlook / US20HRBD00296 / January 2021
      • nni-hcp-bio-rep-troy-outlook / US20HRBD00297 / January 2021
      • nni-hcp-bio-rep-gary-outlook / US20HRBD00298 / January 2021
      • Last updated: 2021-01-19 9:24:46

      • Version: 1

      Subject Line
      • Meeting request: Let’s discuss how I can best support you and your patients

      • I’d like to introduce myself as your Hemophilia Institutional Account Manager

      • Hi, I’m [Rep Name]. I look forward to supporting you as your Hemophilia Institutional Account Manager.

      • Meeting request: I’d like to introduce myself as your Hemophilia Institutional Account Manager

      Preheader
      • N/A
      View / Download

      Handoff: January 19, 2021


      eric m | view | download

      erik w | view | download

      matt | view | download

      jennifer b | view | download

      kelly | view | download

      donna | view | download

      christine | view | download

      carmen | view | download

      maureen | view | download

      troy | view | download

      gary | view | download

      Title / HTML Filename / PRB# Dissemination Date / Litmus
      Subject Line
      Preheader
      View / Download
      Title / HTML Filename / PRB# Dissemination Date / Litmus
      • Outlook Template Files
      • nni-hcp-bio-rep-brian-outlook / US20HCP00079 / October 2020
      • nni-hcp-bio-rep-jennifer-outlook / US20HCP00080 / October 2020
      • nni-hcp-bio-rep-rachel-outlook / US20HCP00081 / October 2020
      • nni-hcp-bio-rep-sonia-outlook / US20HCP00082 / October 2020
      • Last updated: 2020-10-20 16:05:46

      • Version: 1

      Subject Line
      • Meeting request: Let’s discuss how I can best support you and your patients

      • I’d like to introduce myself as your Hemophilia Therapy Manager

      • Hi, I’m [Rep Name]. I look forward to supporting you as your Hemophilia Therapy Manager.

      • Meeting request: I’d like to introduce myself as your Hemophilia Therapy Manager

      Preheader
      • N/A
      View / Download

      Handoff: October 20 2020


      brian | view | download

      jennifer | view | download

      rachel | view | download

      sonia | view | download
      cglife.com